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Abstract 
The human gut microbiota contributes to host health and wellbeing in numerous ways, 
including through polysaccharide fermentation and the production of beneficial short chain 
fatty acids. Microbiota accessible carbohydrates (MACs) pass through the early digestive tract 
intact to nourish the microbiota. 
 
Fructans are plant derived fructose polymers found in the diet which act as MACs and elevate 
short chain fatty acid production. Two linkage types are known between fructose units within 
fructans, β2-1 and β2-6; homopolymers of these are inulin and levan respectively. Fructan 
structures containing both β2-1 and β2-6 linkages are common within the human diet, but the 
role of these as MACs have not been studied. Fructan, particularly inulin and fructo-
oligosaccharides (FOS) have been used as prebiotics to selectively support beneficial 
members of the microbiota. Despite widespread use of inulin as a prebiotic there is a paucity 
of data regarding the mechanisms employed by the microbiota to recognise, import and 
degrade this glycan. 
 
In this thesis, several plant derived fructan extracts were visualised using high performance 
anion exchange chromatography and thin layer chromatography to confirm these contained 
non-linear structures. We show that these non-linear structures may support both inulin- and 
levan- utilising Bacteroides species, despite previously identified mutually exclusivity for one 
of the two homopolymers. 
 
Two key inulin using species were chosen as models to probe inulin utilisation within the 
microbiota; the Gram negative Bacteroides ovatus, and the Gram positive Bifidobacterium 
adolescentis.  
 
B. ovatus is a prominent member of the healthy human microbiota, and contains a large 
number of polysaccharide utilisation loci within the genome, each tightly regulated and 
specific for a selected glycan. Here we show that B. ovatus encodes an inulin utilisation 
system which includes an endo-acting surface located glycoside hydrolase family 91 enzyme 
comprised of two gene products (BACOVA_04502 and BACOVA_04503). This enzyme has 
an appended Carbohydrate Binding Module (CBM) which recognises inulin. SusC/D-
homologue pairs are carbohydrate binding and import proteins commonly found within the 
Bacteroidetes phylum. The structure of a SusD-homologue, BACOVA_04504 was solved and 
we demonstrate that this protein recognises sucrose terminated FOS and inulin, an unusual 
specificity which likely assists in the rapid import of desirable short chain FOS though a SusC-
homologue. High molecular weight inulin is imported through a SusC-homologue for 
periplasmic degradation by a glycoside hydrolase family 32 enzyme (GH32). A waste sugar, 
di-fructose anhydride (DFA), is produced by this system from inulin and released into the 
intestinal environment; we demonstrate that DFA is produced from inulin by faecal 
microbiota from three healthy humans and that DFA is not subsequently broken down. 
 
B. adolescentis is able to rapidly utilise inulin polysaccharide, an unusual phenotype amongst 
Bifidobacterium, which generally utilise only short chain FOS, Indeed it has been shown that 
B. adolescentis is supported well during prebiotic treatment. We demonstrate that B. 
adolescentis contains an additional locus compared with other Bifidobacterium species and 
that this locus is responsible for inulin utilisation. The locus includes an inulin recognising 
extracellular solute binding protein which undergoes a significant conformational change 
upon ligand recognition which we show through structural studies. The locus contains a LacI-
homologue which is able to recognise fructan through the periplasmic binding domain, likely 
to up-regulate the system; and inulin is finally processed internally by a GH32. 
 
We explore the niches occupied by each species in the intestine, and predict that B. ovatus 
“shares” glycan with other microbiota, including members of the bifidobacterium genus. Our 
data enable deeper understanding of how fructans interact with the intestinal microbiota, 
potentially underpinning research into novel and personalised prebiotic therapies. 
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Glossary of Terms and Abbreviations
BACOVA_#:  
Locus tag within the Bacteroides 
ovatus genome 
 
BAD_#:  
Locus tag within the Bifidobacterium 
adolescentis genome 
 
Cazyme:  
Carbohydrate Active Enzyme 
 
CBM:  
Carbohydrate binding module 
 
Cq:  
Quantification cycle, the cycle at which 
signal exceeds noise in qPCR 
experiments. 
 
DP:  
Degree of polymerisation (e.g. chain 
length) 
 
DFA:  
Di-fructose anhydride, a small sugar 
 
DFA-FOS:  
Fructooligosaccharide with a di-
fructose anhydride terminus 
 
ESBP:  
Extracellular Solute Binding Protein 
 
FPLC: 
Fast protein liquid chromatography 
 
FOS:   
Fructooligosaccharide 
 
Fructotriose:  
β2-1 linked fructose trisaccharide  
(Fβ2-1Fβ2-1F) 
 
GH:  
Glycoside hydrolase 
 
G.I. Tract:  
Gastro-intestinal tract 
 
 
 
HEPES:  
4-(2-Hydroxyethyl) piperazine-1-
ethanesulfonic acid, used as a buffering 
agent. 
HPAEC-PAD:  
High performance anion exchange 
chromatography with pulsed 
amperometric detection 
 
HMW:  
High molecular weight (generally 
greater than DP > 8) 
 
ITC:  
Isothermal titration calorimetry; used 
for analysing protein-protein or 
protein-substrate binding. 
 
Kestose:  
Trisaccharide with a terminal Sucrose 
and a β2-1 linked fructose (Gα1-2βFβ2-
1F) 
 
Kestotetraose:   
Tetrasaccharide with a terminal 
Sucrose and two β2-1 linked fructose 
units 
(Gα1-2βFβ2-1Fβ2-1F) 
 
Kestopentaose:   
Pentasaccharide with a terminal 
Sucrose and three β2-1 linked fructose 
units 
(Gα1-2βFβ2-1Fβ2-1Fβ2-1F) 
 
Ka:   
Association constant 
 
Kcat:   
Enzyme turnover; the number of 
molecules of product formed per unit 
of time. 
 
Kd:   
Dissociation constant 
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Km:   
The Michaelis constant, which 
provides an indication of affinity 
 
LMW:   
Low molecular weight (generally fewer 
than DP < 8)  
 
MACs:  
Microbiota Accessible Carbohydrates 
 
Metabolomics:  
Study of the total metabolite content of 
a system 
 
Microbiome:  
The study of the collective genes, 
genomes or an aspect of a microbial 
community, particularly associated 
with humans (e.g. the gut microbiome).  
 
Microbiota: 
A community/population of microbes 
within a specific environment. 
 
MALDI-TOF MS:  
Matrix-assisted laser 
desorption/ionization-time of flight 
mass spectrometry, used to measure the 
mass of small compounds 
 
OD:    
Optical density 
 
PBP:   
Periplasmic Binding Protein 
 
 
PCR:   
Polymerase chain reaction, used to 
amplify DNA 
 
PUL:   
Polysaccharide utilisation loci 
 
Prebiotic:   
Non-living agent used to modulate 
microbiota (usually a carbohydrate) 
 
Probiotic:  
Living agent used to modulate the 
microbiota (usually a native microbial 
species) 
 
qPCR:  
quantitative real-time polymerase chain 
reaction, used to detect and quantify 
specific DNA regions 
 
SDS-PAGE:   
Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis; 
used to separate and visualise proteins 
 
SUS:   
Starch utilisation system 
 
SusA-G:   
Proteins within the prototypic SUS 
 
TLC:  
Thin layer chromatography; used to 
separate and visualise sugars 
 
Vmax:  
The maximum rate (e.g. of an enzyme)
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Chapter 1. Introduction 
 
1.1. Exploring the Healthy Human Gut Microbiota 
1.1.1.  Introduction 
Humans did not arise from within a sterile environment; our relationship with 
microbes is not passive, but intricate and integral to our health and well-being. 
Viable micro-environments on and inside of the human body, such as the skin, 
urogenital tract and digestive tract, are colonised by specialised microbial 
communities (Figure 1.1; Lasken & McLean, 2014). The largest microbial 
populations are established within the human large intestine, estimated to harbour 
1011-1012 cells/ml (Qin et al., 2010; Ley et al., 2006).  
 
The advent of cheaper, high throughput sequencing techniques in the early 2000s 
led to an explosion of available genome sequences; for the first time, detailed 
exploration of the human microbiota as a whole could be undertaken, where 
previously only microbes which could be cultured could be studied. Indeed the 
cost of sequencing still declines as automated methods improve (Metzker, 2010). 
In addition to the identification of thousands of novel genes from intestinal 
microbes, sequencing can now be used to evaluate the bacterial diversity and 
abundance within complex samples without the need for culturing, through 
shotgun metagenomic sequencing, multiple displacement amplification and 16S 
classification. It is these pioneering techniques which have facilitated the 
expansion of research into understanding the microbiota. Whilst powerful, these 
techniques are still developing and researchers must be vigilant and employ well-
informed sampling techniques to avoid artificially skewing the data (Walker et al., 
2015). 
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Figure 1.1. The human body is colonised by specialised microbial communities 
(Lasken & McLean, 2014).  Bacterial diversity (relative abundance) across body sites 
was determined using single cell multiple displacement amplification (a PCR independent 
amplification technique) and subsequent classification of resultant 16S sequences (Lasken 
& McLean, 2014). 
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The microbiome refers to the collective microbial genomes within an individual 
or body site and may also be used to describe the collective action of these genes 
(e.g. during fermentation). The Human Microbiome Project (HMP) was 
established in 2008 with the general aim of characterising the human microbiome, 
including the gut microbiome. 
 
One of the original goals of the HMP is to discover whether there is a core set of 
genes in all healthy individuals, referred to as the “core microbiome” (Figure 1.2; 
Turnbaugh et al., 2007).  
Figure 1.2. The concept of the core human microbiome (Turnbaugh et al., 2007). 
This diagram demonstrates the concept of the core human microbiome (red), the 
collective subset of genes encoded by microbiota across all or the majority of healthy 
humans. Depending on the personalised microbial community of each individual, which 
is influenced by the environmental and internal factors listed, a variable or personalised 
microbiome will arise (blue). The gradient and two-way arrows indicate the relative 
plasticity of the human microbiome compared to the human genome – core genes may 
become superfluous, and genes from the variable microbiome may become part of the 
core subset as humans and their endogenous populations evolve (Turnbaugh et al., 2007). 
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The concept of a core microbiome allows for the identification of genes or 
pathways which are vital to human health and therefore could underpin novel 
therapeutics aimed at maintaining or establishing healthy microbial communities. 
 
The search for a core microbiome has proven difficult however, with healthy 
individuals displaying highly diverse microbial communities. The MetaHIT study 
in 2011 identified three global varieties, or enterotypes, of the healthy human gut 
microbiota. These enterotypes (1-3) were identified by variations in the 
prominence of three genera, Bacteroides, Prevotella and Ruminococcus 
respectively. The authors concluded that microbial diversity in healthy individuals 
was therefore stratified rather than continuous (Figure 1.3; Arumugam et al., 
2011); however, it is argued that classifying the intestinal microbiota in this 
manner is an oversimplification of continuous diversity between individuals 
(Knights et al., 2014). 
Figure 1.3. Three enterotypes of the human gut microbiota (Arumugam et al., 2011). 
The three enterotypes identified by Arumugam et al. can be identified by variations in the 
abundance of three genera Bacteroides (green), Prevotella (red) and Ruminococcus 
(blue). Enterotype 1 is rich in Bacteroides, enterotype 2 in Prevotella and enterotype 3 in 
Ruminococcus. Enterotype 2 displays reduced representation of Bacteroides and 
Ruminococcus whilst the other two enterotypes maintain larger populations of all three 
genera (Arumugam et al., 2011). 
 
1.1.2. Production of Short Chain Fatty Acids and Other 
Metabolites 
As the gut microbiota ferment nutrients, metabolites are released which interact 
with other microbes and the host. The study of the total metabolite content across 
a whole system is known as “metabolomics”.  
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Metabolites can affect the host in a systemic manner; conventionally raised mice 
contained more blood plasma metabolites than germ free mice, and in over 10% 
of metabolites significantly different concentration were observed between the 
germ free and conventional mice (Wikoff et al., 2009). Since the establishment of 
metabolomics as a useful research tool further studies have sought to identify 
metabolite biomarkers for health or disease, and to further understand how the 
metabolome changes over the course of life or during an illness. 
 
Short Chain Fatty Acids (SCFAs) are the main metabolites produced by the 
microbiota upon glycan fermentation. Three SCFAs; acetate, butyrate and 
propionate (typically in a 3:1:1 ratio) are found with a combined concentration of 
50-150 mM in the bowel (Louis et al., 2014). Butyrate producers include 
members of the Firmicutes such as Roseburia spp.; propionate is mainly produced 
by Bacteroidetes (e.g. Bacteroides spp.) during glycan degradation and by 
Firmicutes from succinate or lactate. However two distinct propionate producing 
pathways (the acrylate and propanediol pathways) have also recently been 
identified in gut bacteria (Reichardt et al., 2014). Acetate is the most abundant 
SCFA and is produced by either acetogenic bacteria such as Blautia 
hydrogenotrophica from H2 and CO2 or from formate (Miller & Wolin, 1996) or 
as an additional fermentation product by most of the microbiota (Louis et al., 
2014). SCFAs beneficially affect host physiology in a number of ways.  
Acetate was identified as a factor in the prevention of enteropathogenic infection 
through stimulation of epithelial cells (Fukuda et al., 2011). Butyrate is the 
preferred source of energy for the intestinal epithelium (Roediger, 1980).  
 
All major SCFAs and lactate have been implicated in reducing inflammation in 
the intestinal epithelium through extensive interactions with the host immune 
system (Figure 1.4; Hoeppli et al., 2015; Iraporda et al., 2015; Chang et al., 
2014; Smith et al., 2013) and both butyrate and propionate have been implicated 
in reducing the risk of colorectal cancer (Singh et al., 2014; Fung et al., 2012), 
regulating intestinal gluconeogenesis (Brüssow & Parkinson, 2014) and 
improving satiety (Arora et al., 2011; Hosseini et al., 2011). 
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Figure 1.4. SCFA and Polysaccharide A (PSA) produced by microbial fermentation 
influence the host immune system (Hoeppli et al., 2015). In their recent review Hoeppli 
and colleagues outline the presently known and suspected (?) interactions between 
SCFAs and regulatory T cells (Treg). The authors included PSA, a capsular glycan 
produced by Bacteroides fragilis with established therapeutic effects (Mazmanian et al., 
2008; Hoeppli et al., 2015)  
 
Not all metabolites are beneficial however; the degradation of protein, fat and 
ethanol by the microbiota can produce harmful reactive oxygen species (ROS) 
and other toxic or carcinogenic compounds (Figure 1.5; Louis et al., 2014). 
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Figure 1.5. A summary of major microbial metabolites and the known effect of these 
compounds on the host with regards to the initiation and/or progression of 
colorectal cancer (Louis et al., 2014). Microbial metabolites including SCFAs can have 
a therapeutic effect on the host with regard to colorectal cancer (shown in blue). Other 
metabolites may have carcinogenic effects (shown in red). Understanding the interplay 
between microbial metabolites and cancer will underpin the design of novel therapeutics 
and the identification of metabolite biomarkers (Louis et al., 2014). 
 
 
 
 
 
 8 
1.1.3.  Diversity of the Human Gut Microbiota 
Identifying a “core human microbiome” or distinct gut microbiota enterotypes 
could be a useful tool for categorising microbial diversity in order to distinguish 
between individuals or between healthy and diseased states, however these 
classifications do not give a full picture of the normal human microbial variation 
and remain controversial.  
 
During the study Arumugan and colleagues compared the metagenomes from 39 
individuals of 6 nationalities. The abundance of microbes at the genus level were 
plotted for the 30 most abundance genera (Figure 1.6.) showing that Bacteroides 
were highly prominent, and dominated representation of the Bacteroidetes 
phylum. By contrast, members of the Firmicutes phylum are more diverse at the 
genus level. Actinobacteria are also prominent, represented by two genera 
including the third most abundant genera, Bifidobacterium.  
Figure 1.6. Abundance of the thirty most prominent genera across 39 healthy 
individuals (Arumugan et al., 2011). The thirty most abundant genera by number of 
reads, shown as box plots. Inset: Abundance breakdown at the phylum level. Genus and 
phylum level abundances were calculated using reference genome based mapping using 
85% and 65% cutoffs, respectively (Arumugan et al., 2011). 
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Another large scale study performed by the HMP examined multiple body sites 
across 242 healthy American adults to create microbial diversity profiles for each 
body habitat.  The researchers looked for correlations between microbial variance 
and host phenotype (e.g. weight, age and ethnicity). Whilst some distinct 
correlations were shown; age for example appears to affect the microbial 
composition, particularly on the skin, the variance between subjects could not be 
satisfactorily explained by the phenotypic metadata alone.  
Within the stool samples the Bacteroides genus was most abundant when 16S 
classification was used (Huttenhower et al., 2012). 
 
Both the MetaHIT and HMP studies used stool samples as a proxy for intestinal 
microbial diversity. Stool sampling is a robust and non-invasive method to 
retrieve microbial populations from the distal gut, however these samples are not 
representative of the length of the tract, which is likely to harbour a variety of 
ecological niches and therefore differing communities along its length. As the 
procedure for sample harvest on internal sites is invasive, studies observing 
population diversity across the length of the G.I. tract have been undertaken in 
animal models. Mice display an increase in phylogenetic diversity in the early and 
late G.I. tract (gastric, duodenal; cecum, colon and faeces) compared to the mid 
tract (jejunum and ileum) where total diversity dropped (Gu et al., 2013). The 
authors noted that despite large between subject variability the Bacilli class, 
Lactobacillaceae family and Lactobaccilus genus were enriched in gastric and 
small intestine samples, and in contrast the Clostridia class and the 
Lachnospiraceae, Ruminococcaceae, Prevotellaceae, Rikenellaceae and 
Bacteroidaceae families were enriched in the large intestinal and faecal samples. 
The authors speculate that this observation is due to changes in the availability of 
oxygen along the intestinal tract, based on the facultative and obligate natures of 
observed bacteria (Gu et al., 2013). Similar changes in microbial diversity have 
also been observed along the pig G.I. tract, where a shift in the dominant phyla 
(Firmicute rich to Bacteroidetes rich) occurs from the early to late tract (Kim & 
Isaacson, 2015).  
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1.1.4.  The Infant Microbiota 
The infant is colonised by microbes rapidly, with some evidence to suggest 
colonisation initially takes place in utero (Aagaard et al., 2014; Funkhouser & 
Bordenstein, 2013). After delivery, environmental microbes are key colonisers 
(Penders et al., 2006; Bäckhed et al., 2015). The microbial composition of infants 
occurs in successive stages, initially Firmicutes and Proteobacteria are dominant, 
with a steady increase of Actinobacteria over time, by six months of age 
Bacteroidetes begin to dominate whilst Proteobacteria and Actinobacteria 
gradually decline (Koenig et al., 2011; Vaishampayan et al., 2010). Over the first 
two years of life, the microbiota continues to experience compositional changes, 
before becoming adult-like around the age of three (Yatsunenko et al., 2012).  
 
During early development Actinobacteria, in particular the Bifidobacterium 
genera, are prominent (Bäckhed et al., 2015; Koenig et al., 2011). Human Milk 
Oligosaccharides (HMOs) present in mothers’ milk have been shown to support 
Bifidobacterium spp., likely accounting for the presence of this genus (Sela et al., 
2008; Garrido et al., 2011; Marcobal & Sonnenburg, 2012).  
 
A number of factors may influence the formation of the early microbiota, 
including delivery mode (Biasucci et al., 2008; Bäckhed et al., 2015) and feeding 
(Guaraldi & Salvatori, 2012). The developing microbiota are vulnerable; 
disruptive antibiotic treatment at early stages has been shown to exacerbate 
obesity in mice, demonstrating that perturbations during early development could 
impact health later in life (Cox et al., 2014). Additionally, a correlation between 
low microbial diversity during infancy and development of allergic disease has 
been observed (Bisgaard et al., 2011). In infants with severe or moderate acute 
malnutrition the development of the microbiota is retarded (Subramanian et al., 
2014).  
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1.1.5. The Microbiota and Disease   
Given the central role of the microbiota toward the maintenance of digestive 
health, it is unsurprising that during disease states the microbial community is 
affected. Microbial dysbiosis is not a standardised medical term, but refers to the 
concept of “imbalance” within the microbial ecology (Hawrelak & Myers, 2004).  
Dysbiosis may refer to any state in which the microbial community is divergent 
from what is expected within healthy individuals, but the concept of dysbiosis is 
suggestive of either the loss/reduction of key members of the community, or the 
pronounced over representation of others. A clear, established example of 
microbial dysbiosis is the destruction of the normal microbiota during antibiotic 
treatment resulting in reduced species diversity (Dethlefsen et al., 2011). Such 
loss of species diversity and community robustness may lead to antibiotic 
associated diarrhoea (AAD) via the harmful overgrowth of otherwise normal 
members of the community such as C. difficile (Bien et al., 2013; McFarland, 
1998).  
 
Acute dysbiosis due to antibiotic treatment or pathogen invasion is usually a 
transient state which can be reversed. Chronic dysbiosis, however, is a 
restructuring of entire communities over the course of a long term illness, which 
may span an individual’s entire life. In many of these cases, the underlying cause 
of dysbiosis is obscure and can be a consequence of faulty environmental and/or 
internal host factors. Loss of diversity within the microbiota is a consistent 
indicator of dysbiosis and occurs across a variety of disease states including old 
age, where this phenomenon is correlated with frailty and dietary intake (Claesson 
et al., 2012); increased adiposity, insulin resistance, dyslipidaemia and 
inflammation (Chatelier et al., 2013); Crohn’s disease, where there is a marked 
overall decrease in species richness coupled with aberrant shifts at the family level 
(Gevers et al., 2014) and in type two diabetes where although only a small 
dysbiosis effect was observed, there was an increase in abundance of 
opportunistic pathogens coupled with loss of normal butyrate producing microbes 
(Qin et al., 2012). 
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It is clear that the interplay between endogenous microbes and the host is 
incredibly complex and during disease, pathogenesis may occur through a 
multitude of pathways and mechanisms.  
 
It seems that the gut microbiota plays an integral role in disease onset and may 
exacerbate existing conditions, therefore current and future medical interventions 
which can increase species diversity, and/or stimulate selected populations of 
beneficial microbes will be of value for treating a number of digestive diseases, 
and as a prophylactic treatment for maintaining host health.  
 
1.2. Dietary Fibres, MACs and the Human Microbiota 
1.2.1.  Dietary Fibre and Microbiota Accessible 
Carbohydrates (MACs) 
Monosaccharides such as glucose and fructose, and starch or starch derived 
oligosaccharides are digested and absorbed in the small intestine; however, all 
other oligo- and polysaccharides cannot be accessed by human enzymes and pass, 
partially digested or undigested, to the colon. These glycans, collectively referred 
to as dietary fibre, are derived from dietary sources such as plant storage 
polysaccharides, components of the plant cell wall, animal cartilage and tissue 
(Flint et al., 2008). Not all complex dietary carbohydrates are accessible to the 
microbiota, indeed the greater portion of ingested cellulose remains inaccessible 
to endogenous microbes (Chassard et al., 2010). Furthermore glycans from non-
dietary sources such as host mucins are accessible to some members of the 
microbiota. In addition, the metabolic capacity of each individual’s microbiota to 
access glycan varieties will be personalised to some extent. Therefore a more 
appropriate term to describe those carbohydrates which supply energy to the 
microbiota was coined: Microbiota Accessible Carbohydrates or MACs 
(Sonnenburg & Sonnenburg, 2014). MACs provide the necessary carbon and 
energy for the microbiota to subsist and consists of a portion of the dietary fibre as 
mentioned, with the addition of host glycans and carbohydrates from other gut 
micro-organisms, such as mannan from yeast cell walls or other capsular glycans 
(Figure 1.7; Koropatkin et al., 2012). 
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 Figure 1.7. Examples of glycan sources and structures available to the gut 
microbiota (Koropatkin et al., 2012). Cross section of the intestine (centre) 
demonstrating the availability and structures of five sources of microbiota accessible 
carbohydrates; dietary plants, dietary animal tissue, endogenous microorganisms, the 
mucus layer and breast milk. Representative structures are shown for each source, 
however true structural diversity is incredibly vast. A section of germfree mouse colon 
(inset) is stained to reveal host mucus-secreting goblet cells (GC), secreted mucus (SM), 
the mucus layer (ML) and a fragment of plant cell wall (PW); a demonstration of several 
glycan sources (Koropatkin et al., 2012). 
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Whilst the human genome changes slowly across generations the microbiome is 
plastic. Prolonged selective pressure through the diet may sculpt the metabolic 
power of the microbiota; Bacteroides plebius isolated from Japanese individuals 
contains genes encoding for porphyranases and agarases able to catalyse the 
depolymerisation of porphyran and agar, the authors provide evidence that these 
enzymes are acquired from marine bacteria and likely reflect the niche present in 
Japanese populations where seaweed is commonly consumed, compared to north 
American populations which do not contain these porphyranase genes as part of 
the microbiome (Hehemann et al., 2010).  
 
New technologies in agriculture and the food industry have revolutionised the 
human diet in the developed countries. Western diets now typically contain more 
refined sugar, more meat and less fibre than ancestral diets (Cordain et al., 2005; 
Jew et al., 2009). Traditional diet groups have been the focus of several large 
metagenomic studies; traditional diet groups consist of human populations which 
follow a pre-urbanization diet and lifestyle, such as hunter-gatherers or diets 
similar to those experienced by early human settlers during the birth of agriculture 
(Segata, 2015). 
 
The Hadza contained microbes with a higher diversity of carbohydrate active 
enzymes compared with urban Italians (Rampelli et al., 2015) which may reflect 
more varied MAC content of the Hadza diet compared with their Italian 
counterparts and the need for functional flexibility across seasonal change in diet. 
Changes in microbial composition were observed in the Hadza vs. the Italian 
control group, most notably an increase in the Prevotella genus which is also seen 
in other traditional diet groups. A traditional diet group from Burkina Faso, 
consisting of 14 children were compared with 15 children of EU origin (De 
Fillippo et al., 2010). The microbial composition of each group is consistently 
divergent; the Burkina Faso microbiota is, like the Hadza, dominated by the 
Prevotella genus (De Fillippo et al., 2010; Schnorr et al., 2014).  
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Interestingly, the youngest children surveyed from both groups had enriched 
populations of Actinobacteria consistent with the hypothesis that these microbes 
are supported by breast feeding (De Fillippo et al., 2010). The Yanomami tribe, a 
previously uncontacted tribe isolated for >11,000 years demonstrated the highest 
bacterial and functional diversity of any human group (Clemente et al., 2015).  
 
 Several traditional diet groups from rural populations in South America and 
Africa were examined by Yatsunenko and shown to have microbial populations 
more similar to each other than to their western counterparts, despite distant 
geological locations. This suggests that dietary intake is a key factor in 
determining microbial composition (Yatsunenko et al., 2012).  
 
Dietary intake of fibre has reduced considerably in the western diet over recent 
decades. Many foods, such as dairy, refined sugars and oils, contain little or no 
complex carbohydrates and these make up an increased proportion of our caloric 
intake compared with typical diets from previous centuries or from populations 
following more traditional diets (Cordain et al., 2005; Jew et al., 2009). In the 
U.S.A. the average adult dietary fibre intake was reported at 15.8g per day 
between 1999 and 2008, with little change over the course of the study; far from 
the recommended daily intake of 25-38g per day. The Bukina Faso children 
consumed more fibre than their EU counterparts (1-2 year old: 10g/day compared 
with 5.6g/day; 2-6 year old: 14.2g/day compared with 8.4g/day), the fibre intake 
of other traditional diet groups was not monitored as closely. However, foods 
available to the Hadza and the groups examined by Yatsunenko and colleagues 
also suggested fibre enriched diets (De Fillippo et al., 2010; Schnorr et al., 2014; 
Yatsunenko et al., 2012).  
 
This relatively recent reduction of dietary fibre in the western diet may account 
for the divergence of the western microbiota compared to the traditional diet 
groups and subsequent reduction in diversity (Segata, 2015).  Loss of diversity 
through failing to provide enough dietary MAC to ensure diverse microbial 
growth may leave individuals vulnerable to digestive diseases (King et al., 2012; 
O’Keefe et al., 2015; Sonnenburg & Sonnenburg, 2014). 
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1.2.2. The Concept of Prebiotics 
The concept of prebiotics was first introduced in 1995 by Gibson and Roberfroid, 
who stated that a prebiotic was: 
 
“A non-digestible food ingredient that beneficially affects the host by selectively 
stimulating the growth and/or activity of one or a limited number of bacteria in 
the colon, and thus improves host health” (Gibson & Roberfroid, 1995). 
 
However the authors updated this description in 2004 for clarity, describing the 
characteristics the food ingredient should exhibit to be classified as a prebiotic. 
This updated description allows better distinction between prebiotic compounds, 
added dietary fibre or other food ingredients. The new classification contained 
three major distinctions for a food ingredient to be classified as a prebiotic: 
 
“(1) resists gastric acidity, hydrolysis by mammalian enzymes and 
gastrointestinal absorption;  
(2) is fermented by the intestinal microbiota;  
(3) stimulates selectively the growth and/or activity of intestinal bacteria 
associated with health and wellbeing.” (Gibson et al, 2004) 
 
It is imperative that a prebiotic survives gastric acidity to a good extent, as 
hydrolysis within the early G.I. tract may reduce the prebiotic to monosaccharide 
components accessible to the host in the small intestine, preventing the prebiotic 
from coming into contact with the target microbial populations. Having passed 
through the early digestive system, the prebiotic must be fermented by the 
microbiota. Many recalcitrant glycans, such as crystalline cellulose, cannot be 
classed as prebiotics if the bulk of these pass through the G.I. tract without being 
fermented by the microbial community (Chassard et al., 2010). Finally, a 
prebiotic should act upon a targeted species or community (Gibson et al., 2004); 
this final point is crucial for distinguishing a prebiotic from MACs.  
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Prebiotics should stimulate a defined species or range of species to promote host 
health via an informed manner, rather than broad spectrum effect which may be 
attributed to mechanisms outside of, or in addition to, microbial fermentation. In 
this manner, all carbohydrate prebiotics are MACs, but not all MACs may be 
defined as prebiotics. Additionally, glycans described as MACs tend to be 
ingested passively through the diet, and may include glycans from non-dietary 
sources; in contrast prebiotics are administered deliberately with the purpose of 
enhancing host health. Fructo-oligosaccharides (FOS) and galacto-
oligosaccharides (GOS) are established prebiotics, but the benefits of more novel 
non-digestible glycans such as xylo-oligosaccharides and 
isomaltooligosaccharides are being explored with promising results (Patel & 
Goyal, 2012; Singh et al., 2015). 
 
As discussed in the previous section (Chapter 1.2.1) dietary MACs have been 
dramatically reduced within the western diet, potentially underpinning the 
divergent microbial profiles observed. The reintroduction of this dietary MAC as 
a prebiotic may help in a broad spectrum manner to nourish the microbiota and 
encourage greater species diversity. 
 
The industrial production of HMOs is currently infeasible due to the cost of 
purification from breast milk and the technical complications of in vitro 
production, however with the addition of FOS and GOS to infant formula the 
disparity between the microbial profiles of formula fed and breast fed infants was 
reduced (Knol et al., 2005). The addition of inulin negated the detrimental effects 
of antibiotic intervention on in vitro cultures, suggesting that prebiotics may be 
valuable as a prophylactic therapy during antibiotic treatments in humans 
(Johnson et al., 2015). Subjects fed 16 g/day FOS experienced higher levels of 
GLP-1 and PYY, hormones involved in appetite control, and a reduced caloric 
intake suggesting that prebiotic treatment may assist in weight loss therapies. The 
authors speculate that this effect could be due to increased production of SCFAs 
within the gut (Verhoef et al., 2011). Prebiotic compounds have also 
demonstrated therapeutic effects across a number of disease states including 
inflammation and diabetes (Roberfroid et al., 2010; Rastall & Gibson, 2015). 
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The classical prebiotic targets are members of the Bifidobacterium genus, which 
are thought to be health promoting (Gibson & Roberfroid, 1995; Koenig et al., 
2011; Fanning et al., 2012a; Fanning et al., 2012b). Bifidobacterium spp. are able 
to ferment colonic glycans to produce butyrate and modulate host health through 
the exclusion of pathogens, priming of the immune system and reduction of 
inflammation (Picard et al., 2005; Fukuda et al., 2011).  
 
1.3. Fructans 
1.3.1.  Structure and Function 
Fructans are β-linked fructose polymers which, like many complex carbohydrates, 
are inaccessible to human enzymes and pass through the early digestive tract 
intact (Gibson et al., 2004). Inulin and levan are β-2,1 and β-2,6 linked 
homopolymers respectively (Figure 1.8). Many levans, particularly bacterial 
levans, are highly branched (Blake et al., 1982).  
 
More complex non-linear fructans comprising both linkage types may consist of 
an inulin backbone with levan branches such as found in garlic bulbs and agave 
stems (Baumgartner et al,. 2000; Velazquez-Martinex et al., 2014; Mancilla-
Margalli & Lopez, 2006) or may consist of a levan backbone with inulin branch-
points, such as found in winter wheat (Kawakami & Yoshida, 2012). Other 
fructan structures may include bifurcated inulins, such as those created by the 
onion 6G-fructosyltransferase (Vijn et al., 1997). Whilst non-linear fructans may 
be relatively common, there is a scarcity of data regarding fructan structures in 
common dietary sources, consequently the extent of branching in fructans 
accessible to the microbiota is difficult to ascertain. 
 
Fructans of any structure with a DP less than around 10 units may be referred to 
as FOS. Several branched fructan structures are illustrated (Figure 1.9 A). 
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Figure 1.8. The molecular structure of fructose, sucrose, linear inulin and levan 
(Sonnenburg et al., 2010). This figure shows the structure of polymeric linear fructans 
(β2-1 linked inulin, β2-6 linked levan), sucrose and fructose (Sonnenburg et al., 2010). 
 
Fructan is synthesised through the action of an enzyme, such as those belonging to 
CAZy family GH68 (further described in Chapter 1.4.2). Fructan synthesising 
enzymes characterised to date construct fructan polymer using sucrose as the 
substrate, as fructose is appended to a starting sucrose moiety, unmodified 
fructans are synthesised with one terminal sucrose unit, at what would otherwise 
be the reducing end of the sugar. 
 
Inulin is a more flexible polysaccharide with the furanose rings protruding from 
the backbone, whereas the furanose rings are part of the backbone of levan. Levan 
is less flexible as hydrogen bonding holds the helical structure in place (Figure 
1.9. B). These secondary structural features likely contribute towards the 
properties and functionality of these glycans within fructan synthesising 
organisms (Valluru & Van den Ende, 2008; Vereyken et al., 2003). 
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Linear inulin, low molecular weight levan and non-linear fructans are plant-
derived and generally serve as an energy store in plants (Vijn & Smeekens, 1999) 
and can be found in a variety of plants including cereals such as wheat and barley, 
grasses, and vegetables including garlic, onion and leek (Vijn & Smeekens, 1999; 
Muir et al., 2007; Campbell et al., 1997; Van Loo et al., 1995). In addition to 
acting as reserve carbohydrate, fructans in plants may serve to regulate the sucrose 
levels within the vacuole, preventing sugar-induced feedback inhibition of 
photosynthesis (Vijn & Smeekens, 1999; Wagner & Wiemken, 1983) and/or 
protect against stressors such as drought (Valluru & Van den Ende, 2008). Dietary 
sources of fructans are illustrated (Figure 1.10).  In contrast, high molecular 
weight levan, often highly branched, is found as a component of the extracellular 
polysaccharide matrix surrounding biofilms or as a bacterial capsule. Bacterial 
levan has a high molecular weight and a high degree of branching. E. herbicola, 
Z. mobilis and B. subtilis make levan with similar aqueous properties; these 
solutions are surprisingly elastic and likely assist in biofilm cohesion (Blake et al., 
1982; Benigar et al., 2014). 
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Figure 1.9. An overview of fructan secondary structure (Panel B from Vereyken et 
al., 2003). (A) Fructans are depicted in cartoon form with the inclusion of three non-
linear examples (Baumgartner et al., 2000; Blake et al., 1982; Vijn & Smeekens, 1999, 
Cimini et al., 2015). (B) Predicted conformations of decamers by Vereyken et al., 2003; 
(i) Levan decamer adopts a rigid helix supported by hydrogen bonding. (ii) and (iii) two 
preferred helical conformations of the more flexible inulin decamer (Vereyken et al., 
2003)  
 
 22 
Figure 1.10. Sources of fructan in the diet. Humans consume fructans from a wide 
variety of fruits and vegetables, including but not limited to onion, garlic, leek, chicory, 
asparagus, wheat and banana (Muir et al., 2007; Campbell et al., 1997; Van Loo et al., 
1995).  
 
1.3.2. Dietary Prevalence 
Americans, on average, consumed 2.6g of inulin and 2.5g of FOS per day 
between the years 1994 and 1996 (Moshfegh et al., 1999). In Europe, the daily 
intake of inulin was approximated at 3-11g (Van Loo et al., 1995). In contrast, 
levan intake is difficult to estimate, as there is little information regarding levan 
content of edible plants. Moreover, it is likely that significant microbiota 
accessible levan may arise from other members of the microbiota through 
expressed glycan capsules, or environmental bacteria, and not through dietary 
routes; making it incredibly difficult to predict the amount of levan available to 
the microbiota. One estimate places prehistoric fructan intake near 135g per day 
for an average male residing around the Chihuahuan Desert area; this estimate 
was made based upon well preserved coprolites (Leach & Sobolik, 2010). 
Regardless of the true quantity of fructan consumed by our ancestors, fructan 
intake has almost certainly reduced in recent years, as the total MAC content of 
our diets have decreased (Sonnenburg & Sonnenburg, 2014).  
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1.3.3. Fructans and Industry 
Whilst levan has many potential applications, especially in the cosmetics industry, 
these are relatively under-explored when compared with inulin (Srikanth et al., 
2015). In contrast inulin has become increasingly industrially significant. 
Sinistrin, an inulin-type fructan with short β2-6 branches, is more soluble than 
linear inulin. It can be used to determine glomerular filtration rate as part of a 
diagnostics tool for kidney disorders as it is not broken down within the blood, 
and sinistrin clearance can be directly measured. Sinistrin is manufactured in large 
quantities from red squill for these medical assays (Spies et al., 1992; Zitta et al., 
2013).  
 
Inulin and FOS have been considered prebiotics since the inception of prebiotic 
treatments (Gibson & Roberfroid, 1995; Roberfroid et al., 1998). Both inulin and 
FOS can support Bifidobacterium spp. in vitro (Watson et al., 2013) and ingestion 
of inulin or FOS can promote these species in vivo (Gibson et al,. 1995; Slavin, 
2013). Moreover, inulin and FOS can stimulate mineral absorption (Griffin et al., 
2002) and increase the production of beneficial short chain fatty acids (Van de 
Wiele et al., 2004). Inulin has also been reported to have a beneficial effect on 
bone mineral content, blood lipid profiles, the immune system and energy 
homeostasis (Schaafsma & Slavin, 2015). Consumption of 5-8 g/day of inulin is 
thought to be sufficient to elicit a prebiotic effect (Kolida & Gibson, 2007). 
 
Inulin is an ideal functional food; it is cheap and easy to extract, soluble, neutral 
tasting and has a mouthfeel and texture similar to fat (Franck, 2002).  
 
Inulin is particularly useful in low-calorie dairy drinks, desserts and ice-cream as 
fat content may be reduced in these foods without compromising taste or texture 
in the final product when supplemented with inulin (Buriti & Saad, 2013; Akalin 
& Erisir, 2008). These properties and the versatile nature of inulin have no doubt 
contributed to its success within the food industry, in addition to the role it plays 
as a prebiotic.  
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1.4. Carbohydrate and Fructan Active Enzymes 
1.4.1.  Carbohydrate Active Enzymes (CAZymes) 
Protein-carbohydrate interactions underpin an enormous number of biological 
processes; from central metabolism, to sensing and manipulating the environment. 
Carbohydrates are able to perform such a variety of functions in part, due to the 
structural complexity which can be achieved by these compounds. Complexity of 
monosaccharides arises through variable hydroxyl group positioning, chirality and 
stereochemical conformations (e.g. furanose and pyranose). Monosaccharides 
may also be modified in a number of ways, for example the incorporation of 
sulphate, N-acetyl or carboxyl groups. Glycosidic bonds between 
monosaccharides may be either α or β conformation depending on the 
configuration of the anomeric carbon in relation to the configuration of the chiral 
centre furthest away, typically C5 (Koshland et al., 1954). From this wide variety 
of monosaccharide building-blocks and linkages, incredibly complex and diverse 
polysaccharide chains can arise. In order to facilitate such carbohydrate 
complexity, huge numbers of carbohydrate active enzymes are expressed across 
all domains of life which construct, deconstruct or modify these compounds. 
 
Study of Carbohydrate Active enZymes, or CAZymes, is aided by organisation 
and classification of proteins into sequence related families (Lombard et al., 2014; 
Cantarel et al., 2009). The CAZy database (www.cazy.org) aims to catalogue 
CAZymes, and by doing so enable deeper understanding and prediction of 
unknown CAZymes. Enzymes are split into functional classes, Glycoside 
Hydrolases (GH), Polysaccharide Lyases (PL), Carbohydrate Esterases (CE) and 
Auxiliary Activities (AA).  
 
GH enzymes facilitate the cleavage of glycoside bonds with the inclusion of water 
(hydrolysis). This large class of enzymes contains diverse members with a variety 
of folds and operate through acid-base catalysis with either retention or inversion 
of the stereochemical configuration of the glycosidic bond (Figure 1.11).  
The retaining mechanism has two stages and a covalent glycosyl-enzyme 
intermediate is formed, stereochemistry at the anomeric carbon (C1) is retained. 
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The reaction requires a negatively charged nucleophile and a protonated acid/base, 
normally situated 5.5 Å apart; typically acidic residues glutamate and/or aspartate. 
In the first stage, the catalytic nucleophile attacks the C1 and at the same time the 
acid/base donates a proton to the leaving group. Catalysis proceeds through an 
oxocarbenium ion-like transition state and the covalent intermediate is formed. 
The second stage is carried out by the acid/base residue, which now acts as a 
general base, a proton abstracted from water forms a hydroxyl ion which attacks 
C1 to cleave the covalent intermediate.  The inverting mechanism consists of a 
single step without an intermediate, the stereochemistry of C1 is inverted. Two 
residues, a protonated general acid and a general base are required, situated 
between 6 – 11 Å apart. A proton from water is abstracted by the general base, 
forming a hydroxyl ion which attacks C1. At the same time, a proton is donated 
from the general acid which assists departure of the leaving group. Catalysis 
proceeds through an oxocarbenium ion-like transition state. (McCarter & Withers, 
1994; Davies et al., 1995). 
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 Figure 1.11. The two mechanisms employed by glycoside hydrolases. These diagrams 
adapted from Withers & Williams, “Glycoside Hydrolases” in CAZypedia, available at 
URL http://www.cazypedia.org/. (A) The retaining mechanism, whereby a glycosyl 
enzyme intermediate is formed between two successive steps. Two carboxylate residues, 
an acid/base and nucleophile are required for catalysis. The stereochemistry of the 
anomeric carbon is retained. (B) The inverting mechanism is undertaken in one single 
displacement enzymatic step. Two amino acid residues, a general acid and base, are 
required for catalysis. The stereochemistry of the anomeric carbon is inverted.  
 
 
 27 
 
PL enzymes cleave polysaccharide chains containing uronic acid moieties through 
a β-elimination type mechanism with the formation of an unsaturated product.  
 
In the CAZy database, enzymes within each class are split into sequenced-based 
families. Families are represented numerically, and new families are added 
incrementally. Within families, characterised examples are annotated and any 
observed activities and mechanisms are listed. The database provides links to 
structural studies which provide insight into the enzyme fold and mechanism. All 
of this information allows predictions to be made about unknown members of the 
family, and allow new members to be more easily uncovered in newly sequenced 
genomes. Of course, grouping families by sequence can become misleading for 
predictive purposes in some cases, especially where the family already exhibits a 
diverse range of activities. The predictive power of the CAZy database relies on 
robust characterisation of numerous family member examples, and in some 
enzyme families this predictive power is very weak, with relatively few members 
characterised, however the target linkage type (α or β) and chirality (L or D) are 
almost always consistent within families, furthermore several families target a 
single group of polysaccharides, such as the fructan-active GH32 family, and 
identification of a GH32 encoding gene is highly predictive of a fructan associated 
role. 
 
1.4.2.  Fructan Active Enzymes: Glycoside Hydrolase 
Families 32, 68 and 91 
Three CAZy families are associated with fructans; GH32, GH68 and GH91. 
Family GH32 are the largest β-fructosidase family, with 3,365 members at the 
time of writing. This family is the main hydrolase family associated with fructans 
and enzymes within this group employ the retaining mechanism to cleave both β2-
1 and β2-6 fructans in either an exo- or endo- fashion. So far, only fructanase 
activity is associated with GH32 family enzymes, therefore the presence of a 
GH32 encoding ORF strongly predicts a function associated with fructan 
degradation. 
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GH32 family enzymes have been extensively studied. The catalytic mechanism 
was first identified as retaining by Koshland and Stein in 1954 by using labelled 
oxygen within water (H2O18) and examining where this oxygen was incorporated 
during the reaction (Koshland and Stein, 1954). A catalytic aspartic acid was later 
identified in yeast invertase using conduritol B epoxide, a β-glucosidase inhibitor 
which irreversibly alters the catalytic residue serving as the nucleophile (Reddy & 
Maley, 1990). Two further residues were also elucidated as essential to catalysis, 
a glutamic acid which serves as the acid/base catalyst and a second aspartic acid 
which most likely stabilises a transition state complex (Reddy & Maley, 1990; 
Meng & Fütterer, 2003). The catalytic residues are present within three conserved 
motif regions: WMNDSWP, RDP and EC, where the residues in bold are the 
nucleophile, transition state stabiliser and catalytic acid/base respectively 
(Lammens et al, 2009). The conservation of surrounding residues suggests that 
these play a role in forming a functional active site. Both exo- and endo-acting 
GH32 enzymes retain the same mechanism of action, however the nucleophilic 
aspartate may be replaced with a glutamate in the endo-acting enzyme (Pouyez et 
al., 2012; Vandamme et al., 2013).  
 
The family GH68 contains a few members which exhibit β-fructosidase activity, 
however the majority of characterised members are levan- or inulinsucrase 
enzymes. These enzymes build nascent fructan chains by breaking sucrose into 
the constituent monosaccharides and forming new glycoside bonds between 
fructose monomers in a manner consistent with glycoside transferase activity. The 
catalytic apparatus of GH68 enzymes is very similar to that of family GH32 and 
operates in reverse; the two families are likely to have diverged from a shared 
origin, and contain the same three catalytic residues within similarly structured 
conserved motifs (Lammens et al, 2009). 
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Figure 1.12. Comparison of endo- and exo- acting GH32 family enzyme structures. 
A comparison of the structures of endo-acting INU2 (PDB ID: 3SC7) shown in green and 
exo-acting invertase from T. maritima (PDB ID: 1UYP) shown in blue; two GH32 family 
enzymes which act on inulin. (A) A cartoon representation demonstrates the overall 
GH32 fold; a five bladed β propeller and C-terminal β-sandwich. The overall fold is 
consistent between exo- (left) and endo-acting (right) enzymes. (B) A surface 
representation with the catalytic residues in red, the exo-enzyme forms a pocket (left) 
whereas the endo-enzyme (right) has a larger cleft (Pouyez et al., 2012; Alberto et al., 
2004). 
 
The GH91 family is very small, containing only 55 members at the time of 
writing. Only a few reported activities have been observed which can be roughly 
divided into two groups; the degradation of inulin through the production of 
difructose anhydride (transferase-like) or the degradation of DFA to inulinbiose 
(hydrolase).  
 
At present, only a few members of this family have been characterised, however 
most fall into the former category and are not technically hydrolases, rather 
employing a fructotransferase mechanism.  
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One member, BsIFTase (derived from Bacillus subtilis Inulin-fructotransferase), 
has been characterised and x-ray crystal structures in the presence and absence of 
fructobiose have been determined (Jung et al., 2007). BsIFTase is a homotrimeric 
complex, with an active site formed at the interface between each β-helix 
monomer; three functional active sites are formed. Two catalytic residues were 
identified as part of this study, D233 and E244, these residues appear to be 
conserved in most sequenced GH91 members. The function of D233 is unclear, 
but it is suggested that this residue orientates the substrate within the catalytic site. 
The mechanism is proposed as a single displacement mechanism whereby a 
general base, E244, allows nucleophilic attack. E244 propagates this nucleophilic 
attack, which deprotonates a fructose at the 3’ position. This negatively charged 
hydroxyl group attacks the C1 carbon, forming a second glycosidic bond, the 
attack results in inversion of the stereochemistry of C1. The reaction results in the 
creation of a difructose anhydride, DFA-III (Figure 1.13; Jung et al., 2007).  
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Figure 1.13. The catalytic mechanism of BsIFTase, a GH91 family enzyme (Adapted 
from Jung et al., 2007). The structure of BsIFTase was solved by Jung and colleagues 
and remains the only characterised GH91 family enzyme with the inclusion of a crystal 
structure. (A) Side view and (B) top-down view of BsIFTase crystal structure, showing 
homotrimeric conformation. (C) 2D and (D) 3D representation of the catalytic site 
including fructobiose ligand bound. (E) Proposed catalytic mechanism for BsIFTase, as 
described in the text (Jung et al., 2007). 
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1.5. Fructan Binding Proteins 
Carbohydrate Binding Modules (CBMs) are discrete modules appended to 
enzymes, most commonly, glycoside hydrolases. CBMs are ordered into 
sequenced based families (www.cazy.org) and enhance enzyme activity, for 
example by bringing insoluble substrate into proximity to the active site thereby 
allowing catalysis, through targeting of the enzyme to specific regions of the 
substrate and/or, through the straightforward increase in the local concentration of 
substrate around the active site (Bolam et al., 1998; Cécile et al., 2010; Gilbert et 
al., 2013).  
 
CBM family 66 are generally appended to GH32 enzymes and recognise the non-
reducing fructose termini of fructans. The founding member of this CBM family, 
BsCBM66 targets a non-specific β-fructosidase, SacC, to the chain termini of 
branched levans, enhancing the activity of this enzyme on levan by ~100 fold. The 
CBM is not required for active site formation, as a truncated version of the 
protein, lacking the BsCBM66 retained maximal affinity for non-targeted 
substrates including sucrose and FOS (Cuskin et al., 2012).  
 
A master’s thesis published prior to this doctoral thesis examined a novel domain 
appended to an apparently inactive GH91 enzyme, BACOVA_04502. This 
domain, referred to as BACOVA_04502CTD (derived from C-Terminal Domain) 
bound to inulin with high affinity (Kd = 17 µM) during Isothermal Titration 
Calorimetry (ITC) analysis (Figure 1.14). A crystal structure of 
BACOVA_04502CTD in complex with kestopentaose (a sucrose containing 
pentasaccharide, Gα1-2βFβ2-1Fβ2-1Fβ2-1F) was obtained and the binding site was 
elucidated using targeted alanine mutagenesis and isothermal titration calorimetry 
(Figure 1.14). Despite being appended to an enzyme, the BACOVA_04502CTD 
was not considered a CBM as BACOVA_04502 was thought to be an inactive 
duplicate of BACOVA_04503 (Shapiro, MRes thesis, 2012).  
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Figure 1.14. Recognition of inulin by a discrete binding domain (Shapiro, MRes, 
2012). (A) Two consecutive genes encoding GH91 family enzymes were identified in B. 
ovatus. BACOVA_04502 contained a C-terminal domain (BACOVA_04502 CTD). (B) 
BACOVA_04502 CTD bound inulin (Kd = 17 µM) during ITC analysis, the top frame 
shows the raw heats and the bottom shows the integrated peak areas fitted to a onesite 
model using Microcal origin software. The BACOVA_04502 CTD was crystallised in 
complex with kestopentaose, the structure of which is shown in panel (C). (D) 3D 
representation of the binding cleft, residues are highlighted (red: alanine mutant cannot 
bind, orange: alanine mutant binds weakly, green: a di-sulphide bridge critical to 
binding). (E) Cartoon representation of BACOVA_04502 CTD structure. Two K5 
molecules bound across two protein monomers, mediating a dimer only observed in the 
crystal structure. K5 does not bind well during ITC analysis and the binding of two ligand 
molecules in this manner seems to mimic the preferred substrate, which has a DP greater 
than 8 (Shapiro, MRes thesis, 2012). 
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It was speculated that the full length BACOVA_04502 protein performed an 
analogous function to the SusE of the Starch Utilisation System in Bacteroides 
thetaiotaomicron, this SusE protein binds to polymeric starch at the cell surface 
(Cho & Salyers., 2001; Chapter 1.7.1). This hypothesis is challenged within 
Chapter 4, where evidence is provided for BACOVA_04502CTD being the 
founding member of a novel CBM family. 
 
Fructan binding has also been documented in a SusD-homologue, BT1762, which 
is presented on the surface of B. thetaiotaomicron where it assists the import of 
levan through the SusC-homologue outer-membrane channel, a critical function 
during growth on levan (Sonnenburg et al., 2010).  
 
Extracellular Substrate Binding Proteins (ESBP) have been shown to operate in 
tandem with ABC permeases to import small molecules and short 
oligosaccharides across the bacterial cell membrane (Bertsson et al., 2010; Ejby et 
al., 2013). Putative extracellular solute binding proteins have been identified 
within several inulin utilisation gene clusters, providing a tantalising glimpse of 
novel inulin recognition mechanisms, but little characterisation of these proteins 
has been undertaken (Scott et al.,  2011; Garrido et al., 2011).  
 
There is a paucity of literature on fructan binding proteins, therefore the 
mechanisms by which fructans are recognised by proteins remains largely unclear. 
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1.6. Carbohydrate Capture and Utilisation by the Gut 
Microbiota 
1.6.1.  The Distribution of CAZymes Within the Human 
Microbiota 
Carbohydrate metabolism is an essential function to all life. Given the unique 
environment the intestine provides – a continuously moving, dynamic 
environment furnished with complex carbohydrates indigestible to human 
enzymes which represent the main source of carbon – it is not surprising that the 
resident microbiota have become extremely adept at carbohydrate harvest. An 
impressive array of CAZymes are encoded by the microbiota, many of which are 
highly specialised to the available glycans within the human gut (Kaoutari et al., 
2013). 
 
CAZy enzymes have been identified from most major gut residents and analysis 
of these enzymes demonstrates, to some extent, the ecological niches occupied by 
each group (Kaoutari et al., 2013). Kaoutari and colleagues used bioinformatics 
techniques and the data available via the CAZy database to analyse the wealth of 
CAZymes encoded by sequenced members of the microbiota (Figure 1.15). The 
team used 177 genomes in proportions equivalent to within healthy humans (104 
Firmicutes, 29 Bacteroidetes, 22 Proteobacteria, 12 Actinobacteria, 2 Fusobacteria 
and one each from the phyla Verrucomicrobia, Lentisphaerae, Spirochaetes, 
Thermotogae, Synergistetes, Tenericutes, Elusimicrobia and Cyanobacteria) to 
construct a “mini-microbiome” with which they conducted their analysis. The 
authors show that this mini-microbiome contains 9,120 (57 %) glycoside 
hydrolases, 5,520 (35 %) glycosyltransferases, 950 (6 %) carbohydrate esterases 
and 292 (2 %) polysaccharide lyases.  
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Figure 1.15. Diversity of Glycoside Hydrolyses and Polysaccharide Lyases within a 
Constructed “mini-microbiome” (Kaoutari et al., 2013). In this figure, the authors 
demonstrate the diversity of GH and PL enzymes within the constructed “mini-
microbiome” used for analysis. (A) The number of enzymes mapped against the number 
of represented CAZy families (diversity). (B) The distribution of CAZymes within related 
groups. This graph demonstrates that members of the Bacteroidetes phylum contain the 
highest numbers of CAZymes including high numbers of diverse families. Members with 
high numbers of CAZymes may be able to occupy multiple gut niches, whereas members 
with a narrow set of CAZymes may occupy a more specific niche (Kaoutari et al., 2013). 
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Most commonly, these enzymes target plant and animal glycans. In comparison, 
the human genome is known to encode 91 glycoside hydrolases, only 8 of which 
have a known digestive function. Furthermore, the authors demonstrate the 
diversity and number of encoded enzymes within each genome, allowing 
comparisons to be made between species and phyla – Bacteroides contained by 
far the most enzymes per genome, including a large number of diverse families. 
The data suggest that Bacteroides genus can target a wider range of glycans, 
whereas other genomes are more specific and likely occupy tight niches within the 
intestinal environment (Kaoutari et al., 2013). 
 
1.6.2. Carbohydrate Harvest by Members of the 
Bacteroidetes phylum 
Currently, glycan utilisation within the intestine has been most widely studied in 
the Bacteroides genus. The Bacteroidetes phyla is dominated by the Bacteroides 
class (Arumugam et al., 2011; Huttenhower et al., 2012), a group noted for the 
astonishing ability to recognise, import and degrade a wide variety of glycan 
structures; for example Bacteroides thetaiotaomicron and Bacteroides ovatus 
have between them the capacity to use almost all of the classes of glycan known 
(Martens et al., 2011). Prevotella spp. are also prominent members of 
Bacteroidetes, particularly within the gut of individuals following a higher-fibre 
hunter-gatherer or agrarian diet (Yatsunenko et al., 2012; De Fillippo et al., 2010; 
Rampelli et al., 2015). Prevotella spp. have also been shown to utilise non-
cellulose plant cell wall glycans (Flint et al., 2012), though carbohydrate 
utilisation in this genus is relatively under explored. 
 
Polysaccharide Utilisation Loci (PULs) were first identified in Bacteroides 
thetaiotaomicron in the 20th century (Anderson & Salyers, 1989), however 
genome sequencing has revealed that all sequenced Bacteroidetes contain these 
closely linked, tightly regulated, PULs, each specific for a distinct glycan 
(Martens et al., 2011; Rosewarne et al., 2014). Bacteroides species have PUL-rich 
genomes, B. thetaiotaomicron contains 88 PULs, which occupy roughly 18% of 
the genome (Martens et al., 2009).  
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Recently, advances in prediction software have been made allowing automated 
PUL identification from genomic data (Terrapon et al., 2015).  
 
Bacteroides spp. have become models for the study of glycan utilisation within 
the Bacteroidetes phyla as they are prominent members of the gut microbiota, are 
culturable and encode a multitude of PULs (Arumugam et al., 2011; Huttenhower 
et al., 2012; Martens et al., 2011). The first PUL, encoding for a starch utilisation 
system (SUS) was described by Anderson and Salyers in 1989. Subsequently, 
detailed biochemical studies have provided insight into how the starch utilisation 
system works on a molecular level. The starch utilisation system is a suite of 
periplasmic and outer membrane localised proteins, SusABCDEFGR, which bind 
to, import and degrade starch (Martens et al., 2009). A typical Sus-like system is 
often identified by the presence of a SusC homologue, a SusD homologue, a 
sensor/regulator and a number of CAZymes.  
 
Outer membrane SusC homologues are TonB coupled oligosaccharide importers 
(Reeves et al., 1996) and SusD homologues are predicted surface located 
oligosaccharide binding lipoproteins (Shipman et al., 2000). Initial research on 
susD knock-out strains suggested that the binding role of SusD is essential to the 
function of the starch utilisation system (Koropatkin et al., 2008).  
 
As the SusD protein has previously been found to interact with the SusC import 
protein (Shipman et al., 2000) it is likely that SusD orients or channels the 
polysaccharide for import, however the binding role of SusD appears to be 
superfluous when the system is activated using maltose, though the presence of 
the protein is still required; therefore the role of this protein during import and 
regulation remains unclear (Cameron et al., 2014). In addition to the SusC/SusD 
complex other outer membrane carbohydrate binding apparatus is present 
(Cameron et al., 2014). Although a minority of SusC/D homologue pairs appear 
to stand alone within Bacteroides genomes, all currently characterised PUL 
contain CAZymes which act to deconstruct polysaccharide chains. PUL encoded 
enzymes are highly diverse and play a multitude of roles within glycan 
degradation systems.  
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Many PUL, including the recently elucidated xyloglucan and xylan utilisation 
systems (Rogowski et al., 2015; Larsbrink et al., 2014) and the canonical starch 
utilisation system (Koropatkin & Smith, 2010; Shipman et al., 1999) contain an 
endo-acting enzyme localised to the cell surface. This vanguard enzyme breaks up 
large polymers into shorter oligosaccharides for import mediated by the SusC/D 
pair through the outer membrane and is critical for growth on the polysaccharide 
(Larsbrink et al., 2014; Reeves et al., 1997). It is worth noting that endo-acting 
enzymes have also been found to localise to the periplasm, such as in the case of 
mannan degradation in Bacteroides thetaiotaomicron and xylan degradation in 
Bacteroides ovatus (Rogowski et al., 2015; Cuskin et al., 2015). The localisation 
of these enzymes may depend on the utilisation strategy employed by the 
organism, external endo-acting enzymes will release short oligosaccharides to the 
extracellular environment, which could lead to loss of substrate to competitors. 
Internalised endo-acting enzymes may be part of a “selfish” mechanism, where 
glycans are kept as intact as possible prior to import, preventing this carbohydrate 
loss (Cuskin et al., 2015).  
 
1.6.3.  Carbohydrate Harvest by Members of the Firmicutes 
and Other Phyla 
The SUS paradigm is far from the only mechanism by which intestinal microbiota 
degrade glycans (Flint et al., 2012). Most members of the gut microbiota contain 
significant numbers of glycoside hydrolases (Kaoutari et al., 2013), in this section 
a few selected examples of glycan harvest by gut microbiota through non-SUS 
like mechanisms are illustrated, to demonstrate the diversity and complexity of 
these systems. 
 
ABC transporters are near-ubiquitous and can mediated the import of extracellular 
oligosaccharides (Yan, 2013). ABC transporters are coupled with substrate 
binding domains in some systems which, upon binding, propagate a 
conformational change through the transmembrane domain allowing substrate to 
pass through the channel.  
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Substrate binding domains may be part of a complex with the transporter, 
periplasmic or lipid-anchored to the membrane (Berntsson et al., 2010). 
 
Eubacterium rectale is a member of the Firmicutes phylum and utilises soluble 
starch through the expression of multiple ABC permeases linked with 
extracellular located substrate binding proteins (ESBP) which co-ordinate ABC 
permease import through solute recognition (Figure 1.16; Cockburn et al., 2014).  
 
The Bifidobacterium genus are Gram positive members of Actinobacteria phylum 
able to utilise a range of short oligosaccharides. As discussed previously, 
members of the Bifidobacterium genus are commonly abundant during infancy 
and are the classical target for prebiotic therapy (Chapter 1.1.4, Chapter 1.2.2). 
Bifidobacterium longum dedicates ~8% of its genome toward glycan catabolism, 
typically encoding ABC transporter systems regulated by LacI-class repressors 
(Schell et al., 2002). Members of this genera may utilise human milk 
oligosaccharides, HMOs, present within mother’s milk. HMOs are complex 
oligosaccharides with a range of secondary structures, Bifidobacterium longum 
subsp. infantis encodes a number of ABC permeases and HMO binding proteins, 
enabling it to grow efficiently within the infant gut (Garrido et al., 2011) 
Figure 1.16. Eubacterium rectale employs three ABC transporter and ESBP pairs 
during starch harvest (Cockburn et al., 2014). Tethered to the peptidoglycan layer is 
the multidomain EUR_21100 structure, which binds to starch and releases malto-
oligosaccharides. Released oligosaccharides may be targeted by the ESBPs (red) 
EUR_01830, EUR_31480 and EUR_01240 for import into the cell. The location of the 
second GH13 enzyme, EUR_01860 is unknown (Cockburn et al., 2014). 
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1.7. Fructan Degradation by the Microbiota 
1.7.1.  Fructan Utilisation Loci 
As discussed previously, saccharolytic members of the Bacteroidetes phylum 
express PULs to degrade target polysaccharides (Martens et al., 2011, Chapter 
1.6.2). To date, however, only one fructan PUL has been characterised, the levan 
utilisation system of Bacteroides thetaiotaomicron (Figure 1.17).  
 
Levan is broken up by an extracellular endo-acting GH32 enzyme, BT1760. 
Levan and levanoligosaccharides are bound at the cell surface by a SusE-like 
protein, BT1761 and a SusD-homologue, BT1762. Once imported through the 
SusC-homologue, BT1763, levan is broken down to fructose by two exo-acting 
GH32 enzymes; BT1759 and BT3082.  
 
 42 
Figure 1.17. The levan utilisation system from Bacteroides thetaiotaomicron. The 
levan utilisation system from B. thetaiotaomicron was characterised (Bolam and 
Sonnenburg, 2011). (A) The canonical starch PUL compared with the levan PUL in B. 
thetaiotaomicron. (B) The predicted model for levan utilisation in B. thetaiotaomicron 
(Bolam and Sonnenburg, 2011). 
 
The sensor domain of the Hybrid Two Component System (HTCS) BT1754 
recognises periplasmic fructose as a proxy for levan polysaccharide and is able to 
up-regulate the PUL through a DNA binding domain (Sonnenburg et al., 2010; 
Bolam & Sonnenburg, 2011). 
 
The authors also identified putative fructan PUL from B. ovatus, B. caccae, B. 
fragilis, B. vulgatus and B. uniformis during the study, by searching for 
homologues of the HTCS, BT1754. When cultured on minimal media 
supplemented with fructose, all species grew. When cultured upon levan, only B. 
thetaiotaomicron was able to grow. When cultured on inulin B. ovatus, B. caccae, 
B. fragilis, and B. uniformis grew. B. vulgatus growth was not supported by either 
polysaccharide (Figure 1.18). 
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B. ovatus and B. caccae likely degrade inulin in the same manner, and contain two 
GH91 encoding genes in addition to a further two GH32 encoding genes. B. 
uniformis contains four GH32 enzymes which are most divergent from those 
characterised in B. thetaiotaomicron (Bolam & Sonnenburg, 2011), this 
divergence may indicate a divergent strategy for inulin degradation. B. fragilis is 
also unusual in that it displays two distinct loci, each containing a HTCS gene 
with high sequence similarity to BT1754, the reason for this gene organisation is 
unclear. B. vulgatus was able to utilise fructose, but not polymeric substrates of 
either linkage, this result was consistent with the lack of a SusC/SusD homologue 
pair and no other candidate genes for glycan import across the outer membrane. 
The presence of one GH32, BV1663, suggests that small fructans may be broken 
down in some manner, perhaps outside of the cell as there is no obvious fructan 
import apparatus such as a SusC/D-homologue pair (Sonnenburg et al., 2010; 
Bolam & Sonnenburg, 2011). 
Figure 1.18. Six putative fructan PUL were identified in Bacteroides species 
(Sonnenburg et al., 2010). Sonnenburg and colleagues predicted and compared six 
putative fructan PUL from six Bacteroides species (left). All species were cultured on 
minimal media supplemented with fructose, levan or inulin to identify whether the strains 
could utilise these substrates (right). B. vulgatus could utilise only fructose, whereas the 
remaining five utilised either levan or inulin in addition to fructose. B. thetaiotaomicron 
was the only levan user, with B. ovatus, B. caccae, B. fragilis and B. uniformis able to 
utilise inulin (Sonnenburg et al., 2010). 
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1.7.2. Other Fructan Utilisation Systems 
Fructan utilisation has been observed in several non-Bacteroides members of the 
microbiota. A wide scale study by Watson and colleagues shows a number of 
Bifidobacterium and Lactobacilli species, desirable as probiotic species, are able 
to grow up FOS and inulin (Watson et al., 2013). Whilst there is little mechanistic 
insight into how fructans are imported and degraded within probiotic species, 
several GH32 family CAZymes have been identified within the available genomes 
and are catalogued within the CAZy database. A GH32 enzyme isolated from 
Bifidobacterium longum KN29.1 was characterised with the inclusion of a crystal 
structure by Bujacz and colleagues in 2011.  
 
This enzyme is capable of mediating the depolymerisation of short and mid length 
β2-1 linked FOS and to some extent is active upon polymeric inulin and sucrose. 
The authors did not include data regarding β2-6 linked FOS and levan (Bujacz et 
al., 2011).  
 
Roseburia inulinovorans is a motile member of the Firmicutes phylum able to 
harvest inulin. A cluster of genes, including a GH32 family enzyme and ABC 
transporter is upregulated in the presence of inulin. Co-cultures of R. 
inulinovorans and B. longum on inulin show very little growth of B. longum, 
which is only able to utilise short chain FOS or fructose. These data suggest that 
inulin is imported prior to degradation, such that no breakdown products are 
accessible to B. longum (Scott et al., 2011). This is in contrast to other systems, 
such as inulin utilising strains of Bacteroides which break up inulin prior to 
import, enabling the growth of non-inulin utilising species of Bifidobacterium in 
co-culture (Falony et al., 2009; Rakoff-Nahoum et al., 2014). 
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1.8. Research Objectives 
• To provide mechanistic insight into inulin recognition and utilisation by 
prominent glycan degrading members of the human gut microbiota. 
o In a Gram-negative species, Bacteroides ovatus. 
o In a Gram-positive species, Bifidobacterium adolescentis. 
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Chapter 2. Materials and Methods 
 
2.1. Chemicals, Commercial Kits and Water 
A comprehensive list of chemicals and commercial kits used in this project can be 
found in Appendix II.   
 
Water used generally throughout this project was double distilled and purified to 
18.2 Ω with a Millipore Milli-RO 10 plus Water Purification System. Water was 
used as the solvent for most solutions in this project and this can be assumed 
unless stated otherwise. 
 
Where stated PCR-Grade 0.1 µm filter sterilised DNase, RNase and Protease free 
water was used (Sigma-Aldrich). 
 
2.2. Sterilisation 
Media and glassware were sterilised by autoclaving at 121 °C, 15 1b in-2(psi) for 
20 minutes. Solutions under 1 l were filter sterilised using an 0.25 µm pore 
Millipore filter disc (Supor® Acrodisc® 3.2, Gelman Sciences) and a pre-
sterilised syringe (Plastipak®, Becton Dickinson). Solutions of a larger volume 
were filter sterilised by passing through a 0.2 µm filter (Supor® 200-S PES 
membrane, Pall Sciences) under a vacuum.  
 
2.3. Storage Practices 
2.3.1.   DNA 
DNA was generally stored in PCR grade water or 10 mM Tris-Cl pH 8.5 at -20 
°C. DNA was stored at 4 °C for a maximum of 6 weeks if used regularly to 
minimise freezing and thawing. 
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2.3.2.   Protein 
Protein was stored at 4 °C for a maximum of 2 weeks, with regular positive 
control tests to ensure no loss of function had occurred. Longer term storage was 
not possible with all protein constructs due to degradation however if possible 
proteins were snap-frozen in liquid nitrogen and stored immediately at -80 °C for 
a maximum of 1 year. Experiments involving purified proteins were performed 
from fresh purifications in at least one instance so that any degradation of the 
protein during storage could be monitored. 
 
2.3.3.   Bacterial Cultures 
Bacterial cell cultures were stored on plates at 4 °C for a maximum of 5 weeks. 
Liquid cultures containing 25 % (v/v) glycerol were stored at -80 °C in cryovials.  
 
2.3.4.   Carbohydrates 
Carbohydrate solutions were frozen at -20 °C for long term storage or kept at 4 °C 
over a short period (< 6 weeks). If a large yield of carbohydrate was obtained, this 
was freeze-dried and kept at room temperature. 
 
2.4. Vectors 
Several vectors were needed for the work carried out during this project, these are 
listed below (Table 2.1). 
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Table 2.1. An index of vectors used during this Study 
Plasmid Size (Kbp) Supplier/Reference Features 
pET28a-b  5.4 Novagen Kanr, T7, lac, laciq 
Cloning region includes His 
tag. 
pET32b 5.9 Novagen Ampr, T7, lac, laciq 
Cloning region includes Trx 
tag, His tag. 
pET22a 5.5 Novagen Ampr, T7, lac, laciq 
Cloning region includes PelB, 
His tag. 
pET21a-b 5.4 Novagen Ampr, T7, lac, laciq 
Cloning region includes His 
tag. 
pGEX_6P_1 5.0 GE Healthcare Ampr, tac, lac, laciq. Cloning 
region includes cleaveable 
GST tag. 
Zero Blunt® 3.5 Invitrogen Kanr , lac, laciq 
pExchange-
tdk 
4.2 Provided by Nicole 
Koropatkin  
(Koropatkin et al, 2008) 
Ampr 
 
2.5. Bacterial Strains 
A variety of bacterial strains were used during the project, optimised E. coli 
strains were used for the purposes of cloning and protein expression. Wild-type 
and genetically modified (Bacteroides ovatus only) strains of Bifidobacterium and 
Bacteroides species were used for direct observation/characterisation during 
experimentation. These strains, together with a description of their use are 
displayed below (Table 2.2.)  
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Table 2.2. An index of bacterial strains used during this project. 
 
  
Name Genotype Description 
BL21 
(DE3) 
F– ompT gal dcm lon hsdSB(rB- 
mB-) λ(DE3 [lacI lacUV5-T7 
gene 1 ind1 sam7 nin5]) 
E. coli strain optimised for protein expression using 
a T7 promoter. Routinely used to over-express 
recombinant proteins. (Studier & Moffatt, 1986) 
BL21 
(DE3) pLysS 
F- ompT gal dcm lon hsdSB(rB- 
mB-) λ(DE3) pLysS(cmR)  
 
As BL21, with additional pLysS plasmid (T7 
lysozyme) to lower background expression of the 
target gene prior to induction if leaky expression of 
the recombinant protein interfered with the growth 
of E.coli cells. (Moffatt & Studier, 1987) 
Tuner 
(DE3) 
F- ompT hsdSB(rB- mB-) gal dcm 
lacY1(DE3) 
As BL21 with the addition of a lac permease 
mutation to allow uniform diffusion of IPTG across 
cells, establishing a linear relationship between 
IPTG concentration and expression levels. Tuner 
was used when control over expression levels was 
desired e.g. to improve protein solubility. 
(Novagen) 
Top10 F-mcrAΔ(mrr-hsdRMS-mcrBC) 
φ80lacZ ΔM15 
ΔlacX74nupGrecA1 araD139 
Δ(ara-leu)7697 galE15 galK16 
rpsL(StrR) endA1 λ- 
Routinely used for plasmid propagation and cloning. 
(Invitrogen) 
CC118   
λ-pir 
Δ(ara-leu) araD  ΔlacX74 galE 
galK phoA20 thi-1 rpsE rpoB 
argE (Am) recA1 λ pir 
Used for plasmid propagation and cloning 
(pExchange tdk only) 
(Herrero et al., 1990) 
S17.1  
λ-pir 
hsdR recA pro RP4-2 
(Tc::Mu;KmTn7) 
Conjugation of pExchange tkd plasmids from this 
strain to Bacteroides ovatus (Skorupski & Taylor, 
1996) 
B. ovatus Wild-Type 
ATCC 8483  
DSM-1896, Type strain (HMP Consortium, 2010). 
B. ovatus Δtdk Δtdk Used to generate genomic mutants or gene deletions 
in Bacteroides ovatus through FuDR selection 
(Chapter 2.16). Provided by Eric Martens. 
B. ovatus 
Δ04502 
Δtdk Δ04502 bacova_04502 deletion strain, created as part of this 
project 
B. ovatus  
04503 M 
Δtdk 04503M bacova_04503 E196Q genomic mutant created as 
part of this project 
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Table 2.2. An index of bacterial strains used during this project (continued). 
 
  
Name Genotype Description 
B. ovatus 
Δ04504 
Δtdk Δ04504 bacova_04504 deletion strain created as part of this 
project 
B. ovatus 
Δ04505 
Δtdk Δ04505 bacova_04505 deletion strain created as part of this 
project 
B. ovatus  
04507M 
Δtdk 04507M bacova_04501 D265A genomic mutant created as part 
of this project 
B. caccae  Wild-Type  
ATCC 43185 
DSM-19024, Type strain (HMP Consortium, 2010). 
B. theta 
-iotaomicron  
Wild-Type 
ATCC 29148 
DSM-2079, Type strain (Xu et al., 2003).  
B. xylansolvens  Wild-Type 
CCUG 53782 
DSM-18836, Type strain (HMP Consortium, 2010). 
B. fragilis  Wild-Type 
ATCC 25285 
DSM-2151, Type strain (Cerdeño-Tárraga et al., 2005). 
B. uniformis  Wild-Type 
ATCC 8492 
DSM-6597, Type strain (HMP Consortium, 2010). 
B. intestinalis  Wild-Type 
 JCM 13265 
 
DSM-17393, Type strain (HMP Consortium, 2010). 
B. theta 
-iotaomicron 
8764  
Wild-Type Provided by Eric Martens 
B. adolescentis  Wild-Type 
 
DSM-20083, Type strain (Suzuki et al., 2006) 
B. longum  Wild-Type 
ATCC 15707 
DSM-20219, Type strain (HMP Consortium, 2010). 
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2.6. Growth Media 
Antibiotic selection was used within media to ensure only cells transformed with a 
desired plasmid could grow as outlined (Table 2.3.). 
 
Media were used as plates with the addition of 2 % (w/v) of agar or alone as 
broth. 
Rich media was used when a high cell density was required. Minimal media were 
used in conjunction with 0.5 % final w/v of the desired carbon source to monitor 
bacterial utilisation of target carbohydrates (minimal medium lacking this 
carbohydrate component was unable to support any growth). Selenomethionine 
medium was used for the production of proteins with the inclusion of 
selenomethionine for use during x-ray crystallography analysis in order to solve 
the phase problem. All media, together with a description of use is listed (Table 
2.4.) 
Table 2.3. Antibiotics 
Antibiotic Working Concentration For use with: 
Ampicillin  100 µg/ml pET-32b, pET-22b, pET-21a, PCR Blunt®, 
pGEX_6P_1, pExchange tdk- 
Kanamycin 
 
50 µg/ml pET-28b 
Chloramphenicol 
 
30 µg/ml pLysS 
Gentamycin 
 
200 µg/ml pExchange tdk- 
Erythromycin 
 
25 µg/ml pExchange tdk- 
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Table 2.4. Media  
Medium Composition Quantity 
(per litre) 
Description/Method 
Luria-
Bertani 
(LB) 
LB powder, as supplied (Sigma-
Aldrich) 
25 g Rich culture medium for E. coli 
Components dissolved in water and 
pH adjusted to 7.2 with NaOH. 
Tryptone 
Yeast 
Extract 
Glucose 
(TYG) 
Tryptone 
Yeast Extract 
Glucose 
Cysteine, free base 
1 M KPO4 pH 7.2 
 0.4 mg/ml FeSO4 
1 mg/ml Vitamin K 
0.8 % CaCl2 
0.25 mg/ml Resazurin 
TYG Salt Solution (MgSO4  
0.5 g/l, NaHCO3 10 g/l, NaCl 2 g/l) 
10 g 
5 g 
2 g 
0.5 g 
100 ml 
1 ml 
1 ml 
1 ml 
4 ml 
40 ml 
Rich culture medium for Bacteroides 
 
Components were dissolved in water 
and adjusted to 1 l. This medium is 
self pHing to 7.2. His-heme* was 
added prior to innoculation at a rate of 
1 µl per 1 ml. 
Minimal 
Media 
Bacteroides 
(mm-target 
glycan) 
NH4SO4 
Na2CO3 
Cysteine, free base 
1 M KPO4 pH 7.2 
0.4 mg/ml FeSO4 
1 mg/ml Vitamin K 
0.01 mg/ml Vitamin B12 
0.25 mg/ml Resazurin 
MM Salt Solution (NaCl  
18 g/l,CaCl2 0.53 g/l, MgCl2 0.4 g/l, 
MnCl2 0.2 g/l, CoCl2 0.2 g/l) 
1 g 
1 g 
0.5 g 
100 ml 
10 ml 
1 ml 
0.5 ml 
4 ml 
50 ml 
Minimal Medium optimised for 
growth of Bacteroides with the 
addition of a target glycan 
 
Prepared as with TYG. The target 
glycan (250 µl of a 10 % (w/v) 
solution), was added prior to 
inoculation. His-heme* was added 
prior to innoculation at a rate of 1 µl 
per 1 ml. 
Brain-Heart 
Infusion 
(BHI) 
BHI powder, as supplied (Sigma-
Aldrich) 
37.5 g Rich culture medium for Bacteroides 
and E.coli. His-heme* was added prior 
to innoculation at a rate of 1 µl per 1 
ml. 
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Table 2.4. Media (Continued) 
Medium Composition Quantity 
(per litre) 
Description/Method 
Minimal Media 
Bifidobacteriu
m  
(mm-target 
glycan) 
Peptone 
Tryptone 
KCL 
NaCO3 
NaCl 
MgSO4 
CaCl2 
MnSO4 
FeSO4 
ZnSO4 
Cysteine, free base 
1 mg/ml Vitamin K 
6.5 g 
2.5 g 
2 g 
0.2 g 
4.5 g 
0.5 g 
0.45 g 
0.2 g 
0.005 g 
0.005 g 
0.5 g 
0.005 ml 
Minimal medium optimised for growth of 
Bifidobacterium species with the addition 
of a target glycan. His-heme* was added 
prior to innoculation at a rate of 1 µl per 1 
ml. 
(Heavily adapted from Van der Meulen et 
al., 2006) 
Clostridial 
Media (CM) 
CM powder, as supplied 
(Sigma-Aldrich) 
33 g Rich culture medium for the growth of 
Bifidobacterium. His-heme* was added 
prior to innoculation at a rate of 1 µl per 1 
ml. 
His-Heme* Hematin 
0.42 g/l Histidine HCL pH 8 
1.2 g 
1 l 
Added to several of the above media as 
specified, for enhanced growth of 
Bifidobacterium and Bacteroides species. 
* His-Heme was added to most media after sterilisation, prior to inoculation to improve 
the growth of Bifidobacterium and Bacteroides species. 
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2.7. Routine Equipment Usage 
2.7.1.   Centrifugation 
Large volumes were centrifuged using a Beckman J2-21 centrifuge with a JA-10 
fixed angle rotor in 500 ml centrifuge tubes (Nalgene) at a maximum speed of 
10,000 rpm (17,650 x g). A JA25.5 rotor with 50 ml centrifuge tubes (Nalgene) 
was used for smaller volumes at a maximum speed of 25,000 rpm (75,398 x g).  
A Harrier 18/80R centrifuge with swing out rotor was used with vivaspin® 20 
concentrating centrifuge tubes (Sartorius Stedim Biotech) with a molecular weight 
cutoff of 10, 30 or 50 kDa to concentrate solutions.  
 
Volumes between 2 – 25 ml were centrifuged using 30 ml universal tubes 
(Sterilin) in a Hettich Mikro 220R benchtop centrifuge with fixed angle rotor at a 
maximum of 14,000 rpm (4,025 x g).  
 
Volumes 2ml or under were centrifuged in a Haraeus Instruments Biofuge pico 
using 2 ml or 1.5 ml microfuge tubes (Eppendorf).  
 
2.7.2.   Incubators, Heat Blocks and Water Baths 
Agar plates were inverted and incubated using a static incubator at 37 °C (LEEC 
Ltd). E. coli cultures were incubated, shaking (180 rpm) at 37 °C during growth or  
16 °C during protein expression using an orbital incubator (Sanyo Biomedical). 
 
A heat block was used to incubate volumes under 2 ml using microfuge tubes 
(Eppendorf), most commonly for E. coli transformations at 42 °C. A water bath 
was used to incubate non cell culture material to temperatures between 30-80 °C.  
 
Bacteroides and Bifidobacterium cultures were incubated (static) at 37 °C in an 
anaerobic chamber (Don Whitely Scientific). 
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2.8. Transformation of E.coli 
Competent E.coli were made by Mr. Carl Morland and stored at -80 °C in 100 µl 
aliquots for up to a year. Each aliquot was incubated on ice until thawed and 
approximately 200 ng of the desired plasmid was added. Cells were mixed by 
gentle flicking and incubated on ice for 1 hour. Cells were then subjected to 42 °C 
for 1 minute before being transferred back to ice for a further 2 minutes. LB broth 
(400 µl) was added to the cell suspension and the culture was allowed to grow at 
37 °C for 2 hours. Cells were centrifuged gently (1,000 x g) for 5 minutes and 400 
µl of the supernatant removed. The remaining 100 µl of gently suspended cell 
culture was plated onto plasmid appropriate selective medium and grown at 37 °C 
overnight.  
 
2.9. DNA Manipulation 
2.9.1.   Polymerase Chain Reaction (PCR) 
The Polymerase Chain Reaction (PCR) originally developed by Mullis and 
Faloona in 1987 was used throughout this project for the amplification of targeted 
regions of DNA for use in downstream applications. PCR requires a thermostable 
polymerase protein which extends a region of DNA to which a primer, a small 
DNA fragment, has annealed. Cycles of different temperatures are carried out to 
first melt double stranded DNA, then allow the oligonucleotide primers to anneal 
and finally allow the polymerase to extend the primer through the addition of free 
nucleic acids to the growing DNA chain. Each reaction was made to a final 
volume of 50 µl using PCR grade water in a 200 µl sterile PCR tube (Eppendorf). 
Reactions were constructed as shown (Table 2.5.) 
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Table 2.5. Polymerase Chain Reaction Composition 
Reagent  Concentration in 50µl Reaction 
KOD Hot Start DNA Polymerase*  0.25 U 
10X Buffer for KOD Hot Start DNA 
polymerase* 
0.12 M Tris-HCL, 10 mM KCl, 6 mM (NH4)2SO4, 
0.1 % Triton X-100, 0.001 % BSA, pH 8.0
 
 
 dATP* 0.2 mM  
dTTP* 0.2 mM  
dGTP* 0.2 mM  
dCTP* 0.2 mM  
MgCl2* 0.125 mM  
DMSO 5 % (v/v)  
Forward Primer 50 pM 
Reverse Primer 50 pM 
Template DNA 1 µg/50 µl) 
* Component from Novagen® Hot Start KOD polymerase kit. 
 
Routine PCR reactions were carried out with the following program as standard; 
however annealing temperature was sometimes optimised according to the 
melting temperature of the primer set (3-5 °C below Tm). Additionally, a final 
storage step of 10 °C could be set indefinitely if required. 
 
Table 2.6. Standard Program for Polymerase Chain Reaction. 
Initial Denaturation 95 °C 2 minutes 
                 Denaturation 95 °C 1 minute 
                 Annealing 55 °C 0.5 minutes 
                 Elongation 68 °C 0.5 minutes per 1kb to be amplified 
Final Elongation 68 °C 10 minutes 
 
Sewing PCR required an additional step before running a routine amplification. A 
program of 10 cycles of denaturation, annealing and elongation (lacking the initial 
denaturation and final elongation steps) were carried out.  
 
QuikChange® mutagenesis was carried out in order to alter DNA sequences 
within a defined plasmid. PCR reactions and program were constructed and 
performed as stated in the protocol (QuikChange®, Stratagene).  
35 
cycles 
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2.9.2.  Primer design and usage 
Polymerase Chain Reaction (PCR) requires two primers, each complementary to 
one strand of the DNA and placed, 5’ 3’, at the terminals of the region to be 
amplified. Primers in this project were designed differently to perform one of four 
functions:  
 
1) Amplification Primers: To amplify specific regions of DNA for further use 
(e.g. cloning). 
2) Probe Primers: To amplify a small region of DNA within a target gene for 
detection purposes. 
3) Sewing Primers: To “stitch” two regions of DNA together. These primers 
were used in conjunction with amplification primers. 
4) Mutatgenesis Primers: To mutate a small region of DNA which has been 
cloned into a plasmid. 
 
Amplification primers were the most widely used primer type in this study. Each 
primer was designed to be roughly 20 base pairs in length and, ideally, have a 
melting temperature (Tm) above 55 °C. These primers were prefixed with a single 
codon and a nuclease restriction site. The initial codon was present to allow the 
nuclease protein more space on the DNA fragment to cleave, as efficiency of 
these proteins may drop when the site is present at a fragment terminus. Target 
DNA sequences were checked for naturally occurring restriction sites using the 
online tool, NEBcutter (Vincze et al, 2003). Where possible, primer ends were G-
C rich, as this forms an additional hydrogen bond and can increase annealing 
efficiency. 
 
Probe primers were required for quantitative PCR as discussed later (Chapter 
2.15). Each primer amplified a small region of DNA (100-300 base pairs) and was 
designed without any additional prefix. Primer3Plus (Untergasser et al., 2007) 
was used to generate potential probes, and these were checked for specificity 
using routine PCR to ensure only one band of the correct size could be detected. 
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Probes must be specific to within the target gene, and must not amplify any other 
regions. 
 
Sewing PCR was used to prepare plasmids for gene deletions. This technique is 
discussed separately as part of a larger protocol (Chapter 2.16.). 
 
A set of two mutagenesis primers were created by taking a 30 base pair stretch of 
DNA and making the necessary alterations to the sequence, then creating a 
complementary primer at the same location, with the same mutation. Only one 
codon was altered per round of mutagenesis. Mutagenesis reactions were carried 
out as per the instruction manual (QuikChange ®, Stratagene). 
 
Melting temperatures of primers were checked using the online web tool 
OligoCalc (Kibbe, 2007). This tool uses the following formula to calculate Tm; 
 
Tm = 64.9 + 41(yG + zC –  16.4) (wA +  xT +  yG +  zC)  
 
Where w,x,y and z are the number of bases A, T, G and C in the sequence, 
respectively. 
 
All primers were manufactured by MWG-Biotech and supplied lyophilised. 
Primers were dissolved in PCR grade water to 100 pmol/µl. 
 
A list of key primers used within this project can be found in Appendix I (Table 
I.7.). 
 
2.9.3.   Agarose Gel Electrophoresis 
Linearised DNA fragments were separated by size and visualised by 
electrophoresis in submerged horizontal agarose gels (Brody & Kern, 2004) 
regularly during manipulation to ensure the DNA was the correct size and 
concentration.  
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Agarose gels (1 % w/v) were made by combining 0.5 g of agarose in 50 ml of 
TBE buffer (89 mM Tris-borate and 2 mM EDTA, pH 8.3). The agarose 
suspension was dissolved by boiling and allowed to cool (<50 °C) before addition 
of ethidium bromide (1 µg/ml). Ethidium bromide is a dye which can intercalate 
into the DNA structure and be visualized by UV light.  
 
Gels were cast in mini-gel trays (Applied Biosystems) and once set submerged in 
50 ml TBE buffer. Loading buffer (10x concentration: 0.25 % w/v Bromophenol 
Blue, 50 % v/v Glycerol, 10x TBE) was added (1 µl) to the DNA sample (9 µl). 
DNA samples were loaded into the gel wells adjacent to the appropriately sized 
DNA standards (Hyperladder I or IV, Bioline) and gels were electrophoresed at 
70 volts for 1 hour. 
 
Gels were visualised using a gel documentation system (Bio-Rad Gel Doc 1000, 
Molecular AnalystTM/PC windows Software). Photographs were printed with 
linked Mitubishi Video Copy Processor P68B with Mitsubishi thermal paper. Gel 
images were archived digitally for the duration of this project. 
 
The size of linear double stranded DNA is determined by comparison to the 
known DNA standards (HyperladderTM I or HyperladderTM IV, Bioline), these 
standards are shown (Figure 2.1). DNA fragments migrate through the gel matrix 
at a rate inversely proportional to the log10 of the size of the nucleic acid.  An 
example of an agarose gel from this project is displayed (Figure 2.2).  
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Figure 2.1. DNA ladders. This figure is adapted from the Bioline online catalogue. Two 
DNA ladders were used for comparison during this project, both from Biolone. (A) 
HyperladderTM I was used for viewing fragments between 200 and 10,000 bp and (B) 
HyperladderTM IV was used for viewing smaller fragments, between 100 and 1,000 bp.  
Figure 2.2. Agarose Gel Visualisation. This agarose gel shows a typical step in the 
cloning procedure. Newly cloned plasmids are digested with the two endonuclease 
enzymes used during plasmid construction, resulting in a band which corresponds to the 
vector, and a band which corresponds to the insert when visualised via agarose gel 
electrophoresis. HyperladderTM I (HL1) and the empty linearised vector (Pet21b) are run 
for comparison. Multiple clones are screened in this manner in case ligation efficiency of 
the desired fragment is poor, in this case all 10 clones screened contained an insert of the 
correct size (SusD-homologue, 1.7 kb). 
 
2.9.4.   DNA purification 
PCR products and other DNA fragments were purified using a QIAquick PCR 
Purification Kit as per the manufacturer’s instructions (Qiagen). In cases where 
the desired DNA fragment was impure a Gel Extraction Kit was used as per the 
manufacturer’s instructions (Qiagen). Purified fragments are eluted in 10 mM 
Tris-Cl pH 8.5. 
Vector 
Insert 
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2.9.5.   DNA Digestion and Ligation 
Endonuclease restriction sites were chosen during primer design to match those 
required by the chosen vector. Digestion reactions were made to 40 µl total 
volume with PCR grade water and comprised of 1 µg DNA and the appropriate 
concentration of each enzyme in the buffer recommended by the manufacturer 
(DoubleDigest Caculator, Thermo Scientific). Restriction digests were incubated 
for 1 hour at 37 °C in sterile microfuge tubes (Eppendorf). Digested DNA 
fragments were purified after digestion to remove endonuclease enzymes and 
buffer. 
 
Digested DNA fragments and vectors containing matched cohesive ends were 
used for ligations. 20 µl final volume made up with PCR grade water was used for 
ligation reactions. 4 µl of 5x T4 ligase buffer (250 mM Tris/HCL pH 7.6, 50 mM 
MgCl2, 25 µM ATP, 25 mM dithiothreitol, 25 % (w/v) polyethylene glycol 8,000) 
and 1 µl (5U) T4 ligase were added per reaction. DNA was added so that insert 
was in at least 3 times molar excess of vector. This 3x excess was calculated using 
the formula: 
Mass of insert (ng) = 3 ! Size of Insert (bp)Size of Vector (bp)( ∗ Mass of Vector (ng) 
 
T4 ligase and T4 ligase buffer were produced by Invitrogen. 
 
2.9.6.   Determination of DNA and RNA concentration 
DNA concentration was determined by comparison to known DNA standards on 
an agarose gel. DNA and RNA was quantified using a NanoDrop 2000 UV-Vis 
spectrophotometer (ThermoScientific). For DNA quantification both methods 
were used and respective concentrations were compared to ensure fidelity.  
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2.9.7.   Preparation of Plasmids for Protein Expression 
Plasmids designed for protein expression were compatible with BL21 or Tuner E. 
coli expression strains. Each plasmid contained an appropriate antibiotic 
resistance gene. All plasmid systems contained a lac operator and lacI repressor 
from the lac operon system (Jacob and Monod, 1961), which allows induction of 
protein when IPTG or lactose is present in the media.  
 
PlysS was used in conjunction with an expression vector in order to reduce 
expression during exponential phase before induction. This could be done to 
increase yield of target protein or reduce the effect of protein toxicity during over 
expression.  All constructs used for protein expression contained a His- or GST- 
tag for purification. 
 
Purification of protein using these constructs is further described in Chapter 2.12. 
 
2.9.8.   Preparation of Plasmids for Genomic Disruption 
A plasmid carrying a region homologous to part of the Bacteroides genome, but 
lacking the target gene, was required for genomic disruption in Bacteroides 
ovatus. Genomic disruption in using these plasmids was undertaken as described 
in Chapter 2.16. The CC118 λ pir strain of E.coli was used for cloning of these 
fragments into the pExchange tdk plasmid. Restriction sites BamHI and XbaI 
were routinely used, and SalI or SpeI used if necessary. 
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To remove a gene, a fragment was required which possessed homology to a 
region of at least 1,000 bases upstream and 1,000 base pairs downstream of the 
gene, but lacking the gene ORF entirely. These regions are referred to as the 
upstream and downstream flanks. 
Figure 2.3. Sewing PCR was used to Generate Gene Knockout Fragments. Sewing 
PCR was used to remove a gene from a fragment of DNA. (A) Two 1,000 bp regions 
flanking the gene of interest were amplified during two distinct reactions using an 
amplification primer (primer 1, primer 4) and a sewing primer containing homology to 
the terminus of the flank to be joined (primer 2, primer 3). This step creates two 
fragments with a region of complementarity. (B) The first step of the two-step sewing 
PCR cycle contains only the two gene flanks, which act as both primer and template 
DNA to each other. (C) The second step of the two-step sewing PCR cycle is undertaken 
with the addition of the two amplification primers (primer 1, primer 4). (D) A hybrid 
fragment is created which lacks the target gene. 
 
Four sets of primers were required for construction of this fragment, two 
amplification primers and two internal “sewing” primers which allowed the two 
flanks to be joined (Figure 2.3). The upstream primer (Primer 1) and the 
downstream primer (Primer 4) were designed as for routine amplification primers 
with appropriate restriction sites.  
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Primer 3 and 4 were designed by selecting the 20 bases pairs immediately 
upstream from the start codon and the 20 base pairs directly after the stop codon 
and adding these together to form a 40 base pair sequence. This sequence was 
used in antisense (Primer 3) and sense (Primer 4) to target each DNA strand. 
 
The first step (Figure 2.3 A) is to create the two flanks, with homologous region. 
This is done by using primer set 1 + 2 and primer set 3 + 4 in two distinct routine 
PCR amplifications. 
 
The second step (Figure 2.3 B) is to join these flanks together. This is done using 
a two-step PCR protocol as outlined (Chapter 2.9.1). The first cycle is performed 
with no primers or template DNA, but both flanks in equal concentration around 1 
µg. As the flanks contain complementarity they will act as both primer and 
template to each other. After 10 cycles the amplification primers are added 
(Primer set 1 + 4) in order to efficiently amplify the newly constructed 2,000 base 
pair fragment (Figure 2.3 C).   
 
It was essential to begin with both flanks at equal concentration; otherwise the 
reaction would favour the amplification of one flank above the other and result in 
an undesirable 1,000 base pair product. Once obtained, the 2 kb fragment was 
then purified and ligated into pExchange tdk vector. 
 
If obtaining the sewing fragment was unusually difficult, PCR Blunt vector was 
used as an intermediate vector after the second PCR step. PCR Blunt accepts 
undigested PCR products directly and may be transformed. The sewing fragment 
could then be digested from this intermediate vector and re-ligated into the desired 
conjugation vector pExchange tdk.  
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Figure 2.4. An Example Sewing Fragment. This 2 kb fragment was obtained during 
preparation of a Δbacova_04507 knockout construct. HyperladderTM I (HL1) was used for 
size comparison. The sewing fragment (arrowed) is 2 kb in size, however there are 
contaminating flank regions which will lower ligation efficiency. The sewing reaction 
was done in quadruplicate so that successful fragments could be pooled. 
 
2.9.9.   DNA Sequencing 
Automated DNA sequencing was performed using the MWG value read service 
(MWG- Biotech). 100 ng of DNA was dried by vacuum lyophilisation at room 
temperature in a 1.5 ml microfuge tube (Eppendorf) with a pre-ordered label 
provided by the company applied. This was sent to the company by postal service. 
 
Sequencing primers were synthesised, stored and used by MWG-Biotech during 
automated DNA sequencing. Most plasmids contained regions targeted by 
standard sequencing primers, such as T7 (TAATACGACTCACTATAGGG) and 
T7term (CTAGTTATTGCTCAGCGGT). If no standard primers were available, 
custom primers were designed to amplify the region of interest, these were 
designed as for normal amplification primers (Chapter 2.9.2.) however no prefix 
was required. 
 
Sequences returned by the company were aligned to the expected sequence using 
online alignment tools such as Clustal Omega and Multalign (Sievers et al., 2011; 
Corpet 1988) to ensure the sequence is as expected. 
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2.10. Routine Protein Analysis 
2.10.1. Determination of Protein Concentration 
Protein concentration could be roughly estimated by comparison to known 
markers using SDS-PAGE. This was performed prior to further analysis to ensure 
the protein sample was pure, and the target protein was of the expected size. 
 
The absorbance of the appropriately diluted pure protein was measured using a 
NanoDrop 2000 UV-Vis spectrophotometer (ThermoScientific) and the 
concentration of protein determined using Beer-Lambert’s law, below: 
 
* = +,- 
 
Where A = Absorbance at 280-320 nm, ε = Extinction co-efficient (M) of the target 
protein calculated online using the EXPASY ProtParam program (Gasteiger, 2005), c = 
concentration (M), and l = path length (cm).  
 
2.10.2.  Adjustment of Protein Concentration and Buffer 
Exchange 
Filtered protein solutions were concentrated using 20 ml or 2 ml VivaspinTM 
centrifugal concentrators (VivaScience) by centrifugation. Buffer exchange could 
be achieved through concentration of the protein solution followed by dilution 
with the required buffer. At least two rounds of concentration were undertaken to 
ensure complete buffer exchange. 
 
For larger volumes buffers were exchanged by dialysis. Protein samples were 
contained with a section of dialysis tubing with a MW cut-off of 13.5 kDa and 
both ends sealed with clips. This was submerged in 4 l of the appropriate buffer 
and 16-24 hours was allowed at 4 °C, stirring, for buffer exchange to take place. 
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2.10.3. Sodium Dodecylsulphate Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) 
Protein was visualised by SDS-PAGE as described by Laemmli (Laemmli, 1970) 
to determine the size, relative purity and relative quantity of the protein. 12.5 % 
polyacrylamide gels (Acrylogel 3; BDH Electran®) were routinely used for 
protein visualisation in conjunction with the AE-6450 apparatus from ATTO 
Corporation (Genetic Research Instruments) which utilises 12 cm x 10 cm glass 
plates sealed with a rubber gasket. All reagents for the creation of these buffers 
and gels are listed (Table 2.7, Table 2.8). The resolving gel was poured into the 
plates, covered with water and allowed to polymerise. The water was then 
removed and the stacking gel poured on top of the resolving gel. A comb is added 
and polymerisation of this second layer is allowed to take place. Before use, the 
comb and rubber seal is removed and the gel affixed within the gel tank, which is 
filled with running buffer. Loading dye is added to samples at a ratio of 1:2 and 
samples are boiled for 2 minutes to denature the proteins. Samples were loaded, 
alongside standards for comparison (Figure 2.5), into the gel wells and a current 
of 30 A (per gel) was applied. 
 
After electrophoresis, the gel was soaked in InstantBlueTM stain (Expedeon) for 15 
minutes to reveal protein bands, after which they were washed in distilled water. 
Gels were then photographed and catalogued (Bio-Rad Gel Doc 1000, Molecular 
AnalystTM/PC windows Software). An example gel is shown (Figure 2.6). 
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Figure 2.5. SDS-PAGE Standards. This figure is adapted from Sigma-Aldrich online 
catalogue. A high molecular weight (A) and a low molecular weight (B) standard (Sigma-
Aldrich) were run on each SDS-PAGE gel for size comparison.  
Figure 2.6. An Example SDS-PAGE Gel. The markers (HMW and LMW) are run so 
that sample sizes can be determined. Well 1 contains a protein of ~70 kDa (GH91 
Enzyme) and well 2 contains a protein domain of ~33 kDa (Inulin Binding Domain). 
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Table 2.7. Preparation of SDS-PAGE Buffers 
Component Reagent  Volume or Concentration 
Running Buffer 
(For 1 l*) 
32 mM Tris/190mM glycine, pH 8.3 
SDS 
350 ml 
0.1 % (w/v) 
Loading Buffer 
(For 10 ml*) 
SDS 
0.25M Tris/HCl, pH 8.8 
Glycerol 
β-mercaptoethanol 
Bromophenol blue dye 
10 % (w/v) 
5 ml 
25 % (w/v) 
2.5 ml 
0.1 % (v/v) 
* Made up to this volume with d.d. H2O. 
 
Table 2.8. Preparation of SDS-PAGE Gels 
Component Reagent  Volume per gel 
Resolving Gel  0.75 M Tris/HCl, pH 8.8 with 0.2 % SDS 
40 % Acrylamide (BDH Electran 
acrylamide, 3 % (w/v) bisacrylamide) 
d.d. H2O 
10 % (w/v) Ammonium persulphate 
TEMED 
2.35 ml 
1.45 ml 
 
0.875 ml 
22.5 µl 
7.5 µl 
Stacking Gel 0.25 M Tris/HCl, pH 8.8 with 0.2 % SDS 
40 % Acrylamide (BDH Electran 
acrylamide, 3 % (w/v) bisacrylamide) 
d.d. H2O 
10 % (w/v) Ammonium persulphate 
TEMED 
0.938 ml 
0.188 ml 
 
0.75 ml 
15 µl 
5 µl 
* Total volume listed is for one gel; gels were routinely made in batches of four. 
 
2.11. Protein Expression 
2.11.1. Protein Overexpression in E.coli 
Plasmids were designed as described (Chapter 2.9.7) and transformed (Chapter 
2.8). A single colony was picked from the resulting transformation plate and 
grown in 5ml of LB broth containing the appropriate concentration of antibiotic 
for 16 hours.  
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The entirety of this culture was used to inoculate 1 l of LB broth with antibiotic 
and this was grown for roughly 4 hours until the culture reached an optical density 
of 0.4-0.8 at 600 nm. Flasks were then cooled to 16 °C by incubation for up to 1 
hour before induction with IPTG (100 mM, final concentration). Induced flasks 
were incubated overnight at 16 °C.   
 
Cells were harvested by centrifugation (10 minutes at 4412.2 x g, 4 °C) and re-
suspended in TALONTM (20 mM Tris/HCL pH 8.0, 300 mM NaCl) or GST 
binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 
pH 7.3) at a rate of 5 ml buffer per 1 l of cell culture. This suspension could be 
stored at -20 °C for up to 3 months before crude protein extracts were prepared. 
 
2.11.2. Preparation of Cell Free Extracts 
Cell suspensions containing the target protein were thawed by incubation at room 
temperature. This cell suspension was sonicated for 2 minutes using a B. Braun 
Labsonic U sonicator set at low intensity (~42 watts and 0.5 second cycling) to 
lyse the cells. Insoluble cell debris was compacted to a pellet by centrifugation (30 
minutes at 27143.1 x g, 4 °C) and the soluble supernatant, the cell free extract, 
was retained for further use. The insoluble fraction was re-suspended in the 
appropriate buffer at a rate of 10 ml per 1 l cell culture and a sample was 
visualised by SDS-PAGE alongside a sample of cell free extract to ensure the 
target protein was present in the soluble fraction. 
 
2.12. Protein Purification 
2.12.1. Immobilised Metal Affinity Chromatography (IMAC) 
His tagged proteins were separated using Immobilised Metal Affinity 
Chromatography (IMAC). Histidine residues interact with electropositive 
transition metals such as cobalt and nickel. Metals are immobilised in a column 
and the His-tag, which is generally six histidine residues long, will stick to this 
column through interaction with the immobilised metal.   
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Imidazole disrupts this interaction by competitively binding to the column; in this 
manner bound proteins may be released and eluted with an imidazole gradient. In 
this project, TALONTM resins containing cobalt ions were used (Clontech 
Laboratories Inc.).  
 
Columns were prepared by allowing 3 cm3 of TALONTM resin settle in a gravity 
flow column. Column volumes were increased up to 5 cm3 if a high protein yield 
was expected. A new column was used for every 2 l of starting culture. Columns 
were equilibrated with 3x column volumes of TALONTM buffer and eluent 
discarded. Cell free extracts (5-20 ml) were applied to the column and the eluent 
collected and retained for SDS-PAGE analysis.  
 
Columns were washed with TALONTM buffer to remove unbound proteins; the 
eluent was collected and retained for SDS-PAGE analysis. 
Columns were then subjected to two concentrations of imadazole (10 mM or 100 
mM imidazole in TALONTM buffer) to elute weakly bound proteins prior to 
tightly bound proteins in 10 ml fractions. This gradient was important for protein 
purity and could be adjusted for each target protein in subsequent purifications.  
 
A sample of each fraction (initial eluent, TALONTM buffer wash, and imidazole 
eluent fractions) was retained for SDS-PAGE analysis, often alongside samples of 
soluble cell free extract and insoluble cell debris. An example of this routine 
analysis is displayed (Figure 2.7). 
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Figure 2.7. Protein Purification using a His-tag. An example of a protein purified using 
a His-tag. Cell free extract (CFE), Cell Pellet (CP) and the initial TALONTM wash (TW) 
contain an impure mix of cell proteins. The target protein is then purified using two 5 ml 
washes of 10 mM imidazole and two 5 ml washes of 100 mM imidazole. The protein, the 
C-terminal region of BACOVA_04502 was ~30kDa. 
 
The TALONTM column could also be used to trap cleaved his-tag after protease 
digestion, allowing pure untagged protein to be collected in the eluent.  
 
2.12.2. GST Tag purification using Glutathione Sepharose 4B 
Glutathione S Transferase (GST) is a small protein which binds with high affinity 
to reduced glutathione. GST fusion proteins can be purified based upon this 
interaction and may also benefit from increased solubility. In this study, GST 
fusion proteins were selectively purified using a glutathione sepharose 4B resin 
(GE Healthcare). GST-fusion proteins bind to immobilised glutathione present in 
the column and are released in fractions by the repeated application of an excess 
of free reduced glutathione. 
 
1 ml of this resin was allowed to settle in a gravity flow column. This was 
equilibrated with 10 ml GST binding buffer. A stopper was applied to the column 
and 5-10 mL of cell free extract was added and incubated for 10 minutes.  
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The stopper was then removed and the flow through collected. A further 10 ml of 
binding buffer was applied to the column to wash off excess unbound proteins.  
1 ml of an elution buffer (50 mM Tris-HCl, 10 mM reduced glutathione, pH 8.0) 
was then applied to elute GST-fusion proteins, this step was repeated up to 5 
times, and fractions containing target protein were pooled. SDS gel visualisation 
was routinely performed during GST purification to ensure the target protein was 
bound and eluted completely. An example of this routine analysis is displayed 
(Figure 2.8). 
 
The glutathione sepharose 4B column could also be used to trap cleaved GST tag 
after protease digestion, allowing pure untagged protein to be collected in the 
eluent. 
 
 
Figure 2.8. Protein Purification using a GST tag. LMW ladder was run for 
comparison. Cell Free Extract (CFE) and Cell Pellet (CP) contain a crude protein mix. 
The initial Flow Through (FT) from the column and the Buffer Wash (BW) shows little 
target protein, suggesting it has bound to the column. The protein is eluted, in this 
example, using two washes (E1, E2) of elution buffer resulting in purified protein. This 
protein is the 3C protease and is ~43 kDa. 
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2.12.3. Gel Filtration Chromatography 
Proteins were purified by gel filtration chromatography using Fast Protein Liquid 
Chromatography (FPLC) with a HiLoadTM 16/60 SuperdexTM 200 Prep grade 
column (GE Healthcare).  
The column was used in conjunction with an ÄKTA pure 25 chromatography 
system (GE Healthcare). The column was equilibrated with two column volumes 
of buffer A (50 mM Tris, 150 mM NaCl, pH 7.5) at a rate of 1 ml/minute. Crude 
protein was concentrated to a volume under 1 ml or 5 ml and loaded with a clean 
1 ml or 5 ml loop respectively.  
 
Proteins were separated on the column using Buffer A at a flow rate of 1 
ml/minute and collected using a fraction collector. Fractions were visualised using 
SDS gels and those containing high yields of pure protein were pooled for further 
use. 
 
2.12.4. Protease Treatment  
Protein constructs were tagged for purification. In some cases this tag became 
undesirable after this purification step and was removed through protease 
treatment; most commonly this was done in preparation for crystallisation trials 
where a flexible tag region could hamper crystal lattice formation.  
 
During cloning it was ensured a protease cleavage site was present between the 
protein of interest and its purification tag. Thrombin or Enterokinase was used in 
conjunction with a pET vector His-tag; 3C protease was used in conjunction with 
P-GEX 6p-1 GST-tag.  
 
Due to differing exposure of the cleavage site within different protein constructs, 
pilot assays (Figure 2.9) were carried out to identify the correct concentration of 
protease to use. Freshly prepared protease (10-50 µM) was diluted and added to 
the protein sample (50+ µM) and incubated for three hours. Based on the results, 
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an appropriate concentration of protease for the sample was chosen and used 
during for full scale reaction. 
 
Figure 2.9. A Pilot 3C Protease Assay. This assay shows the cleavage of a GST tag 
from a protein by the 3C protease. In this assay, 3C protease was used at 10 µM, 5 µM 
and 1 µM and samples were taken at 1, 2 and 3 hours. Uncleaved protein (C) and a LMW 
marker were run as references. Most cleavage appeared to take place within the initial 
two hours, and no further cleavage was seen after overnight incubation. In this instance, 
3C protease was used at the high concentration during the scaled up experiment. 
 
2.13. Protein Characterisation 
2.13.1. Fructose Detection Linked Enzyme Assays 
Fructose was detected using the Megazyme fructose detection kit (Megazyme) in 
order to monitor β-fructosidase activity. This kit relies on three linked enzymatic 
steps to generate nicotinamide-adinine dinucleotide phosphate (NADPH); free 
fructose is phosphorylated by hexokinase, the resulting fructose-6-phosphate is 
then converted to glucose-6-phosphate by phosphoglucose isomerase. In the 
presence of glucose-6-phosphate dehydrogenase, glucose-6-phosphate is oxidised 
by nicotinamide-adenine dinucleotide phosphate (NADP+) to gluconate-6-
phosphate, generating the reduced NADPH (Figure 2.10).  
 
One molecule of NADPH is representative of one liberated fructose unit, however 
as the kit also detects glucose two NADPH molecules are generated upon the 
66kDa 
45kDa 
36kDa 
29kDa 
24kDa 
14.2kDa 
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breakdown of one sucrose molecule (this was accounted for by dividing the final 
values by two when sucrose was the substrate).  
NADPH, thus liberated fructose, can be measured by the increase in absorbance at 
340 nm using the extinction coefficient (6300 M-1 cm-1).  
 
 
Figure 2.10. The Megazyme Linked Fructose Detection Kit.  (A) Liberated fructose is 
phosphorylated and (B) converted to glucose-6-phosphate. (C) Glucose-6-phosphate is 
oxidised by nicotinamide-adenine dinucleotide phosphate (NADP+), resulting in the 
formation of gluconate-6-phosphate and NADPH. NADPH can be measured at 340 nm 
and has an extinction coefficient of 6300 M-1 cm-1. 
 
A spectrophotometer (Pharmacia Ultrospec 4000) was used in conjunction with 
quartz cuvettes to continuously measure absorbance at 340 nm. Cuvettes and 
reaction components were pre-incubated to 37 °C. Reactions were carried out as 
per the manufacturer’s instructions in triplicate with protein from at least two 
fresh preparations using a range of substrate concentrations so that kinetic 
parameters could be elucidated. Data was plotted using Prism 6.0 (GraphPad). 
 
2.13.2. Isothermal Titration Calorimetry (ITC) 
ITC was used to characterise protein – carbohydrate interactions. A MicroCalTM 
VP-Isothermal Titration Calorimeter was used at 25 °C following standard 
procedures. Proteins were dialysed extensively in buffer (20 mM HEPES, pH 7) 
and ligands were dissolved in this dialysis buffer to minimise any heats from 
dilution. Degassed protein solution (1.4331 ml) at high concentration (45-100 
µM) was equilibrated in the reaction cell. Ligand was titrated into this cell in 28 
aliquots of 10 µl with rapid stirring (307 rpm) at 200 second intervals.  
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Ligand concentration was optimised to elucidate binding parameters, but typically 
concentrations around 10 mM for oligosaccharides, and 10 mg/ml for 
polysaccharides were used.  
 
Upon binding, heat is commonly released (exothermic reaction) or absorbed 
(endothermic reaction); during titration the difference in electrical power required 
to maintain the temperature of the reaction cell vs. the reference cell was recorded 
and from these differences the heat change on binding was calculated. 
 
The molar concentration of binding sites present in polysaccharide ligands could 
be calculated following the method used by Szabo and colleagues (Szabo et al., 
2001). If the protein contained a known number of binding sites (e.g. from 
structural studies or previous titrations against oligosaccharides of known 
molecular weight) the concentration of polysaccharide could be estimated; 
concentration was fitted in an iterative fashion until the n-value was as close as 
possible to one. This method was used to calculate the concentration of inulin 
polysaccharide, a previously characterised exo-binding inactive enzyme (BT3082 
D147A) with one binding site was used (Figure 2.11; Szabo et al., 2001; Cuskin, 
Doctoral Thesis, 2012). The levan used in this thesis was estimated at 1 % = 0.25 
mM in the manner described above by Cuskin, 2012 and this estimation was used 
in this thesis (Cuskin, Doctoral Thesis, 2012). 
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Figure 2.11. Estimation of inulin concentration. ITC titration for characterised inactive 
enzyme (BT3082 D147A) predicted the concentration of 1 % (w/v) inulin to be 
approximately 4 mM using the method outlined in the text (Szabo et al., 2001, Cuskin, 
Doctoral Thesis, 2012; Cuskin et al., 2012). 
 
Integrated heat effects, after correction for heats of dilution where necessary, were 
analysed by nonlinear regression using a single site-binding model (Microcal 
Origin, version 7.0.). The fitted data yield the association constant (Ka) and the 
enthalpy of binding (ΔH). Further parameters could be elucidated using the 
following equation: 
 
./01234	  	56	  	57 . 058 
 
Where R is the gas constant (1.99 cal.K-1.mol-1), T is the absolute temperature (298.15 K), 
ΔG is the change in free enthalpy and ΔS is the entropy of binding. 
 
Multiple titrations were undertaken, and average values were calculated for each 
ligand. As the number of datasets collected was variable, these are stated 
alongside binding parameters. Where only one dataset was collected, values were 
estimated from the fitted model. 
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2.13.3. Protein Crystallisation 
Proteins solutions were prepared for crystallisation by IMAC or Glutathione 
Sepharose 4B purification, followed by a further purification step by gel filtration. 
Proteins were concentrated to between 10 mg/ml and 50 mg/ml in water.  
 
Initial protein crystallisation screens (Figure 2.12 A) were performed using 
commercially available screening kits: JCSG+, PACT, Morpheus and Structure 
Screen I (Molecular Dimensions). Screens were conducted on MRC 96 well 
crystallisation plates (Molecular Dimensions) using two sitting drops containing 
200 nl protein solution + 100 nl crystallisation condition and 100 nl protein 
solution + 100 nl crystallisation condition. Screens were set up using a 
MosquitoTM (TTP Labtech) and sealed. Co-crystallisation was performed by 
incubating protein solutions with 20-200 mM required ligand prior to 
crystallisation. Plates were examined using a Leica MZ-6 crystallisation 
microscope (Leica MicroSystems).  
 
Generally, crystals were harvested from screen conditions, however hanging-drop 
24 well Linbro plates (Molecular Dimensions) were set up in some cases to 
achieve larger crystals (Figure 2.12 B). These plates also contained two drops (1 
µl protein solution + 1 µl crystallisation condition and 2 µl protein solution + 1 µl 
crystallisation condition) and were assembled manually. 
 
Three crystal structures were obtained during this thesis, the crystallisation 
conditions are shown in Table 2.9 below: 
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Table 2.9. Crystallisation conditions 
Protein [Protein] 
(mg/ml) 
Ligand: 
[Ligand] 
(mM) 
Condition Cryoprotectant 
SusD-
homologue 
 
BACOVA_ 
04504  
 
Chapter 4.7.4 
25 Sucrose: 
200 
20% (w/v) PEG 3350 
0.2 M Sodium nitrate  
20% PEG 400 
ESBP Open 
Form 
 
BAD_1330 
 
Chapter 5.7.2 
10 N/A 
 
10% (w/v) PEG 20 000, 
20% (v/v) PEG MME 550, 
0.02 M of each 
monosaccharide,  
0.1 M bicine/Trizma base 
pH 8.5 
 
As described (Gorrec, 2009) 
ethylene glycol 
included in screen 
condition 
ESBP Closed 
Form 
 
BAD_1330 
 
Chapter 5.7.2 
10 Kesto-
tetraose: 
200 
12.5 % (w/v) PEG 1000, 
12.5 % (w/v) PEG 3350, 
12.5 % MPD,  
0.03 M ethylene glycol,  
0.1 M bicine/Trizma base 
pH 8.5  
 
As described (Gorrec, 2009) 
ethylene glycol 
included in screen 
condition 
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Figure 2.12. Sitting Drop and Hanging Drop Crystallisation. Crystal screens were 
conducted using (A) sitting drop crystallisation plates, consisting of a protein + 
crystallisation solution drop which sits upon a shelf above the reservoir of crystallisation 
solution. (B) Hanging drop crystallisation plates were used to optimise conditions for 
larger crystals. These were constructed using vacuum grease to seal an inverted coverslip 
containing the protein + crystallisation solution drop above the reservoir. 
 
2.14. Bacterial Cultures 
2.14.1. Culture Preparation and Monitoring 
Bacterial cultures were set up by inoculation of the desired medium using a rate of 
10 µl active bacterial culture or 20-50 µl glycerol stock per 1ml of growth 
medium. All experimental cultures were inoculated from actively growing 
cultures (these were seeded using glycerol stocks). 
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Bacterial cultures could be monitored directly throughout growth using a 96 well 
or 24 well corning® costar ® culture plate (Sigma-Aldrich) in conjunction with an 
Epoch microplate spectrometer (Biotek Instruments Ltd.) inside of an anaerobic 
chamber (Don Whitely Scientific), data was manipulated in Gen5 2.05 software 
and later plotted using Prism 6.0 (GraphPad). 96 well plates allowed for culture 
volumes of 250 µl, and 24 well plates of 1 ml. The plate reader measured and 
recorded the optical density (at 600 nm) of each well at 15 minute intervals. Each 
well was prepared in triplicate and the data averaged. Media without bacterial 
inoculum was always run as a control to ensure no contamination has occurred 
throughout the growth period.  
 
For larger cultures glass test tubes were used to hold 5 ml aliquots of media. 
These were plugged with cotton wool to prevent contamination prior to 
sterilisation. Tubes were inoculated and incubated in an anaerobic chamber (Don 
Whitely Scientific). OD (at 600 nm) was measured using a CO 7500 
spectrophotometer (Biochrom). 
 
2.14.2. DNA Extraction 
DNA extraction from 5 ml cultures was undertaken using the GenEluteTM 
Bacterial Genomic DNA Kit (Sigma Aldrich) according to the manufacturer’s 
instructions. 
 
2.14.3. RNA Extraction and cDNA generation 
RNA extraction from 5 ml cultures was undertaken by first stabilising the culture 
using 10 ml RNAprotect Bacteria Reagent (Qiagen) as per manufacturer’s 
instructions. RNA was extracted using the RNeasy Mini Kit as per manufacturer’s 
instructions. RNA was kept on ice for the duration of the extraction and all 
equipment washed and sterilised prior to the extraction to minimise 
contamination.  
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RNA was quantified after extraction using the NanoDrop 2000 UV-Vis 
spectrophotometer (ThermoScientific). As RNA is unstable, it was converted to 
cDNA immediately after extraction using the QuantiTect Reverse Transcriptase 
Kit (Qiagen) as per manufacturer’s instructions. 
 
2.14.4. Inactive Whole Cell Assays 
5 ml cell cultures were gently harvested by centrifugation (5,000 x g), the 
supernatant removed and the pellet washed with Phosophate Buffered Saline 
Buffer (PBS). This step was repeated twice to ensure thorough washing before the 
pellet was finally re-suspended using 1 ml PBS. In the presence of oxygen, the 
cells are metabolically inactive but retain structural integrity. Thus, proteins which 
do not require ATP (such as CAZymes) presented at the cell surface remain active 
and can be observed. 
 
Whole cells preparations were used as the catalytic agent during assays to detect 
CAZyme activity. 1 ml total reaction volume was used (500 µl whole cell assays, 
500 µl 1 % glycan solution in PBS). Cells were boiled for 10 minutes and this 
matter used as a control reaction. To stop this reaction, samples were centrifuged 
(to remove cells) and the supernatant boiled. These samples were analysed by 
TLC. 
 
2.14.5. Supernatant Analysis 
5 ml cell cultures were pelleted by centrifugation (5,000 x g) and the supernatant 
removed. The supernatant was filter sterilised and visualised via TLC. Enzyme 
activity could be tested by adding glycan to this supernatant and monitoring any 
degradation by TLC visualisation.  
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2.15. Real-time Quantitative Polymerase Chain Reaction 
(qPCR) 
cDNA or gDNA harvested from monocultures or batch cultures could be 
quantified using qPCR (in this thesis, all qPCR was real time qPCR).  
qPCR relies on a dye which releases measurable light during amplification. This 
project used SYBR Green I (Roche), an intercalating dye which absorbs light at 
497 nm and emits light at 520 nm when intercalated into double stranded DNA. 
During each amplification step the samples are illuminated at 497 nm and emitted 
light at 520 nm is measured. The more amplification which occurs during the PCR 
reaction, the greater the intensity of light released, as the dye is incorporated into 
new double strands. A CQ (quantification cycle) value is obtained at the cycle 
where fluorescence from the sample exceeds background florescence, this is the 
point at which it is clear that a fragment is being amplified. A low CQ value 
means fewer cycles were required to detect amplification, whilst a higher CQ 
value shows that more cycles were required. Every experiment included a control 
with the probe set but no template DNA to ensure that background florescence 
was not classed as amplification throughout the experiment. 
 
10 µl Reactions were set up using 5 µl of the SYBR Green I Master Mix (Roche), 
1 µl of each probe (5 µM forward primer, 5 µM reverse primer), 2 µl of template 
gDNA or cDNA and 1 µl of PCR grade water. qPCR was carried out using a 
LightCycler® 480 (Roche) or using a Roche LightCycler® 96. 
 
The qPCR program used is shown below (Table 2.10). 
Table 2.10. qPCR Program and Parameters used throughout this Project 
Initial Denaturation 95 °C 600 seconds 
                 Denaturation 95 °C 10 seconds 
                 Annealing 57 °C 10 seconds 
                 Elongation 
                Measurement* 
72 °C 
72 °C 
10 seconds 
- 
* Measurement taken by exciting samples at 497 nm and measuring emitted light at 520 
nm. 
 
45 
cycles 
 85 
2.16. Genomic Disruption of Genes in Bacteroides ovatus 
pExchange tdk plasmids containing a knockout fragment were prepared (Chapter 
2.9.8). These were transformed into S17 λ pir E.coli cells, referred to as the 
“donor” strain. Bacteroides ovatus tdk- is the “recipient” strain. The donor and 
recipient strains were cultured (5 ml) to roughly equivalent cell densities in LB 
broth and TYG media respectively (Figure 2.13 A).  
Cells were harvested by centrifugation and washed in TYG medium. Equal sized 
cell pellets were then re-suspended in 1 mL TYG medium and spread evenly on 
the surface of BHI plates with no antibiotic. These plates were incubated agar side 
down and grown for 16-24 hours until a thick lawn has formed; E.coli should 
grow first, creating an anaerobic environment underneath this growth in which 
Bacteroides ovatus can thrive, providing the necessary conditions for plasmid 
conjugation from the donor to the recipient strains (Figure 2.13 B). This biomass 
was scraped from the plate and re-suspended in 5 ml TYG medium. 100 µl of this 
solution, along with three serial dilutions (1:10, 1:100, 1:1000) were plated onto 
BHI + gentamycin (200 µg/ml) + erythromycin (25 µg/ml) plates. These 
antibiotics select for the recipient strain and the pExchange tdk plasmid, thus 
colonies represent single recombinant where the pExchange tdk has recombined 
with the genomic DNA via one of the flanks. These plates were incubated 
anaerobically for up to 2 days or until colonies formed, then 10 colonies were 
picked and re-streaked onto fresh BHI + gentamycin + erythromycin plates to 
minimise wild type contamination (Figure 2.13 C). 10 colonies were cultured 
overnight in TYG medium, 1 ml of each culture was taken and a pooled stock 
created. A glycerol stock can be made at this stage for safekeeping (Figure 2.13 
D).  
The pooled stock alongside three serial dilutions (1:10, 1:100, 1:1000) was plated 
upon BHI + FUdR (200 µg/ml) and allowed to grow anaerobically for 2 days or 
until colonies appeared. FUdR is toxic to strains able to synthesise thymidine. The 
recipient strain lacks the tdk gene, but this has been complemented within the 
pExchange tdk plasmid, in this manner FUdR selects for the second 
recombination event, whereby the second flank incorporates into the genome and 
the pExchange tdk sequence is eliminated.  
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10 FUdR resistant colonies were re-streaked onto fresh BHI + FUdR plates to 
minimise wild-type contamination (Figure 2.13 E). 10 resistant colonies were 
picked and cultured in 5 ml of TYG so that genomic DNA could be extracted and 
glycerol stocks could be made (Figure 2.13 F). 
 
Isolated DNA was screened for successful knockout mutations using PCR. The 
downstream and upstream primers used to create the plasmid (primer 1 & primer 
4, Figure 2.3) were used to amplify the clones, using wild-type Bacteroides 
ovatus as a control; the wild-type strain will produce a fragment which is the 
length of the target gene (500-2000 bp), plus the length of both flanks (1,000 bp 
each). Any successful knockouts will lack the target gene, yielding a fragment of 
2,000 bp. Clones which appeared successful after screening were then sequenced 
to ensure the correct mutation had taken place. 
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Figure 2.13. Generating Knockout Strains of Bacteroides ovatus. (A) The donor and 
recipient strains were cultured in 5 ml of LB and TYG media respectively. (B) Equal size 
cell pellets were harvested by centrifugation, washed in TYG, combined and re-
suspended in 5 ml TYG and plated onto BHI plates containing no antibiotics (yellow). 
These plates were not inverted during growth. (C) The plates were scraped and the 
biomass re-suspended in 5 ml TYG. This was plated onto BHI plates containing 
gentamycin (200 µg/ml) and erthyromycin (25 µg/ml) (green). Resistant colonies were 
re-streaked onto fresh plates to minimise wild-type contamination. (D) 10 colonies (these 
represent the first recombination event) were picked and cultured overnight in TYG. (E) 
The cultures were pooled into one stock, which was plated onto BHI containing FUdR 
(200 µg/ml) (blue) to select for the second recombination event, as before these are re-
streaked. (F) 10 resistant colonies are cultured overnight in TYG. Glycerol stocks are 
prepared and DNA extracted for analysis. Inset: A visualisation of the donor and recipient 
DNA, and the first and second recombination events. 
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2.17. Analysis of Carbohydrates 
2.17.1. Purification of Fructans from Plant Material 
Fructans were purified successfully from garlic bulbs using this method, but it can 
be applied to other fructan containing plant material. This method was adapted 
from Baumgartner et al., 2000. 
 
200 g of garlic (raw, broken into segments with the papery skin removed) was 
chopped roughly and transferred to a mortar and pestle and crushed into a rough 
paste. This garlic paste was added to 200 ml hot water at 80 °C. Some of this 
water was used to rinse the mortar in order to retain as much plant matter as 
possible. The mixture was incubated at 80 °C for 1 hour before boiling for 5 
minutes. The mixture was then cooled and strained through cheese cloth to 
remove the solid material. The cloudy filtrate was then centrifuged at 14,000 x g 
for 20 minutes to pellet any additional insoluble material. The supernatant (which 
is now clear) should contain the soluble fructan fraction and can be freeze dried or 
stored at -80 °C.  
 
Analysis by TLC or HPAEC-PAD was required to ensure fructan was present. If 
too much low molecular weight FOS or fructose was contaminating the sample 
further purification could be done by dialysing the solution in water using dialysis 
tubing with an appropriate molecular weight cut off. 
 
2.17.2. Acid Hydrolysis Analysis of Polysaccharides 
Polysaccharides could be hydrolysed to their constituent parts or partially 
hydrolysed into oligosaccharides using acid hydrolysis. 
 
Complete acid hydrolysis was undertaken by incubating the glycan solution (1 % 
w/v) at room temperature (25 °C) for 1 hour with 1 M HCl. Samples were 
neutralised carefully with NaOH and the dilution factor noted. Samples were 
visualised using TLC. 
 
 89 
Partial acid hydrolysis was done as with complete hydrolysis, but an initial pilot 
assay was required; samples were taken at 10 minute intervals and visualised by 
TLC. The time taken for the desired partial hydrolysis was noted and used as the 
stop-point for the scaled-up hydrolysis reaction. 
 
2.17.3. Visualisation of Sugars by Thin Layer 
Chromatography (TLC) 
Thin layer chromatography (TLC) uses a solvent system to separate non-volatile 
mixtures, in this project sugars, across a foil backed silica plate (Silicagel 60, 20 x 
20, Merck). The plate is cut to an appropriate size with a height of at least 10 cm 
and a line drawn 1 cm from the bottom edge across the plate. A small cross was 
drawn every 1 cm along this line to serve as a guide when loading the plate. The 
adsorbent silica layer is loaded with a small quantity of glycan solution (3-5 µl) by 
spotting this onto a cross and allowing the spot to dry. If the solution is too low a 
concentration to accurately detect, additional spots can be added on top of the first 
spot allowing each application to dry. The solvent (comprised of 1-butanol/acetic 
acid/water at 2:1:1) was added to a glass chromatography tank (50 ml per tank of 
dimensions 23 cm x 23 cm x 7.5 cm) and the tank covered tightly. Vapours were 
allowed to equilibrate for at least 2 hours prior to use. The dry TLC plate was then 
placed into the tank, with the solvent reaching just below the pencil line. Different 
sugars will migrate with the solvent at different rates; this is due to differences in 
solubilisation and attraction to the adsorbent layer. Generally, smaller compounds 
will migrate more rapidly than larger compounds, but this is not always the case. 
The TLC was left until the solvent line reached within 1 cm of the top edge of the 
plate, it was then removed, dried and replaced and this mobile phase repeated, this 
results in clearer separation of sugars with similar sizes and solubility within the 
solvent system. Plates were then dried a second time and immersed for 20 seconds 
in orcinol sulphuric acid (comprised of sulphuric acid/ethanol/water 3:70:20 v/v, 1 
% orcinol), this reagent stains sugars and allows for visualisation. Finally, these 
plates were dried and baked at 60-120 °C until sugar bands were visible.  
TLC standards consisting of relevant sugars were always run for comparison. An 
example TLC plate is shown (Figure 2.14) 
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Figure 2.14. An Example TLC plate. This TLC plate shows several different sugars at 
10 mg/ml. Standards (S) consisting of 2 mg/ml (each) of fructose (F), sucrose (Suc), 
kestose (K3), kestotetraose (K4) and kestopentaose (K5) are run for comparison. Samples 
run were fructose (F), glucose (G), kestose (K3), acid-hydrolysed kestose (AH-K3), 
fructotriose (F3), acid-hydrolysed fructotriose (AH-F3), Difructose anhydride + Fructose 
mixture (DFA + F), DFA, and DFA-terminated FOS (DFA-FOS). 
 
2.17.4. Separation of Sugars by High Performance Anion 
Exchange Chromatography with Pulsed Amperometric 
Detection (HPAEC-PAD) 
Oligo- and polysaccharides were also analysed by HPAEC-PAD using an 
analytical CARBOPACTM PA-100 anion exchange column (Dionex) equipped 
with a CARBOPACTM PA-100 guard column.  
The fully automated system (ICS-3000 gradient pump, detector compartment, 
electrochemical detector, auto sampler) had a loop size of 100 µl, flow rate of 1.0 
ml/min, pressure of ≈ 2000 psi and was kept at room temperature; sugars were 
detected by pulsed amerpometric detection (PAD), the PAD settings were  
E1 = +0.05, E2 = +0.6 and E3 = -0.6. The column was equilibrated with sodium 
hydroxide before a gradient of sodium acetate was applied. 100% sodium acetate 
was then applied to elute any material still adhered to the column after the 
gradient step.  
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The column was washed with 500 mM sodium hydroxide and equilibrated with 66 
mM sodium hydroxide for the next run (Table 2.11). Appropriate standards were 
run for comparison. Sugars were loaded onto the column at concentrations of 
around 10 µg/ml. A glucose standard was run before and after data collection to 
control for any loss of detection or variance in elution time over the course of the 
collection period. Data were collected and manipulated using ChromeleonTM 
Chromatography Management System V.6.8 (Dionex) via a ChromeleonTM Server 
(Dionex). Final graphs were drawn with Prism 6.0 (GraphPad). 
 
Table 2.11. Typical HPAEC-PAD Buffers and Program. 
Step Solution Gradient (mM) Time (min) 
1 66mM sodium hydroxide N/A 10 
2 500mM sodium acetate in 66mM sodium 
hydroxide 
0mM – 200mM 
0mM – 500mM 
50 
90 
3 500mM sodium acetate in 66mM sodium 
hydroxide 
N/A 10 
4 500mM sodium hydroxide N/A 10 
5 66mM sodium hydroxide N/A 10 
* Step two consisted of a gradient whereby sodium acetate concentration was increased 
linearly over the allotted time, polysaccharide samples were analysed with a longer 
gradient step than mono- or oligo- saccharides. 
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2.17.5. Identification of small sugars by Matrix Assisted 
Laser Desorption/Ionisation (MALDI) – Time of Flight 
(TOF) Mass Spectrometry  
MALDI-TOF mass spectrometry was undertaken using an ABI Voyager-DE ™ 
STR Biospectrometry™ Workstation (Applied Biosystems) through the Pinnacle 
Facility at Newcastle University. Sugars were mixed with a matrix solution (2,5-
dihydroxybenzoic acid) and applied to the metal plate. Multiple datasets (3x) were 
collected to ensure peaks were consistent.  
An adduct calculator was used to determine peak identity, this calculator was 
developed by the Fien Lab at UC Davis and is available online 
(http://fiehnlab.ucdavis.edu/staff/kind/Metabolomics/MS-Adduct-Calculator). 
 
2.18. pH Controlled Batch Cultures using Human Faecal 
Inoculum 
Batch cultures were performed in collaboration with Ms. Roberta Grimaldi, Dr. 
Adele Costabile and Prof. Glenn Gibson at Reading University, with use of their 
facilities and equipment. Batch cultures were performed as described by Brück et 
al., 2002: 
 
Each culture was set up inside a temperature and pH controlled glass 100 ml 
vessel consisting of an N2 inlet, gas outlet, glass stopper, pH probe, vessel clamp, 
vessel, lid, rubber ring seal, magnetic flea and an acid/base feeder. The magnetic 
flea was placed inside the vessel and the lid sealed on using the rubber seal, a 
liberal application of vacuum grease and the vessel clamp. The vessel has five 
ports within the lid allowing for the placement of the pH probe, the acid/base 
feeder, the gas outlet, the N2 inlet and the stopper, and two ports on the vessel 
jacket which connect to the water bath; all ports were fitted with vacuum grease to 
form a tight seal, the vessels were then sterilised using an autoclave.  
 
The vessels were connected to a water bath through two ports on either side of the 
vessel which allow water flow through a glass jacket around the vessel, keeping 
the contents at 37 °C.  
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All the ports were connected to the necessary apparatus, the pH controller was 
connected to the acid/base feeder and set to correct (by feeding small quantities of 
NaOH or HCl into the vessel) for fluctuations in pH to keep this between 6.7 and 
6.9 during growth. 
 
Autoclaved basal media (35 ml), 5 % (w/v) carbohydrate (10 ml) and freshly 
prepared homogenised faecal slurry in PBS (5 ml) were added to each vessel 
(Table 2.12). Growth occurred over 48 hours; two 1 ml samples were removed 
from each vessel at 0 hours, 4 hours, 8 hours, 24 hours and 48 hours post 
inoculation. These samples were split into a cell pellet fraction and a supernatant 
fraction by gentle centrifugation (5,000 x g) and frozen.  
 
Samples were transported to Newcastle University on dry ice where supernatant 
fluid fractions were visualised by TLC and DNA extracted from the cell pellet 
fraction was examined using qPCR. 
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Table 2.12. Reagents used for Batch Culture Experiments. 
Reagent Composition Description 
Basal Medium (1 litre) 1 g peptone 
1 g yeast extract 
0.05 g NaCl 
0.02 g K2HPO4 
0.005 g MgSO4·7H2O  
0.005 g CaCl2·6H2O  
1 g NaHCO3  
1 ml Tween 80  
0.0025 g haemin  
5 μl vitamin K1  
0.25 g cysteine HCl  
0.25 g bile salts 
Media was dissolved in 1 l 
deionised water and adjusted to 
pH 7.0 before sterilisation by 
autoclaving.  
Carbohydrate Solution  
(10 ml) 
0.5 g Target Carbohydrate 5 % (w/v) carbohydrate solution. 
This was 1 % (w/v) final in the 
vessels.  
Faecal Slurry  10 % (w/v) faecal sample in PBS The fresh faecal sample was 
collected and stored in an 
anaerobic jar at the beginning of 
the experiment and processed 
immediately. Faecal matter was 
weighed and the appropriate 
amount of PBS buffer added for 
a 10 % (w/v) solution (e.g. 10 g 
per 100 ml). This was 
homogenised and particulate 
matter removed prior to use. 
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2.19. Bioinformatics Tools 
2.19.1. Signal Peptide Prediction 
• LipoP 1.0 Server, sequence based prediction of lipid anchored (Type II) 
signal peptides (Bagos et al., 2008). 
• SignalP 4.1 Server, sequence based prediction of periplasmic (Type I) 
signal peptides (Petersen et al., 2011). 
• PRED-Lipo, sequence based prediction of lipid anchored (Type II) signal 
peptides (Juncker et al., 2003). 
 
2.19.2. Crystallography  
• PyMol, visualisation and manipulation of protein structures 
(www.pymol.org). 
• DynDom V2.0, analysis of dynamic domains 
(http://fizz.cmp.uea.ac.uk/dyndom/). 
• DALI Server, identification of structural homologues (Holm & 
Rosenström, 2010). 
• PDBSum Generate, for analysis of protein secondary structure (de Beer 
et al., 2014). 
 
2.19.3. Multiple Sequence Alignments 
• Multalin, multiple sequence alignment (Corpet, 1988). 
• Clustal Omega and Clustal W2, multiple sequence alignment (Sievers et 
al., 2011; Larkin et al., 2007). 
 
2.19.4. Protein Parameters 
• ProtParam, calculates protein parameters based on sequence (Gasteiger et 
al., 2005). 
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2.19.5. Primer Design 
• Oligocalc, calculates oligosaccharide parameters based on sequence 
(Kibbe, 2007). 
• Primer3Plus, assists probe primer design within a given sequence 
(Untergasser et al., 2007). 
• NEBcutter V2.0., checks a DNA sequence for native restriction sites 
(Vincze et al., 2003). 
 
2.19.6. Genetics Tools 
• BLAST (Basic Local Alignment Search Tool), Suite of tools used to 
compare sequence alignments against each other or against a reference 
database (http://blast.ncbi.nlm.nih.gov/Blast.cgi; Altschul, et al., 1990)  
• IMG (Integrated Microbial Genomes), database and toolset for the 
searching and comparison of microbial genome and metagenome datasets 
(Markowitz et al., 2014). 
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Chapter 3 – Analysis of Non-Linear Fructan Structures 
 
3.1. Chapter Overview  
There is a great deal of research into the modulation of the microbiota by linear 
inulin and FOS compared with non-linear fructan structures, including levan and 
plant derived branched inulins; this is likely due to the relevance of linear inulin 
as a prebiotic, however non-linear fructans are found within commonly consumed 
plants and environmental bacteria and therefore presumably make up a significant 
portion of total fructan accessible to the microbiota, although there are too few 
data available at present to provide an accurate estimation of non-linear fructan 
intake. Furthermore, the main body of literature regarding non-linear fructan 
remains within the sphere of plant physiology; with little known regarding their 
role in human nutrition or as MACs. What can be asserted, however, is the 
presence of non-linear fructans from common dietary sources (Table 3.1); wheat, 
onion, garlic and agave have all been shown to contain non-linear fructans 
(Baumgartner et al., 2000; Arrizon et al., 2010; Velazquez-Martinez et al., 2014; 
Verspreet et al., 2007; Bancal et al., 1991; Vijn et al., 1997).  Fructan extracts 
from these plants were either made or obtained for use during this project, an 
overview of the literature on these fructan structures is shown (Table 3.1).  
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 Table 3.1. Common Non-Linear Fructan Structures 
Fructan Source Description* Reference 
Wheat Low molecular weight (LMW) branched 
structures containing both β2-1 and β2-6 
linkages, including bifurcose.  
(Verspreet et al., 2013; 
Bancal et al., 1991; 
Cimini et al., 2015) 
Garlic High molecular weight (HMW) β2-1 
backbone with regular, short β2-6 
branches. 
(Baumgartner et al., 
2000) 
Agave HMW fraction with β2-1 backbone with 
regular, short β2-6 branches; low molecular 
weight fraction is highly branched. 
(Arrizon et al., 2010; 
Velazquez-Martinez et 
al., 2014; Praznik et 
al., 2013; Lopez et al., 
2003) 
Onion LMW fraction includes bifurcose. (Vihn et al., 1997) 
Bacterial Levan Bacterial levan, found in species such as E. 
herbicola, Z. mobilis and B. subtilis is 
highly branched but contains 
predominantly β2-6 linkages. 
(Benigar et al., 2014) 
* A visualisation of the structures of bifurcose, branched inulin from garlic, bacterial 
levan and linear fructan homopolymers are shown in Figure 1.9, Chapter 1.3.1 
 
Previous studies show that Bacteroides ovatus and Bacteroides thetaiotaomicron 
display a mutual exclusivity for linkage type and will only grow on inulin or levan 
polysaccharide respectively (Sonnenburg et al., 2010). The levan utilisation 
system from B. thetaiotaomicron was characterised previously and the inulin 
utilisation system from B. ovatus has been characterised as part of this thesis 
(Sonnenburg et al., 2010; Chapter 4). In this chapter the ability of these two 
species to use mixed-linkage fructans are investigated.  
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3.2. Objectives 
• To visualise extracts from common crop plants using TLC and HPAEC-
PAD, in order to provide evidence for mixed linkage or branched 
structures. 
• To investigate whether Bacteroides ovatus and Bacteroides 
thetaiotaomicron are able to degrade mixed-linkage or branched fructans. 
 
3.3. Acquisition and Analysis of Common Fructan Structures 
3.3.1. Fructan Sources 
Fructan extracts from plants purported to contain non-linear fructans (Table 3.1) 
were obtained in order to further investigate these structures with regards to the 
microbiota. Crude fructan extract was obtained by hot water extraction performed 
as outlined (Chapter 2.17.1) for garlic. Other fructan extracts, also obtained 
through hot water extraction, were a gift from Megazyme (Wheat, Onion and 
Agave). Linear inulin and branched bacterial levan were obtained from Sigma-
Aldrich (Inulin: Chicory and Dahlia; Levan: Z. mobilis and E. herbicola).  
 
Inulin and levan substrates used in this study have been characterised and are 
comprised of exclusively linear β2-1 linkages in the case of the two inulin 
substrates used, Chicory and Dahlia, and mostly β2-6 linkages in the case of both 
levan substrates from E. herbicola and Z. mobilis (Niness, 1999; Blake et al., 
1982; Benigar et al., 2014). Levan samples were of a higher molecular weight 
than inulin samples, and were insoluble above 5% w/v. All other fructan samples 
were soluble at concentrations used within the study, up to 10% w/v.  
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3.3.2. Extraction of Garlic Inulin from Raw Garlic Cloves. 
Garlic fructan was extracted from garlic cloves. To ensure that this garlic extract 
obtained contained soluble carbohydrate polysaccharide, this was visualised via 
TLC (Figure 3.1 A).  The fructose content of the extracted carbohydrate was then 
examined by acid hydrolysis of the garlic extract to component monosaccharides. 
Acid hydrolysis revealed that the extracted carbohydrates were comprised of 
fructose and therefore fructans (Figure 3.1 B).  
The absence of contaminating monosaccharides after hydrolysis indicates that the 
glycan component of the extract is exclusively fructan. The presence of glucose 
was expected, as fructans generally contain a sucrose terminus and thus glucose is 
a minor component of most fructan chains, however the glucose component of 
this glycan may be too low in concentration to detect, or masked by the presence 
of fructose. Once it was confirmed that the extract was comprised of fructan it 
was freeze-dried until a fine dry powder was obtained.  
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Figure 3.1. Acid hydrolysed garlic extract. Two TLC plates are shown before (A) and 
after (B) acid hydrolysis of extracted garlic fructan. Hydrolysis products were visualised 
after diluting with water 1 in 20 for clarity. Standards (0.2 mg/ml of each: fructose, 
sucrose, kestose, kestotetraose, kestopentaose) were visualised for comparison. The 
presence of large quantities of fructose and no obvious contaminants indicate that 
extracted glycans are fructans.  
 
3.3.3. Visualisation of Fructan Structures 
3.3.4.  Thin Layer Chromatography (TLC) Analysis of 
Fructan Sizes 
Fructans were separated based upon size and visualised using TLC as described 
(Chapter 2.17.3). Onion, wheat, agave, chicory, dahlia and garlic hot water plant 
extracts, neosugar® and raftilose® FOS mixtures and bacterial levan from Z. 
mobilis were visualised (Figure 3.2). Dark circles at the bottom of the plate 
indicate high molecular weight (HMW) structures which do not migrate (DP > 
~8). Low molecular weight (LMW) structures could be separated (DP < ~8). 
Defined bands represent structures which have very similar molecular weights and 
similar solubility within the solvent system used; when smears are seen multiple 
different structures are present which do not separate well into distinct bands.  
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Defined bands usually indicate a single molecular weight product which can be 
separated, increasing DP can be observed in the kestose-series standards used 
which produce a clear series of bands.  
 
This pilot study shows that onion, wheat, agave and garlic fructans contain a 
multitude of relatively low molecular weight fructan structures (Figure 3.2). 
These did not separate well into defined bands and are thought to represent 
multiple branched or decorated isomers with similar charges. Agave, chicory, 
dahlia and garlic fructans contained a large proportion of HMW structures which 
did not migrate. Levan (E. herbicola) did not migrate. Onion, wheat and agave 
contained LMW FOS, fructose and sucrose to varying extents. Onion and wheat 
displayed distinct bands, indicating relatively little structural diversity, compared 
with garlic and agave, which migrated in smears. The two FOS fractions run in 
this experiment contained defined oligosaccharides which migrated with the 
kestose series standards used (Figure 3.2). 
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Figure 3.2. TLC visualisation of the different fructans used in this study. Standards 
(S) comprising of 2 mg/ml each of fructose (F), sucrose (Suc), kestose (K3), kestotetraose 
(K4) and kestopentase (K5) were loaded for reference. Onion (O) and wheat (W) fructans 
contain distinct bands with relatively low DP which do not co-migrate with each other. 
Agave (A) fructan is contaminated with fructose monosaccharide but it, chicory (C), 
dahlia (D) and garlic (G) do not migrate indicating that the bulk of this substrate is HMW. 
Neosugar® (NS) and Raftilose® (Rf) are two FOS mixtures obtained from Megazyme 
which contain DP 3-4 and DP 3-6 respectively. Levan (L) from E. herbicola was loaded 
separately with the same standards for reference, and did not migrate. 
 
3.3.5. HPAEC-PAD Analysis of Fructans 
Fructans were visualised by HPAEC-PAD (Figure 3.3.). Onion, wheat, garlic and 
agave fructan display a profile of several irregularly spaced peaks, which are not 
well defined, whilst chicory and dahlia displayed distinct, regular peaks 
characteristic of linear inulins with various chain lengths, despite the bulk of the 
glycan eluting during the wash. Linear kestose series standard with DP up to five 
were used to show increasing DP. The less distinct profiles of onion, wheat, garlic 
and agave suggest that multiple, LMW fructan structures with similar molecular 
weights (i.e. isomers, rather than increasing DP) exist within these extracts 
(Figure 3.3.). These data are consistent with the structures identified in the 
literature (Table 3.1.) and the TLC data (Figure 3.2). 
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Figure 3.3. HPAEC-PAD Visualisation of Fructans. HPAEC-PAD visualisation of 
wheat, agave, garlic, chicory, dahlia and onion fructan extractions. Kestose series 
standards, fructose (F), sucrose (S), kestose (K3), kestotetraose (K4) and kestopentaose 
(K5) were loaded for comparison. A glucose standard was also run but is not shown on 
the graph, instead, a glucose peak (G) from wheat is labelled. All fructans were eluted on 
a sodium acetate gradient (0-200mM). A wash (500mM sodium acetate) was undertaken 
after the gradient was completed. For each trace above the standards, the Y values have 
been staggered to prevent overlapping. Wheat, Agave and Onion extracts contain a 
substantial diversity of small sugars (green box) in addition to glucose (G) and fructose 
(F). Agave, Garlic, Chicory and dahlia contained HMW fructans which did not elute until 
the wash step (dotted line). Chicory and dahlia show three regularly spaced peaks prior to 
the wash step, suggestive of linear inulin of increasing DP. Onion, wheat, and to some 
extent, garlic fractions contained small to mid-length FOS which did not align well with 
the standards and appear to represent multiple structures for each DP, indicating these are 
non-linear fructan structures (grey boxes). 
 
Fructans with HMW from dahlia, agave, chicory and garlic were further analysed 
using a steeper sodium acetate gradient (0-500mM) during HPAEC-PAD 
visualisation, as these could not be satisfactorily visualised using the lower 
gradient shown above (Figure 3.4.). 
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Figure 3.4. HPAEC-PAD analysis of HMW Fructans. HMW fructans were eluted 
using a 0-500mM sodium acetate gradient. Agave and Garlic fructans elute earlier from 
the column, without defined peaks (grey boxes). The lack of distinct, regular peaks 
indicate multiple different fructan structures with similar molecular weights, these 
isoforms likely represent variations in the structure, which cannot occur in linear linkage 
homopolymers, therefore it is likely these structures are non-linear. In contrast, dahlia and 
chicory fructan has a defined peak for each additional fructose unit. Early peaks in these 
two substrates seem split (labelled), it may be that these peaks represent fructans with and 
without sucrose terminations. 
 
Fructan from chicory has been previously characterised as linear β2-1 linked 
inulin (Niness, 1999), dahlia inulin appears to be highly similar to that of chicory 
(Figure 3.4.). Garlic and Agave fructan both display a multitude of overlapping 
peaks highly suggestive of a variety of fructan secondary structures with similar 
molecular weights (Figure 3.4.). 
 
3.4. B. ovatus and B. thetaiotaomicron Cultures Provide Insight 
into Non-Linear Fructan Utilisation in the Gut 
Most of the avaliable fructan substrates were used as the sole carbon source 
during the growth (Figure 3.5 A) of a levan specific Bacteroides species, B. 
thetaiotaomicron, and an inulin utilising species, B. ovatus (Sonnenburg et al., 
2010) to determine if the non-linear fructans were levan, inulin or a mixture of 
linkages.  
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Spent culture supernatant fluid was visualised after 35 hours via TLC to show any 
unused fructan components (Figure 3.5 B). Control cultures without bacterial 
inoculum were visualised for comparison. Both species were cultured in minimal 
media supplemented with glucose as a control as glucose can be utilised very 
effectively by both species (Appendix I – Figure I.5).  
 
As previously observed by Sonnenburg and colleagues, B. ovatus grew on inulin 
but not levan, and B. thetaiotaomicron grew on levan, but not inulin (Sonnenburg 
et al., 2010). The TLC visualisation (Figure 3.5 B) shows a very slight release of 
fructose from inulin by B. thetaiotaomicron despite lack of growth; levan is 
completely depleted from the medium. B. ovatus was unable to degrade levan, 
which was expected as it did not grow (Figure 3.5). B. ovatus grew on inulin and 
depleted the polysaccharide from the media with the production of a waste 
product (later identified as di-fructose anhydride or DFA, Chapter 4.6.7). A 
defined β2-1 linked tetrasaccharide (Kestotetraose) was also tested, which 
demonstrated that B. thetaiotaomicron is unable to use even small inulin 
oligosaccharides.  
 
Garlic fructan supported the growth of both species, with B. ovatus able to utilise 
this substrate more rapidly. The visualised spent supernatant fluid samples 
demonstrate that B. ovatus is able to utilise the entire fructan chain without 
creating DFA, whereas B. thetaiotaomicron is able to utilise the LMW component 
of garlic fructan only (Figure 3.5). 
 
Wheat fructan supported both species. B. thetaiotaomicron was able to clear the 
substrate entirely from the culture medium and B. ovatus depleted much of, but 
not all substrate. No DFA was produced by B. ovatus during growth on wheat 
fructan (Figure 3.5).   
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Figure 3.5. Growth of an Inulin User, Bacteroides ovatus, and a Levan User, 
Bacteroides thetaiotaomicron on various Fructan Extracts. Both species were cultured 
in minimal media supplemented with 0.5 % of each fructan extract, which contain non-
linear fructans. (A)  B. ovatus (blue) grew upon kestotetraose, chicory, onion, wheat and 
garlic extracts but did not grow on levan. B. thetaiotaomicron (red) grew robustly on 
levan and wheat extract, but weakly on onion and garlic extracts and did not grow at all 
on chicory inulin or kestotetraose. Triplicate technical repeats were performed and 
averaged as shown here, several datasets were collected to ensure consistency, and these 
data are representative. (B) Spent supernatant taken after 35 hours post growth reveals the 
extent of degradation of each fructan structure. A standard containing 2 mg/ml each of 
fructose (F), Sucrose (S), Kestose (K3), Kestotetraose (K4) and Kestopentaose (K5), was 
run for comparison.  
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Onion fructan supported the growth of B. ovatus well and resulted in the 
accumulation of DFA suggesting that a component of this glycan is linear inulin 
accessible to the GH91 enzyme. B. thetaiotaomicron was also supported, though 
to a lesser extent (Figure 3.5). 
 
3.5. Discussion 
The findings obtained for each fructan extract were in agreement with previous 
literature exploring the structure of these compounds. 
 
Wheat fructan contained LMW FOS which did not map well to the known, linear 
inulin standards (Figure 3.2 & Figure 3.3). This was consistent with the 
structures expected from the literature, where wheat fructan was comprised of 
both β2-1 and β2-6 linkages, with branching occurring from a “bifurcose” moiety 
(Cimini et al., 2015; Bancal et al., 1991). It remains unknown whether B. ovatus 
can utilise short levan oligosaccharides, however B. thetaiotaomicron cannot use 
LMW β2-1 linked FOS; because B. thetaiotaomicron can fully clear wheat fructan 
from the culture supernatant during growth (Figure 3.5 B) it is unlikely that wheat 
fructan is comprised of β2-1 linked FOS. DFA may only be produced from B. 
ovatus growth on linear inulin (Chapter 4.6), no DFA is observed which would be 
expected if wheat fructan is non-linear. Wheat fructan does not display a regular 
pattern of peaks associated with increasing chain length and is unlikely to be 
solely linear levan; therefore branched levan or mixed linkage fructans are likely 
to be present (Figure 3.3). B. ovatus is able to clear most of the fructans in the 
wheat extract mixture (Figure 3.5 B) and therefore must be able to utilise LMW 
levans, or mixed-linkage fructans such as bifurcose. B. ovatus grows on wheat 
more slowly than B. thetaiotaomicron, though it reaches a similar final optical 
density (Figure 3.5 A) suggesting that it is not as efficient in degrading the 
substrate but may utilise most or all of what is available. 
 
Onion fructan was expected to contain bifurcose (Vijn et al., 1997) but indeed must 
contain a portion of linear inulin as DFA is made during growth on onion fructan 
by B. ovatus (Figure 3.5 B).  
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B. thetaiotaomicron may use some of the available substrate as it rapidly grows 
but to a much lower maximal optical density than B. ovatus, these data indicate 
that a portion of the fructan mixture, presumably the linear inulin, cannot be 
utilised by B. thetaiotaomicron (Figure 3.5 A). Therefore we suggest that a 
portion of onion fructan is bifurcose but this substrate is mainly inulin. 
Interestingly, B. thetaiotaomicron is able to clear much of the larger substrate 
from the media, potentially indicating the presence of large bifurcose type sugars 
which could be utilised or branch points which may be targeted.  
 
Garlic fructan was shown to have a β2-1 linked inulin backbone, with regular β2-6 
linked branch points of 2 or 3 fructose units each (Baumgartner et al., 2000). 
Consistent with this, B. ovatus is able to utilise garlic fructan well, and B. 
thetaiotaomicron may only grow slowly, and to a much lower final OD (Figure 
3.5).  
 
The data suggest that whilst a general preference for either inulin or levan is 
observed in B. ovatus and B. thetaiotaomicron respectively, they may still have 
somewhat overlapping niches regarding non-linear fructan within the human 
intestine. 
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Chapter 4. Inulin Utilisation by Bacteroides ovatus 
 
4.1. Chapter Overview  
The Bacteroides genus is highly abundant in the healthy human intestine. This 
genus is the dominant genus within the prominent Gram negative Bacteroidetes 
phylum (Arumugam et al., 2011; Huttenhower et al., 2012; Eckburg et al., 2005; 
Walter & Ley, 2011).  
 
All saccharolytic members of the Bacteroidetes phylum have been found to 
encode polysaccharide utilisation loci or PULs (Marten et al., 2011). PULs are co-
regulated gene clusters which encode SUS-like systems; SUS systems, named for 
the canonical Starch Utilisation System, are gene products which act collectively 
to target, import and degrade specific glycans (Koropatkin et al., 2012; Martens et 
al., 2009; Flint et al., 2012). Members of the Bacteroides genus encode staggering 
numbers of these systems in order to utilise a wider variety of glycans (Martens et 
al., 2011). The success of this genus in the gut may indeed be due, at least in part, 
to the efficiency and wide variety of these glycan utilisation systems. Bacteroides 
ovatus is a prominent member of the microbiota, and has been shown previously 
to utilise inulin (Martens et al., 2011; Sonnenburg et al., 2010). As such, 
Bacteroides ovatus represents a major potential pathway for inulin degradation 
within the human bowel. 
 
Bacteroides species, particularly B. thetaiotaomicron, have served as models for 
studying PUL. B. thetaiotaomicron was found to utilise levan, but not inulin, 
through a levan PUL, which was characterised using biochemical and genetic 
techniques (Sonnenburg et al., 2010). Sonnenburg and colleagues identified a 
putative fructan utilisation locus within B. ovatus and showed that this species 
utilised inulin, rather than levan (Sonnenburg et al., 2010). However, no insight 
has yet been obtained regarding the mechanism of this putative PUL. 
This chapter describes the biochemical and genetic characterisation of the B. 
ovatus inulin utilisation locus.  
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4.2. Chapter Objectives 
• To experimentally confirm the predicted B. ovatus inulin utilisation 
apparatus. 
• To biochemically and genetically characterise the B. ovatus inulin 
utilisation apparatus. 
• To use these data to construct a molecular model for inulin recognition, 
import and degradation by Bacteroides ovatus. 
 
4.3. Bacteroides ovatus Releases a Range of Glycan Breakdown 
Products during Growth on Inulin 
B. ovatus had previously been shown to utilise inulin (Sonnenburg et al., 2010). B. 
ovatus was cultured using minimal media supplemented with inulin or with 
glucose as a control (Figure 4.1). Culture samples were taken over the course of 
growth and cells removed by centrifugation. The supernatant fluid was visualised 
via TLC to monitor degradation of inulin within the culture media. Extracellular 
oligosaccharides were produced from very early stages of growth; these 
accumulated during the exponential growth phase and were only depleted after 
stationary phase had been reached. A waste product, later identified as DFA 
(Chapter 4.6.7) accumulated in the media. 
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Figure 4.1. Glycan breakdown products are accumulated in the media over the 
course of B. ovatus growth on inulin. (A) Growth was monitored by measuring optical 
density (OD) at 600 nm at 1 hour intervals. Samples were taken over the course of 
growth, sampling points and OD are arrowed (maximum measurable OD600nm = 2). 
Cultures were conducted in duplicate, continuous error bars are displayed using a dotted 
line. (B) Sample supernatant fluid was visualised using TLC. A media only control, C, 
was run alongside the B. ovatus cultures, this was harvested with the last sample to check 
that inulin did not degrade over time in a B. ovatus independent manner. Standards (2 
mg/ml each, stock) consisting of fructose (F), sucrose (Suc), kestose (K3), kestotetraose 
(K4) and kestopentaose (K5) were run for comparison. A waste product later identified as 
Difructose anhydride (DFA, arrowed, Chapter 4.6.7) accumulated and did not appear to 
be degraded. 
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4.4. The Putative Bacteroides ovatus inulin PUL  
The B. ovatus ATCC 8483 genome has been sequenced as part of the HMP 
Reference Genomes project and is avaliable on the Integrated Microbial Genomes 
Database (HMP Consortium, 2010). This genome was used throughout the 
project. The putative PUL identified by Sonnenburg et al., consisted of twelve 
annotated ORFs (bacova_04496  bacova_04507) as illustrated (Figure 4.2. A; 
Sonnenburg et al., 2010). Several genes including a hybrid two component system 
(HTCS) sensor-regulator, fructose kinase and permease and two GH32 family 
enzymes bore high sequence identity to genes from the previously characterised 
B. thetaiotaomicron levan PUL (Sonnenburg et al., 2010; Figure 4.2 B); however 
two GH91 family enzymes are present in B. ovatus but not in B. thetaiotaomicron 
and the SusD- and SusC-homologues are more divergent. B. thetaiotomicron has a 
SusE-like gene, however B. ovatus does not contain an obvious SusE-like 
candidate (Figure 4.2, Sonnenburg et al., 2010).  
Figure 4.2. The putative inulin PUL from B. ovatus compared with the levan PUL 
from B. thetaiotaomicron. (A) The putative inulin PUL from B. ovatus, predicted gene 
product functionality is annotated. (B) The B. ovatus PUL contains genes which share 
high sequence identity with genes from the previously characterised B. thetaiotaomicron 
levan PUL (Sonnenburg et al., 2010), however the SusC/D pair is divergent and two 
GH91 family enzymes are present in B. ovatus but not B. thetaiotaomicron. 
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BACOVA_04498 is a predicted fructokinase with high sequence identity to a 
previously characterised fructokinase, FruK, from Prevotella intermedia (Fuse et 
al., 2012) and BACOVA_04500 is a member of the major facilitator superfamily 
(MFS), this family of proteins mediate the passage of small solutes across lipid 
membranes (Yan, 2013). BACOVA_04500 shares 22% sequence identity with 
FucP, a fucose permease from E. coli which has been found to also import 
fructose (Gunn et al., 1994; Kornberg & Lourenco, 2006); it is likely that 
BACOVA_04498 phosphorylates fructose within the cytoplasm of the cell and 
BACOVA_04500 mediates transport of fructose monosaccharide across the inner 
membrane.  
 
4.5. The putative inulin PUL is up-regulated in the presence of 
inulin and fructose 
Template cDNA was prepared from cultures grown with inulin or fructose as the 
sole carbohydrate source. Quantitative PCR (qPCR) was performed as outlined 
(Chapter 2.15) with probe sets targeting each predicted gene from the locus, 
excluding bacova_04497 and bacova_04499 which were very small. Cultures 
grown on minimal media with fructose and minimal media with inulin were 
compared with cultures grown on minimal media with glucose, which should not 
elicit up-regulation of genes involved in complex carbohydrate processing. The 
fold change of the genes grown on the target glycans was obtained compared to 
the genes grown on glucose.  
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A pilot experiment focused on the SusC-homologue encoding gene bacova_04505 
for which a probe set was designed. SusC-homologues have previously been used 
successfully as proxies for whole PUL activation (Martens et al., 2011; Rogowski 
et al., 2015). The susC-homologue, bacova_04393, from the B. ovatus xylan PUL 
was used as a control (Martens et al., 2011; Rogowski et al., 2015). When B. 
ovatus was grown on xylan only bacova_04393 was upregulated, in accordance 
with the results obtained by Martens and colleagues (Figure 4.3). When grown on 
inulin and fructose, bacova_04505 was strongly up-regulated and bacova_04393 
was not. These data support that the putative inulin utilisation locus was activated 
in the presence of inulin and fructose. 
 
Figure 4.3. Expression of susC-homologues on xylan, inulin and fructose compared 
to glucose. The abundance of transcripts encoding two susC-homologues from B. ovatus 
cultures grown on minimal media supplemented with a target glycan was compared to 
that of cultures grown on minimal media with glucose to obtain a fold change. The susC-
homologue from the xylan PUL, bacova_04393 was up-regulated on xylan but not on 
inulin or fructose. The susC-homologue from the putative inulin PUL, bacova_04505, 
was up-regulated on inulin and fructose, but not xylan. 
 
Probes were designed to target the remaining nine genes and fold upregulation of 
each gene was examined in the same manner (Figure 4.4). Inulin consistently 
elicits a higher fold up-regulation than fructose in most cases, with the exception 
of bacova_04500, the putative fructose permease.  
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Up-regulation of genes in the presence of the monosaccharide fructose in addition 
to that of the polysaccharide strongly indicates that fructose is recognised as a 
signalling molecule for the presence of polymeric inulin, these data match the 
findings for the HTCS present in the B. thetaiotaomicron levan PUL which binds 
to fructose within the periplasm (Sonnenburg et al., 2010).  
 
 
Figure 4.4. The putative B. ovatus fructan locus is upregulated in the presence of 
inulin and fructose. (A) PUL diagram illustrating the genes probed and their annotated 
function. (B) The fold up-regulation of each gene in the presence of fructose or inulin 
compared with glucose is shown, including standard error of the mean (SEM). All genes, 
with the exception of bacova_04506 were up-regulated on inulin compared with glucose. 
Statistical significance (ns = P > 0.05, * = P < 0.05, ** = P < 0.01, *** = P < 0.001) of 
the experimental value compared with the value obtained from the same probe set on 
glucose was determined using a one way ANOVA followed by Tukey’s multiple 
comparison test. Full data is shown in Appendix I Table I.2.   
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4.6. Inulin is processed at the Cell Surface by a Heteromeric 
GH91 Family Enzyme 
4.6.1.   Identification of Endo-Inulinase Activity 
To explore the initial step in inulin breakdown by B. ovatus supernatant fluid from 
cultures grown on inulin was analysed by TLC (Figure 4.1). The data show that 
the supernatant contained FOS (DP ~2-6), indicating that inulin is broken down 
externally prior to import - either at the cell surface or within the media. To 
determine if this activity was localised to the cell surface, B. ovatus was grown on 
inulin and glucose until mid-exponential phase was reached (OD600nm = 0.8-1) and 
inactive whole cells were prepared as outlined to probe surface activity (Chapter 
2.14.4). Whole cells prepared in this manner are metabolically inactive due to 
aerobic conditions, and are unable to actively transport glycans. Endo-inulinase 
activity was observed (Figure 4.5) which matched the activity seen in actively 
growing cultures, this shows that activity is localised to the cell surface. Activity 
was greatly reduced in cells grown on glucose, demonstrating that the enzyme(s) 
responsible are up-regulated in response to inulin.  
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Figure 4.5. Whole cell assays show surface endo-inulinase activity. TLC was used to 
visualise the degradation of inulin by surface associated enzymes in B. ovatus. Assays 
were performed in the presence of inulin with cells harvested from either minimal media 
with 0.5 % inulin (A) or minimal media with 0.5 % glucose (B). Reactions were 
incubated for 5 hours, with sampling every hour. There is clear endo-inulinase activity 
from the cells initially grown on inulin, with FOS, fructose and an unknown product, later 
identified as DFA (Chapter 4.6.7) accumulating over time. The glucose grown cells also 
display some endo-inulinase activity, but this is much less than from cells grown on 
inulin. Standards (2 mg/ml each, stock) consisting of fructose (F), sucrose (Suc), kestose 
(K3), kestotetraose (K4) and kestopentaose (K5) were loaded for reference. 
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4.6.2.   The Two GH91 Enzymes (BACOVA_04502 & 
BACOVA_04503) are Candidates for Endo-activity  
The surface endo-activity detected in growing cultures was initially attributed to 
one of the two GH91 family enzymes present within the putative inulin PUL; 
BACOVA_04502 or BACOVA_04503.  
 
Both genes products contained a predicted type II signal peptide sequence (LipoP 
1.0 Server) indicating that both localised to the cell membrane by attachment to a 
lipid anchor (Figure 4.6).  Previously characterised glycan utilisation systems 
from Bacteroides often contain proteins localised to the cell surface through the 
presence of these Type II signal sequences; making these enzymes candidates for 
mediating the endo-activity seen during whole cell assays (Rogowski et al., 2015, 
Cuskin et al., 2015; Cameron et al., 2014; Larsbrink et al., 2014). 
 
The proteins are members of the GH91 family. BACOVA_04502 is significantly 
larger than BACOVA_04503, containing a region of 273 amino acids at the C-
terminus which does not share homology with other GH91 family enzymes and 
forms a novel carbohydrate binding module which has been previously 
characterised (Shapiro, MRes thesis, 2012; Chapter 1.5). When aligned together 
without this region, BACOVA_04502 and BACOVA_04503 are 31.51 % 
identical (Figure 4.7). Two residues, an aspartate and a glutamate, are thought to 
be directly involved in catalysis in GH91s, as discussed in more detail in the 
introduction (Chapter 1.4.2). These residues were mapped on to the alignment by 
comparing each enzyme with other GH91 family members. Unexpectedly, neither 
protein has both residues; BACOVA_04502 has the catalytic aspartate (D185) and 
BACOVA_04503 has the catalytic glutamate (E196).  This information suggested 
that these proteins operated through a different mechanism than the previously 
characterised BsIFTase (Jung et al., 2007). 
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Figure 4.6. Prediction of Type II signal sequences in BACOVA_04502 and 
BACOVA_04503 using LipoP 1.0 Server. These data are the output files from the 
LipoP1.0 Server, which show strong type II signal sequences predictions for both 
BACOVA_04502 and BACOVA_04503. In Bacteroides species, this suggests that the 
proteins may localise to the cell surface (Sonnenburg et al., 2010; Rogowski et al., 2015; 
Larsbrink et al., 2014). 
  
 121 
 
Figure 4.7. An alignment of the two GH91 enzymes, BACOVA_04502 and 
BACOVA_04503. (A) Sequence alignment between the two GH91 family enzymes 
(BACOVA_04502 0-359 aa; BACOVA_04503 0-357 aa). The predicted type II signal 
peptides are underlined and the two predicted catalytic residues are highlighted; note that 
BACOVA_04502 has the catalytic aspartic acid at 185, but has lost the glutamic acid at 
196; BACOVA_04503 has the glutamic acid at 196, but has lost the aspartic acid at 185 
(B) A visual representation of the gene domains, including the 273 aa inulin binding 
domain from BACOVA_04502. 
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4.6.3.   The GH91 Proteins Interact to form an Active Endo-
Inulinase 
Each GH91 enzyme was cloned and expressed using recombinant E. coli as 
described (Chapters 2.9.7 and 2.11). Proteins were purified using IMAC (Chapter 
2.12.1). Further construct details are listed (Appendix I.8). 
 
Both GH91 proteins were incubated individually with inulin, however no activity 
could be detected with either enzyme. Reaction conditions were optimised by 
altering pH (5-8), salt (0 mM or 150 mM), buffer (tris or sodium phosphate) and 
calcium content (0 mM – 5 mM) to no effect. 
 
However when the two GH91 proteins were added to the same reaction, enzyme 
activity was detected (Figure 4.8).  The largest product formed appears to be 
around DP ~6, therefore this enzyme cannot be active upon inulin series 
oligosaccharides with DP < ~6 (Figure 4.8). 
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Figure 4.8. Endo-inulinase activity requires both GH91 enzymes. To observe the 
progression of the GH91 reaction, both recombinant enzymes (1µM each) were added to 
a 1ml reaction containing 0.25% inulin in 20 mM Tris, 150 mM NaCl, pH 7 at 37 °C. 
Samples were taken at 0, 5, 15, 30 and 60 minutes. A control reaction containing boiled 
enzyme (Boiled Control) was also run for the full 60 minutes before visualisation. Under 
these conditions, the reaction is complete by 30 minutes. All samples and relevant 
standards (stock. 2 mg/ml each) consisting of fructose (F), sucrose (Suc), kestose (K3), 
kestotetraose (K4) and kestopentaose (K5) were visualised via TLC. 
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To see whether inulinase activity was due to sequential action of each protein or 
the formation of an active complex, reactions were set up where each protein was 
incubated with inulin and then boiled to stop the reaction. Reactions were returned 
to 37 °C and incubated with the other GH91 family protein. If both enzymes 
formed an active complex, no activity would be seen under these conditions, 
however if one enzyme modified inulin for cleavage by its functional partner 
activity would be seen in one of these conditions. To test whether an active 
complex was formed, both proteins were also incubated together (Figure 4.9 A-
E). Activity was only seen when both proteins were mixed together, supporting 
that activity is due to an active complex rather than sequential activity. 
 
To explore the importance of the predicted catalytic residues in the GH91 enzyme 
(BACOVA_04502/3) the candidate catalytic residues were mutated to alanine, 
this experiment also allows us to speculate on the formation of the catalytic site 
between the two protein monomers. BsIFTase D233 aligned to BACOVA_04502 
D185 and BsIFTase D244 aligned to BACOVA_04503 E196. Neither of the 
mutant proteins (BACOVA_04502 D185A, BACOVA_04503 E196A) were 
active when incubated with its wild-type partner (Figure 4.9. F & G). 
 
Finally, the enzymatic function of the C-terminal CBM of BACOVA_04502 (377 
aa-650 aa) was explored by expressing this region independently 
(BACOVA_04502 CTD) and by expressing a truncation (0 aa-376 aa) which 
lacks this region (BACOVA_04502 NTD). These constructs were probed for 
activity with the wild type BACOVA_04503 partner. Activity was observed with 
BACOVA_04502 NTD but not with BACOVA_04502 CTD indicating that this 
C-terminal region was not crucial for enzyme function (Figure 4.9. H & I).  
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Figure 4.9. BACOVA_04502 and BACOVA_04503 form an active complex. (A) A 
TLC visualisation of several reaction conditions used to determine the relationship 
between the two GH91 enzymes, BACOVA_04502 and BACOVA_04503. Standards (2 
mg/ml each, stock) of fructose (F), sucrose (S), kestose (K3), kestotetraose (K4) and 
kestopentaose (K5) were visualised for reference. A positive control showing enzyme 
activity (E) and two negative controls (J and K) show no activity. Reaction products are 
arrowed. All reactions (outlined below) contained 1 µM of the relevant construct(s), 0.5 
% inulin in 20 mM Tris, 150 mM NaCl, pH 7 at 37 °C and were incubated for 3 hours 
unless otherwise stated. (B) A visual guide to the constructs used during this experiment 
Reaction Condition: 
A: BACOVA_04502 incubated for 1.5 hours, inactivated. BACOVA_04503 added and 
incubated a further 1.5 hours.  
B: As 1 with BACOVA_04503 incubated prior to addition of BACOVA_04502. 
C: BACOVA_04502 only.  
D: BACOVA_04503 only.  
E: BACOVA_04502 and BACOVA_04503.  
F: BACOVA_04502 and BACOVA_04503 E196A.  
G: BACOVA_04502 D185A and BACOVA_04503.  
H: BACOVA_04502 CTD and BACOVA_04503.  
I: BACOVA_04502 NTD and BACOVA_04503.  
J: BACOVA_04502 and BACOVA_04503 boiled enzymes control.  
K: No enzyme control. 
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An attempt was made to restore enzyme activity within homogenous enzyme 
reactions by reinstating the lost catalytic residue in each monomer 
(BACOVA_04502 D196E and BACOVA_04503 K185D) however neither of 
these constructs was active, suggesting that active complex formation requires 
specific  interaction between BACOVA_04502 and BACOVA_04503 (Figure 
4.10. D & E). We also investigated whether the mutant BACOVA_04502 D185N 
was also able to form an active complex, given that the equivalent mutation was 
not active in BsIFTase (Jung et al., 2007). Asparagine is similar in structure to the 
aspartate it replaces, containing a nitrogen (-NH2) in place of an oxygen (=O) at 
C4. This substitution should form a hydrogen bond at the same place as the 
oxygen within the active site, and it was surprising in BsIFTase that activity was 
lost, though substrate recognition was retained when this mutation was made. 
Activity is retained in BACOVA_04502 D185N (Figure 4.10. C) showing that 
the sugar can still be co-ordinated within the active site by the asparagine in a way 
that activity remains possible - it remains unclear why this is not the case in 
BsIFTase (Jung et al., 2007). 
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Figure 4.10. Mutant GH91 constructs reveal putative active site residues. TLC 
visualisation of the end-point samples from enzyme assays with different GH91 mutant 
constructs. All assays were performed using 1 µM of each enzyme and 0.25 % inulin in 
20 mM Tris, 150 mM NaCl, pH 7 and were incubated at 37 °C for 3 hours. Standards 
(stock, 2mg/ml each) consisting of fructose, sucrose, kestose (K3), kestotetraose (K4) and 
kestopentaose (K5) were run for reference. Positive (F) and negative (G) controls were 
run to visualise reaction products and no reaction respectively. 
Reaction Condition: 
(A) BACOVA_04502 + BACOVA_04503 E196A.  
(B) BACOVA_04502 D185A + BACOVA_04503.  
(C) BACOVA_04502 D185N + BACOVA_04503.  
(D) BACOVA_04502 D196E.  
(E) BACOVA_04503 K185D.  
(F) BACOVA_04502 + BACOVA_04503 positive control.  
(G) BACOVA_04502 + BACOVA_04503 boiled enzymes control. 
 
4.6.4.   The C-Terminal CBM of BACOVA_04502 GH91 
Contributes to the Rate of Endo-Inulinase Activity 
The C-terminal truncation construct, BACOVA_04502 NTD, lacks the inulin 
binding CBM. Incubation of BACOVA_04502 NTD and BACOVA_04503 on 
inulin did not result in altered end-point products compared with wild-type 
BACOVA_04502. To determine if the CBM region contributed to enzyme 
activity rate the BACOVA_04502 NTD and BACOVA_04503 construct mix was 
assayed over a time course of 1 hour and compared to wild type 
(BACOVA_04502 + BACOVA_04503) activity (Figure 4.11).  
Both wild type GH91 enzymes resulted in complete formation of end products 
between 15 and 30 minutes, however when BACOVA_04502 NTD was used, the 
reaction took longer to reach completion, between 30 minutes and 60 minutes, 
suggesting that the CBM may, unusually, play a role during catalysis (Figure 
4.11). This may be explained as the CBM may bring inulin closer to the active 
site, or loss of the CBM region may disrupt protein-protein interactions formed by 
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the two monomers. The accepted paradigm for CBM activity suggests that CBM 
do not enhance activity rate on soluble material, however confer a distinct 
advantage on insoluble matter (Boraston et al., 2004).  
 
Figure 4.11. The C-terminal CBM appended to the GH91 has an effect on enzyme 
activity rate. Two identical enzyme reactions were set up using either 1 µM 
BACOVA_04502 (A) or BACOVA_04502 NTD (B) and wild-type BACOVA_04503, 
0.25 % inulin in 20 mM Tris, 150 mM NaCl, pH 7. Samples were taken at 0, 5, 15, 30 
and 60 minutes and visualised via TLC with the appropriate standards (stock, 2 mg/ml 
each) of fructose, sucrose, kestose (K3), kestotetraose (K4), kestopentaose (K5). The end 
time point of a boiled enzyme control was also run in each case as a negative control. At 
15 minutes (arrowed) there is a clear difference between the progresses of the two 
reactions. 
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4.6.5.   HPAEC-PAD Visualisation of GH91 Inulin 
Breakdown Products  
The GH91 (BACOVA_04502/3) inulin breakdown products were visualised via 
HPAEC-PAD along with kestose series standards. Previous TLC data suggest 
these products co-migrate fairly well with the standards (see Figure 4.8) however 
when visualised with HPAEC-PAD the inulin breakdown products appear larger 
(Figure 4.12).  
Figure 4.12. HPAEC-PAD visualisation of the GH91 products. HPAEC-PAD was 
used to visualise GH91 products (0.1 % w/v). Kestose-series standard consisting of 0.1 
mg/ml each of fructose (F), sucrose (S), kestose (K3), kestotetroase (K4), kestopentaose 
(K5) were run for comparison. 
 
4.6.6.   Enzymatic Hydrolysis of GH91 Products Reveal an 
Unknown Compound 
BsIFTase creates a difructose anhydride (DFA) product (Jung et al., 2007) and we 
wished to investigate the possibility that the BACOVA_04502/3 GH91 enzyme 
created an anhydrous terminus during internal cleavage of inulin. This could also 
explain the discrepancy observed between the co-migration of the GH91 inulin 
breakdown products with the kestose series standards on TLC but not HPAEC-
PAD (Figure 4.8; Figure 4.12).  
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GH91 inulin breakdown products were hydrolysed using BACOVA_04501, a 
GH32 enzyme isolated from the B. ovatus PUL (Chapter 4.8). GH91 products 
(from 2.5 % inulin) were incubated with 1 µM BACOVA_04501 for 3 hours. 
HPAEC-PAD visualisation of the hydrolysed products revealed three products; 
fructose and glucose and an unknown sugar (Figure 4.13). This unknown sugar 
was suspected to be DFA. 
Figure 4.13. Hydrolysis of GH91 inulin breakdown products by an exo-fructosidase. 
HPAEC-PAD was used to visualise the three end-products created by digesting GH91 
products using am exo-fructosidase from the PUL (BACOVA_04501). Two of the three 
products co-migrate well with known monosaccharide standards (0.125 mM each of 
fructose and glucose). The third product (arrowed) did not co-migrate with either of the 
standards used. 
 
4.6.7. DFA-FOS is a Product of the GH91 Enzyme 
BACOVA_04502/3 
4.6.7.1. MALDI-TOF Mass Spectrometry 
The GH32 hydrolysed GH91 products were analysed using MALDI-TOF mass 
spectrometry (Chapter 2.17.5), in which the samples were calibrated using peaks 
of known mass present in the matrix. Several datasets were collected to ensure 
peaks detected were reproducible and not machine artefacts (Figure 4.14).  
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The hydrolysed GH91 products sample (containing glucose, fructose and 
unknown sugar) detected a compound at 347.1 m/z (Figure 4.14 A).  A control 
sample was prepared in the same manner by hydrolysing inulin directly with the 
GH32, BACOVA_04501 (i.e. without GH91 treatment, thus containing only 
fructose and glucose) and in this instance the peak at 347.1 m/z was not detected 
(Figure 4.14 B). Sugars often form lithium adducts, and in the presence of lithium 
a new peak was detected at 331.1 m/z, which was not present in the control 
sample (Figure 4.14 C). The shift in mass in the presence of lithium was 
consistent with a sugar forming lithium adducts. Lithium has a known mass of 
6.941, therefore the mass of the unknown sugar could be calculated as 324.2, and 
the peak detected at 347.1 m/z in the absence of lithium is congruent with a 
sodium adduct of the same size (324.2 + 23 = 347.2). As the GH91 enzyme is an 
endo-inulinase (Chapter 4.6.3), glucose was ruled out as a component of this 
compound. Fructose has a molecular weight (MW) of 180.16, upon glycosidic 
bond formation a water molecule (MW = 18.015) is lost. Therefore a fructose 
disaccharide with one glycosidic bond (180.16 x 2 – 18.015) would produce a 
peak at 342.3 m/z plus adduct mass and a fructose disaccharide with two 
glycosidic bonds (180.16 x 2 – 18.015 x 2) would induce a peak at 324.3 m/z plus 
adduct mass. An error of 0.1 m/z is well within normal detection error of this 
technique and thus the unknown sugar was concluded to be a difructose-anhydride 
with a retained β2-1 linkage and a secondary glycosidic bond of unknown linkage. 
This is consistent with products made by other members of the GH91 family. 
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Figure 4.14. MS of GH91 inulin breakdown products after hydrolysis by 
BACOVA_04501 GH32 exo-fructosidase. (A) Hydrolysed GH91 inulin breakdown 
products (glucose, fructose, unknown) yield a peak at 347.1 m/z which is not seen in (B), 
the hydrolysed inulin (glucose, fructose) control. (C) Hydrolysed GH91 products in the 
presence of lithium result in a lithium adduct of the unknown sugar with a mass of 331.17 
m/z. Given that lithium has a mass of 6.94 m/z, the unknown sugar has a mass of 324.2 
m/z. The peak at 347.1 m/z is an adduct of the unknown sugar and sodium (23 m/z).  
Based upon the predicted mechanism of GH91 family enzymes the unknown sugar 
therefore was identified as difructose-anhydride, the structure of DFA is shown (inset). 
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4.6.7.2. DFA Accumulates in Cultures of Bacteroides ovatus 
Grown on Inulin 
It was suspected that the sugar which accumulates over time in the culture 
medium during growth of B. ovatus on inulin (Figure 4.1) was the terminal DFA 
moiety produced by the GH91 enzyme BACOVA_04502/3 during inulin 
breakdown. To demonstrate this, hydrolysed GH91 products containing DFA and 
spent culture supernatant fluid were visualised by HPAEC-PAD (Figure 4.15). 
The peak identified as DFA during MS (Figure 4.14) co-migrates with the peak 
detected in the culture supernatant fluid, which is strongly supportive of the 
presence of DFA. The GH91 enzyme (BACOVA_04502/3) produces a range of 
DFA-terminated oligosaccharides, these data demonstrate that whilst the majority 
of the breakdown products can be utilised, this DFA moiety is not fermented and 
is released into the media where it accumulates.  
Figure 4.15. DFA produced by the GH91 enzyme is released into the culture 
medium. Hydrolysed GH91 products contain glucose (G), fructose (F) and difructose 
anhydride (DFA). The known DFA from this sample co-migrates during HPAEC-PAD 
visualisation with the unknown sugar from supernatant fluid harvested from late 
stationary phase B. ovatus cultures (minimal media + 0.5 % inulin, e.g. such as shown in 
Figure 4.1 at approx. 24 hours). This demonstrates that the unknown sugar within the 
culture media is DFA produced by the GH91 enzyme during inulin breakdown. 
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4.6.8.   Analysing the Interaction between the 
BACOVA_04502 and BACOVA_04503 GH91 Monomers 
BsIFTase is a homotrimer with a functional catalytic site at the interface between 
each monomer, forming three catalytic sites (Jung et al., 2007). It is unclear 
whether BACOVA_04502/3 is also a trimer. As each subunit contributes a 
catalytic residue (Figure 4.10) only one functional catalytic site would be created 
in either a heterodimer or heterotrimer conformation, therefore, it seems likely 
that BACOVA_04502/3 would form a dimer.  
 
To determine both the ratio of subunits within the functional protein, and to 
characterise the interaction between the two proteins a range of techniques were 
used including affinity gel electrophoresis (AGE), gel filtration and ITC (Figure 
4.16). Where possible (AGE, ITC) experiments were conducted in the presence 
and absence of inulin, in case binding is mediated by substrate; additionally, 
experiments were conducted with wild-type protein or with one of the two 
catalytic mutants (BACOVA_04502 D185A, BACOVA_04503 E196A) to 
prevent catalytic activity interfering with binding kinetics. In all cases no 
interaction between the two protein monomers could be detected. 
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Figure 4.16. Analysis of the interaction between BACOVA_04502 and 
BACOVA_04503 GH91 proteins. (A) When BACOVA_04502 (6 and 2) is loaded the 
band is retarded on inulin (right) compared with water (left) due to the interaction of the 
inulin binding CBM with inulin. To monitor other interactions the CTD truncation, 
BACOVA_04502 NTD was used in conjunction with the BACOVA_04503 catalytic 
mutant, BACOVA_04503 E196Q (3) so that no inulin breakdown could occur. The 
proteins were run individually (4, 5) and BSA (1) was also run as a control. AGE analysis 
showed no difference in band pattern in any of the conditions tried, therefore there was no 
evidence for oligomerisation. (B) Gel filtration chromatograms showed only two peaks 
corresponding to BACOVA_04502 and BACOVA_04503 in monomeric state. Full gel 
filtration data is available in Appendix I (Figure I.2 and I.3). (C) ITC analysis. The 
control (BACOVA_04503 into buffer) demonstrates a dilution event is occurring, and no 
evidence for binding was seen. 
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4.6.9.   Phyre2 Modelling Allows Insight  into GH91 
Structures 
Despite extensive screening, no crystals were obtained for either GH91 protein, 
both individually and together. To provide insight into the possible structure 
adopted by the GH91 oligomer (BACOVA_04502/3) we modelled the structure of 
each monomer using BsIFTase as a template using Phyre2, a program to predict 
the 3D structures of proteins with structural homologues (Kelly et al., 2015). 
BACOVA_04502 NTD and BACOVA_04503 models were aligned with the 
subunits from BsIFTase and the ligand bound with BsIFTase, fructobiose, was 
retained (Figure 4.17). A long dimerization interface joins the two subunits 
together, and there is a wide cleft containing the two catalytic residues and the 
ligand modelled with BsIFTase. BsIFTase is exo-acting and the catalytic site is 
within a pocket which forms interactions around the chain terminus of inulin 
(Jung et al., 2007; Figure 4.17 A). As BACOVA_04502/3 is endo-acting and 
binds to inulin internally on the polysaccharide chain, the active site is predicted 
to adopt a more cleft-like conformation, with space for the polysaccharide to 
extend in both directions; the BACOVA_04502/3 model shows a space around 
the catalytic site which is not apparent in BsIFTase, supporting the requirements 
for endo-activity. In the model the two known catalytic residues are close to each 
other (~11Å), which also fits what is expected from the B. ovatus GH91 enzyme. 
 
 
 
 
  
 137 
Figure 4.17. Phyre2 predictions of BACOVA_04502/3 structure, using BsIFTase 
(2INV) as a model. The structure of BsIFTase (2INV) compared with the Phyre2 
predictions for the structure of BACOVA_04502/3 aligned into a putative dimer. 
Fructobiose (yellow sticks) from 2INV has been modelled in to the Phyre2 predictions. 
(A) Surface representation highlighting the binding pocket of 2INV vs. the cleft predicted 
in the Phyre2 model. (B) The proteins in cartoon representation, with a close up of 
fructobiose and the two catalytic residues (orange) within the active site. 
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4.6.10. The GH91 Enzyme is not Required for Growth on 
Inulin or FOS 
To explore the role of the GH91 heteromeric enzymes (BACOVA_04502/3), two 
strains were made to disrupt catalysis; Δbacova_04502 and Δbacova_04503 
E196Q. These were made as described in (Chapter 2.16) and are a complete 
knockout of bacova_04502 (one of the GH91 monomers) and a catalytic mutant 
of the full enzyme, respectively. Neither of these mutants displayed surface endo-
inulinase activity, confirming that the two gene products are required for surface 
endo-activity and spent supernatants from neither mutant contains DFA (Figure 
4.27; Figure 4.18). 
 
Figure 4.18. Spent culture supernatant fluid analysis of GH91 mutants. B. ovatus 
wild type (WT), Δbacova_04502 and Δbacova_04503 E196Q strains were grown on 
kestotetraose (K4) or inulin for 24 hours until late stationary phase (OD600nm > 2). 
Supernatant fluid from each culture was harvested by centrifugation. Wild type B. ovatus 
produces DFA (arrowed) as a waste product from inulin however DFA is not produced 
during growth on K4 or by the GH91 genetic mutant strains Δbacova_04502 and 
Δbacova_04503 E196Q. These data show that the GH91 is inactive in Δbacova_04502 
and Δbacova_04503 E196Q and on short FOS such as kestotetose. 
 
Both GH91 mutant strains grew on all substrates similar to wild type (Figure 
4.19). These data show that the GH91 is not essential for growth on any of the 
fructan substrates tested. 
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Figure 4.19. Disruption of the GH91 enzyme does not result in a growth defect on 
any of the substrates tested. The growth of Δbacova_04502 and Δbacova_04503 E196Q 
was monitored in comparison to wild type, these two strains lack active GH91 surface 
endoactivity. All strains were grown on minimal media supplemented with 0.5 % of 
either inulin, glucose, sucrose, kestose, kestetraose or kestopentaose. No growth defects 
were observed in either of these mutants. Multiple datasets were obtained for each 
condition (2-4) and representative data performed in triplicate are shown with continuous 
error bars. 
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4.7. Unprocessed Inulin and FOS are Targeted for Import by a 
SusD-homologue 
4.7.1.   The Bacteroides ovatus PUL Contains a SusD-
homologue, BACOVA_04504 
Other characterised glycan utilisation systems, including the canonical SUS 
system import glycans into the periplasmic space through a SusC/D-homologue 
pair. The SusD-homologue fulfils a binding role and typically targets the 
breakdown products produced by extracellular enzymes (Sonnenburg et al., 2010; 
Rogowski et al., 2015; Cuskin et al., 2015; Larsbrink et al., 2014; Koropatkin et 
al., 2008). 
 
A SusD-homologue, BACOVA_04504, is encoded within the B. ovatus inulin 
PUL. This protein has sequence identity to other SusD family proteins, including 
the SusD, with which it retains 24 % sequence identity.  
 
The SusD is known to localise to the cell surface (Shipman et al., 2000). All 
characterised SusD-homologues contain a conserved type II signal peptide and 
cysteine which is anchored to a lipid within the membrane after signal sequence 
cleavage. All characterised SusD-homologues are thought to localise to the cell 
surface (Sonnenburg et al., 2010; Rogowski et al., 2015; Cuskin et al., 2015; 
Larsbrink et al., 2014; Koropatkin et al., 2008); as BACOVA_04504 retains the 
signal sequence and cysteine it is also thought to be a surface localised 
lipoprotein.  
 
BACOVA_04504 was cloned and expressed using recombinant E. coli as 
described (Chapters 2.9.7 and 2.11). Proteins were purified using IMAC or GST-
purification (Chapter 2.12). Further construct details are listed (Appendix I.8). 
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4.7.2.   The SusD-homologue, BACOVA_04504, Binds to 
Inulin, FOS and Sucrose 
ITC analysis revealed that the SusD-homologue, BACOVA_04504, bound to 
inulin, FOS and sucrose with an affinity (Kd ~0.05 – 0.5 mM) similar to reported 
affinities of other SusD-homologues to their target substrates (Koropatkin et al., 
2008; Cuskin et al., 2015; Sonnenburg et al., 2010). As no significant increase in 
affinity was associated with increasing chain length, BACOVA_04504 was 
predicted to bind to a chain terminus. BACOVA_04504 did not bind to free 
fructose or glucose. Full binding parameters of this protein with the ligands 
described are displayed (Table 4.1.) and representative ITC traces for binding to 
each ligand are shown (Figure 4.20).  
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Figure 4.20. ITC traces showing the SusD-homologue, BACOVA_04504, binding to 
fructan derived ligands. Representative ITC binding traces of the SusD-homologue, 
BACOVA_04504, with β2-1 linked fructan oligosaccharides and inulin. Binding was not 
observed with fructose or glucose. Where binding was observed the data were fitted to a 
single site model shown in the lower panels. Multiple runs for each condition were 
undertaken and each graph shown is representative within this set of repeats. 50-60 µM of 
protein was used during each assay. The buffer was 20 mM HEPES, pH 7.0. 
*Concentration of inulin was estimated as outlined in Chapter 2.13.2 
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Table 4.1. ITC data for the SusD-homologue, BACOVA_04504, binding to inulin, 
FOS and sucrose. 
Ligand N  Ka x 103 
(M-1) 
ΔG  
(kcal mol-1) 
ΔH  
(kcal mol-1) 
TΔS  
(kcal mol-1) 
Sucrose 1.0 
± 0.1 
0.8  
± 0.3 
-3.9 -9 
± 8.2 
-5.1 
Kestose 1.0 
± 0.1 
0.9 
± 0.3 
-4.0 -7.1 
± 1.6 
-3.1 
Kesto- 
tetraose 
1.1 
± 0.1 
1.2 
± 0.4 
-4.2 -10.7 
±7.6 
-6.5 
Kestopentaose 1.0 
± 0.3 
1.2 
0.4 
-4.2 -20 
±9.4 
-15.8 
Inulin* 1.0 
± 0.1 
4.3 
± 0.6 
-5.0 -7.8 
± 1.1 
-2.8 
Multiple (2-6) datasets were used to determine binding parameters for each ligand, 
average values ± standard deviation (SD) are shown. 
*The concentration of inulin was estimated as described (Chapter 2.13.2) 
 
4.7.3.   The SusD-homologue, BACOVA_04504, Recognises 
a Sucrose Chain Terminus 
Experiments were designed to determine which end of the fructan chain the SusD-
homologue, BACOVA_04504, recognised. Unprocessed inulin has two non-
reducing termini, as it is capped by a sucrose moiety at what would otherwise be 
the reducing end of the polysaccharide. Breakdown of the inulin chain through 
acid hydrolysis will result in the presence of reducing fructose ends as the sucrose 
moiety is lost. Additionally, the GH91 enzyme (BACOVA_04502/3) creates a 
DFA terminus during breakdown (Chapter 4.6.7). Therefore, four candidate chain 
end types for inulin exist; reducing fructose and non-reducing fructose, sucrose 
and DFA termini. 
 
To increase the molar concentration of both reducing and non-reducing fructose 
ends inulin was treated with acid (partial hydrolysis).  
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As other SusD-homologues recognise extracellular breakdown products 
(Rogowski et al., 2015; Cuskin et al., 2015; Koropatkin et al., 2008) we 
hypothesised that the SusD-homologue (BACOVA_04504) may recognise GH91 
inulin breakdown products which contain an increase in the molar ratio of both 
DFA and non-reducing fructose ends. 
 
If BACOVA_04504 recognises any of these three end types (reducing fructose, 
non-reducing fructose or DFA), saturation of the assay will occur more rapidly in 
one or both of the treated inulin conditions as more binding targets per weight of 
substrate are available. We demonstrate this effect using a characterised GH32 
mutant (BT3082) which binds to non-reducing fructose ends. BT3082 saturates 
far more quickly on both GH91 products and acid hydrolysed inulin, as the 
number of non-reducing fructose ends available has substantially increased 
(Figure 4.21 A). BACOVA_04504 did not saturate more quickly under any of 
these conditions compared to untreated inulin (Figure 4.21 B) leading to the 
conclusion that neither the non-reducing fructose, reducing fructose and DFA 
terminus was recognised by BACOVA_04504. 
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Figure 4.21. ITC reveals the SusD-homologue, BACOVA_04504, has a similar 
affinity for untreated and treated inulin. (A) BT3082 recognises non-reducing fructose 
ends and the titration of this protein into either GH91 products (DFA-FOS) or partially 
acid hydrolysed inulin saturates far more quickly than on unprocessed inulin. (B) The 
SusD-homologue bound in a similar manner to untreated inulin polysaccharide, partially 
acid hydrolysed inulin and inulin treated with the GH91 enzyme, though reduced heats 
indicates less available substrate. Saturation was not achieved more rapidly in either 
treatment condition suggesting that BACOVA_04504 did not recognise DFA or fructose 
ends. (C) Two TLC plates show inulin and partially acid hydrolysed inulin (left) and 
GH91 products and inulin (right). Both TLC plates contain standards of fructose (F), 
sucrose (Suc), kestose (K3), kestotetraose (K4) and kestopentaose (K5) for comparison. 
ITC experiments were conducted in 20 mM HEPES, pH 7 with 50-60 µM of protein. 
Representative ITC binding traces for each condition are shown. 
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To confirm that the SusD-homologue recognised the sucrose we compared 
binding of BACOVA_04504 to Kestose and Fructotriose, which contain and lack 
the sucrose moiety respectively (Figure 4.22 A). BACOVA_04504 bound kestose 
(Kd ~1.2 mM), and bound to fructotriose with a significant drop in affinity, the 
binding was too weak to fit to a model (Figure 4.22 B). These data allow us to 
conclude that BACOVA_04504 shows a strong preference for the sucrose 
terminal present on unprocessed inulin. 
             
 
Figure 4.22. The SusD-homologue, BACOVA_04504, binds to kestose but not 
fructotriose. (A) The chemical structures of kestose (left) and fructotriose (right) are 
pictured. (B) ITC analysis reveals that BACOVA_04504 binds to kestose, but not 
fructotriose, indicating that a terminal sucrose motif is recognised. Binding was too weak 
to fit for fructotriose. Multiple datasets (3-5) were obtained, shown are representative 
datasets. Experiments were conducted in 20 mM HEPES, pH 7.0, using 50 µM protein. 
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4.7.4.   X-Ray Crystallography Reveals the Structure of 
BACOVA_04504 
BACOVA_04504 was expressed without the type II signal peptide in E. coli using 
PGEX 6P-1 and the GST tag removed for crystal trials. Initial screening was 
unsuccessful. The N-terminus of the crystal structure of the SusD is not visible 
and therefore may be disordered (Koropatkin et al., 2008). Screening with various 
N-terminal BACOVA_04504 truncations (Figure 4.23) was therefore undertaken 
to remove any disordered region which may be preventing crystal formation. 
Figure 4.23. BACOVA_04504 truncations made for crystal screening. Screening with 
the original construct (purple) was unsuccessful. The structure of SusD-homologues, 
including SusD (PDB: 3CKB) did not have visible N-terminal regions, suggesting this 
area may be flexible. Flexible regions may hamper crystal lattice formation, therefore 
three new constructs with truncated N-terminal regions were made (red, green and blue) 
to reduce this potential flexible region and improve crystal formation.  
 
Truncation 1 (31-585 aa) and truncation 2 (39-585 aa) did not yield crystals, but 
truncation 3 yielded crystals in several conditions and the structure was solved as 
outlined (Chapter 2.13.3).  
 
Good candidate crystals were passed to Dr Arnaud Baslé who harvested crystals, 
collected datasets, solved the phase problem and fit the structural model. Full 
crystal model data from Dr Arnaud Baslé is shown (Appendix I, Table I.4 and 
I.5). 
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The BACOVA_04504 structure (Figure 4.24) is highly similar to other SusD-
homologue structures, including SusD itself. BACOVA_04504 is a monomer with 
an α-helical fold. It contains 21 α-helices and 3 pairs of anti-parallel β-strands.  
 
The SusD-homologue retains the four tetratricopeptide repeat (TPR) domains 
found in SusD and other SusD-homologues (Koropatkin et al., 2008, Koropatkin 
et al., 2009). These are formed from eight of the helices in pairs: α1 (43-53 aa), α3 
(104-130 aa), α4 (138-162 aa), α5 (185-204 aa), α6 (215-231 aa), α7 (244-258 aa), 
α15 (434-449 aa) and α16 (450-470 aa). These units form a right handed super 
helix along one side of the structure, another helix loop helix α17 (498-515 aa) 
and α18 (519-528 aa) is packed against this super helix, connecting it to the rest of 
the structure.  
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Figure 4.24. The structure of the SusD-homologue, BACOVA_04504. The structure of 
BACOVA_04504 was solved through x-ray crystallography. (A) Cartoon representation 
of BACOVA_04504 coloured from N-terminus (Labelled, Blue) to C-terminus (Red). (B) 
BACOVA_04504 is shown as a cartoon in green, with TPR helices coloured in red (C) 
The structure of BACOVA_04504 in green is overlaid with SusD, BT3701, (PDB ID 
3CKB) shown in blue. The ligand from 3CKB, maltotriose, was retained in the overlay 
and is shown as orange sticks. We predicted the binding site in BACOVA_04504 is in a 
similar location as SusD. 
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4.7.5.   Targeted Mutagenesis Reveals the Binding Site of 
BACOVA_04504 SusD-homologue 
Despite several crystallisation screens in the presence of sucrose or kestose no 
crystals could be obtained with ligand. Therefore, to determine the location of the 
binding site putative ligand binding residues were mutated to alanine and the 
capacity of each mutant to bind to inulin was assessed. 
 
Structural alignment of the SusD (BT3701; PDB ID 3CK9) to the inulin binding 
SusD-homologue, BACOVA_04504, revealed a similar topology (Figure 4.25). 
A putative binding site, similar in overall structure to SusD, was present. Several 
candidate aromatic residues and residues which may form hydrogen bonds with 
the sucrose terminal of inulin were identified in the BACOVA_04504 structure. 
These residues are highlighted (Figure 4.26 A) and mutant constructs were made 
whereby each annotated residue was changed to an alanine. Of the 
BACOVA_04504 mutants created D88A and R394A did not express; F321A, 
W420A and W22A bound inulin with a wild-type like affinity (Kd = ~0.4 mM), 
and three mutants, F321A, W420A and W422A resulted in protein which no 
longer bound inulin (Figure 4.26). 
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Figure 4.25. The SusD-homologue, BACOVA_04504 was compared with the 
canonical SusD. (A) Shows the sequence alignment of BACOVA_04504 SusD-
homologue (SusD-h) and BT3701 (SusD). Putative SusD-h binding residues (green) and 
known SusD binding residues (blue) are shown (B) The overlaid SusD-h (green) and 
SusD (blue) structures with binding residues from both proteins shown as sticks. 
Maltotriose from the SusD structure is shown (orange sticks). Inset: The SusD binding 
site with maltotriose (top) and the SusD-h putative binding site with maltotriose (orange 
sticks) retained from the overlay. 
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Figure 4.26. Identification of the ligand binding site of BACOVA_04504 SusD-
homologue. (A) ITC analysis of alanine mutants of the putative binding residues from 
BACOVA_04504 SusD-h. F321A , W420A, and W422A bound sucrose with wild type 
affinity whilst H62A, W63A, and D319A were no longer able to bind sucrose. 
Representative datasets from multiple titrations (2-4) are shown. These were conducted in 
20 mM HEPES, pH 7. 50-60 µM protein was used. (B) A visualisation of the putative 
binding site showing the residues mutated to alanine, residues which retained binding 
(green), were not tested (orange) and residues which could not bind (red) to sucrose are 
shown. Resides which (upon mutation to alanine) were no longer able to bind sucrose are 
likely to be involved in ligand recognition. 
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4.7.6. Importance of the SusD-homologue, 
BACOVA_04504, during Fructan Utilisation 
The role of the SusD-homologue within glycan utilisation systems has been 
previously shown to be critical to PUL function on polymeric substrates 
(Sonnenburg et al., 2010; Cuskin et al., 2015). SusD (BT3701) from the SUS 
system is required for growth on polymeric starch (Koropatkin et al., 2008) 
however whilst the presence of SusD protein is absolutely required, a SusD 
mutant which does not bind starch is able to grow on starch in the presence of 
small quantities of maltose despite being unable to grow on starch alone 
(Cameron et al., 2014). Maltose is able to induce up-regulation of the SUS, 
however the exact role of the SusD remains unclear; SusD may be fulfilling both a 
key structural role through mediating protein-protein interactions, and a less 
critical binding role which may be circumvented through the addition of small 
quantities of maltose (Cameron et al., 2014). The levan specific SusD-homologue 
from B. thetaiotaomicron (BT1762) was necessary for rapid growth on levan, but 
removal of this gene from the genome did not result in complete lack of growth 
(Sonnenburg et al., 2010). It was expected that the Δbacova_04504 strain would 
display a significant growth defect when grown on polymeric inulin, similar to the 
levan SusD-homologue BT1762. The strain, Δbacova_04504, was made as 
described in (Chapter 2.16) and is a complete deletion of the bacova_04504 gene. 
 
Δbacova_04504 did grow when cultured with inulin as the sole carbon source but 
had a reproducible lag phase of about 5 hours compared with wild-type B. ovatus 
(Figure 4.27). This lag phase was also seen in kestose series fructo-
oligosaccharides, but not with sucrose or the glucose control. These data suggest 
that BACOVA_04504 confers an advantage during growth on inulin and FOS, but 
is not essential.  
 
The growth defect of Δbacova_04504 was not as pronounced on inulin as the 
defect of Δbt1762 on levan as described by Sonnenburg and colleagues 
(Sonnenburg et al., 2010). 
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Figure 4.27. The growth of the SusD-homologue knockout Δbacova_04505 is  
retarded on inulin and FOS. The growth of Δbacova_04504 compared with wild-type 
B. ovatus was monitored when grown on minimal media supplemented with 0.5 % of 
either inulin, glucose, sucrose, kestose, kestetraose or kestopentaose. Growth of 
Δbacova_04504 on inulin, kestose, kestotetraose and kestopentaose is retarded, but 
growth on glucose and sucrose are comparable to wild-type B. ovatus. Multiple datasets 
were obtained for each condition (2-4) and representative data performed in triplicate are 
shown with continuous error bars. 
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4.8. Characterisation of the Two PUL-Encoded GH32 Enzymes 
4.8.1.   BACOVA_04501 and BACOVA_04507 are GH32 
family enzymes Which Localise to the Cell Envelope 
Two GH32 family enzymes are encoded by the B. ovatus inulin PUL. 
BACOVA_04501 contains a putative type I signal peptide, type I signal peptides 
typically contain a hydrophobic region followed by a cleavage site (Figure 4.28 
A); enzymes containing a type I signal peptide have been previously shown to 
localise to the periplasmic space in Bacteroides PUL systems (Cuskin et al., 2015; 
Rogowski et al., 2015). This type I signal peptide was predicted by Signal P4.1. 
BACOVA_04507 contains a predicted type II signal peptide (Figure 4.28 B). 
This was predicted using LipoP1.0. Lipoproteins are generally cleaved at a 
position around 18 to 20 amino acids from the N-terminus after a hydrophobic 
region, a cysteine present at this position is covalently attached to a lipid post-
cleavage and anchored into the membrane. In Bacteroides spp. these lipoproteins 
are often on the outside face of the cell membrane (Shipman et al., 2000; Cuskin 
et al., 2015; Rogowski et al., 2015). 
 
Whilst predictive localisation tools are useful, localisation of the protein should be 
experimentally confirmed. If either GH32 is present at the cell surface, exo-β-
fructosidase activity will take place; we predict that BACOVA_04507 will be 
present at the cell surface due to the N-terminal type II signal sequence, whilst 
BACOVA_04501, with a Type I signal sequence, will localise to the periplasm.  
 
A GH91 mutant Δbacova_04503 E196Q, was used to examine surface activity of 
B. ovatus inactive whole cells, without the known activity of the GH91 endo-
inulinase (chapter 4.6.2). Indeed, fructosidase activity was detected at the cell 
surface (Figure 4.29).  
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It is suspected that this activity is due to BACOVA_04507 as this enzyme appears 
to be a lipoprotein, and is likely to localise to the cell surface (Shipman et al., 
2000; Cuskin et al., 2015; Rogowski et al., 2015). As fructose is accumulated, we 
expect this enzyme to be exo-acting. 
Figure 4.28. Predicting Localisation of the two GH32 enzymes: BACOVA_04501 
and BACOVA_04507. (A) BACOVA_04501 contains a putative type I signal peptide 
highlighted in yellow (B) BACOVA_04507 contains a putative type II signal peptide 
highlighted in yellow, with the candidate cysteine highlighted in cyan. 
 
Figure 4.29. Analysis of inactive whole cells for exo-fructosidase activity. The GH91 
mutant stain, Δbacova_04503 E196Q initially grown on minimal media with inulin was 
used to prepare inactive whole cells for assays to detect surface exo-β-fructosidase 
activity, these were visualised via TLC. Whole cells were incubated with (A) 0.5 % 
sucrose or (B) 0.5 % inulin. Standards (S) containing 2 mg/ml each of fructose (F), 
sucrose (Suc), kestose (K3), kestotetraose (K4) and kestopentaose (K5) were run for 
reference. Fructose release indicative of exo-fructosidase activity was detected on both 
substrates, indicating the presence of one of the GH32 family enzymes 
(BACOVA_04501 or BACOVA_04507) at the cell surface. We suspect this activity is 
attributed to BACOVA_04507 as signal peptide analysis suggests that this enzyme has a 
type II signal peptide, which are often extracellular in Bacteroides PUL systems 
(Shipman et al., 2000; Cuskin et al., 2015; Rogowski et al., 2015). 
 
Inulin 
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4.8.2.   BACOVA_04501 and BACOVA_04507 are Both 
Exo-acting β-fructosidases 
Both GH32 enzymes (BACOVA_04501 and BACOVA_04507) were cloned and 
expressed in recombinant E.coli as described (Chapters 2.9.7 and 2.11). Proteins 
were purified using IMAC (Chapter 2.12.1). Further construct details are listed 
(Appendix I.8).  
Pilot enzyme assays were undertaken and visualised via TLC to examine the 
product profiles of each GH32 enzyme (Figure 4.30). Both enzymes release 
fructose from inulin over time indicating that both of these enzymes are exo-
acting (Figure 4.30). 
Figure 4.30. Examining the product profiles of both GH32 enzymes on inulin. (A) 
BACOVA_04501 and (B) BACOVA_04507 were in incubated with inulin for one hour, 
both enzymes released fructose, which is suggestive of exo-activity. Standards (2 mg/ml 
each, stock) consisting of  fructose (F), sucrose (Suc), kestose (K3), kestotetraose (K4) 
and kestopentaose (K5) were run for comparison. Both GH32 reactions were carried out 
in 20 mM phosphate buffer pH 7.0 with 0.5 % inulin and 1 µM enzyme. 
 
As fructose is released, the kinetic parameters for both GH32 enzymes 
(BACOVA_04501 and BACOVA_04507) were elucidated through fructose 
detection assays (Table 4.2). BACOVA_04501 displayed a preference for β2-1 
linkages, but would degrade levan. BACOVA_04507 appears to be a sucrase, 
with decreasing affinity for longer substrates. Our data are similar to those 
elucidated for the two GH32 homologues from the characterised levan PUL 
Inulin Inulin 
Fructose 
 158 
(Sonnenburg et al., 2010). Key Michaelis-Menton curves from both enzymes are 
shown (Figure 4.31). 
Table 4.2. Kinetic parameters for the two PUL encoded GH32 exo-fructosidases on 
sucrose, FOS, Inulin and Levan 
  
 
 
BACOVA_04501 BACOVA_04507 
Kcat  
(Min-1) 
Km  
(mM) 
Kcat/Km  
(min-1 
/mM-1) 
Kcat  
(Min-1) 
Km  
(mM) 
Kcat/Km  
(min-1/ 
mM-1) 
Sucrose 5367 ± 
416 
3 ± 0.8 1789 12087 ± 
555 
1.7 ± 
0.3 
7110 
Kestose 1669 ± 
115 
1.7  ± 0.4 982 1506 ± 
182 
12.2 ± 
3.2  
123 
Kestotetraose 2461 ± 
272 
1.4 ± 0.5 1758 1295 ± 
45.5 
2.6 ± 
0.26 
498 
Kestopentaose - - - 3040 ± 
655 
12  
± 4.3 
253 
Fructotriose - - - 2065 ± 
280 
5.6 ± 
1.9 
369 
Inulin* 2353 ± 
208 
0.8 ± 0.2 2941 - - ~ 322  
Levan* - - ~2900  - - ~ 220  
* Concentration in mM for polysaccharides was calculated as described in Chapter 
2.13.2.  
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Figure 4.31. Michaelis-Menton plots from PUL encoded GH32 enzymes on defined 
substrates. Michaelis-mention curves from BACOVA_04501 and BACOVA_04507 on 
sucrose, kestose series FOS, inulin and levan. Experiments were undertaken using the 
megazyme fructose detection kit in 20 mM Tris, 150 mM NaCl buffer, pH 7.0. 
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4.8.3. The GH32, BACOVA_04507, Does not have a Clear 
Role During Inulin Harvest 
The role of the GH32 exo-fructosidase, BACOVA_04507, was probed through 
the creation of a catalytically inactive mutant strain, Δbacova_04507 D265A. 
BACOVA_04507 is a predicted lipoprotein (Figure 4.28) and appears to target 
sucrose and short chain FOS. 
 
No growth defect was observed when Δbacova_04507 D265A was grown on 
minimal media supplemented with a range of defined fructan substrates when 
compared with the growth of wild type B. ovatus (Figure 4.32). These data 
suggest that this enzyme is not critical for growth on any of the substrates tested. 
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Figure 4.32. The growth of the GH32 catalytic mutant, Δbacova_04507, is not 
different to growth of wild type B. ovatus on the fructan substrates tested. The 
growth of Δbacova_04507 D265A compared with wild-type B. ovatus was monitored 
when grown on minimal media supplemented with 0.5 % of either inulin, glucose, 
sucrose, kestose, kestetraose or kestopentaose. All mutant growth conditions were 
comparable to wild-type B. ovatus. Multiple datasets were obtained for each condition (2-
4) and representative data performed in triplicate are shown with continuous error bars. 
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4.9. Exploring fructan utilisation by Bacteroides ovatus 
Through Generation of Knock-out Strains 
4.9.1.   Importance of the PUL encoded SusC-homologue, 
BACOVA_04505, during Fructan Utilisation 
The SusC-homologue, BACOVA_04505, was hypothesised to be critical to PUL 
function. SusC-homologues are outer membrane transport proteins which partner 
with SusD-homologues to form a complex (Shipman et al., 2000; Koropatkin et 
al., 2008). SusC-homologues are TonB-dependent porins, outer membrane 
spanning transporters which are able to transfer macromolecules through the outer 
member to the periplasmic space using energy derived from the TonB-ExbBD 
complex (Martens et al., 2009). A knockout strain of B. thetaiotaomicron lacking 
the prototypic SusC is unable to utilise starch (Cameron et al., 2014). 
 
The entire gene region was removed from the genome following the protocol 
outlined (Chapter 2.16). The growth of Δbacova_04505 was monitored and 
compared with that of wild type on minimal media supplemented with target 
fructans (Figure 4.33). The data showed a significant growth defect compared 
with wild type on inulin and FOS however there is no noticeable defect between 
wild type B. ovatus and Δbacova_04505 growth on sucrose (Figure 4.33).   
  
 163 
 
Figure 4.33. The SusC-homologue knockout Δbacova_04505 has a growth defect on 
inulin and FOS. The growth of the SusC-knockout strain Δbacova_04505 was monitored 
and compared with wild-type B. ovatus when grown on minimal media supplemented 
with 0.5% of either inulin, glucose, sucrose, kestose, kestetraose or kestopentaose. The 
SusC-knockout has an extremely long lag before growth on inulin and FOS, but grows at 
a similar rate and to a final density comparable to WT on glucose and sucrose. Multiple 
datasets were obtained for each condition (2-4) and representative data performed in 
triplicate are shown with continuous error bars. 
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4.9.2.  Growth of the Inulin PUL Mutant Strains on a Range 
of Fructans 
Each mutant plus wild type B. ovatus was grown with different fructan structures 
as the sole carbon source under the same conditions (Figure 4.34). These assays 
allow insight into both the structures of the fructans used and of the limitations 
and functionality of the B. ovatus inulin utilisation system. Linear inulin (chicory) 
and glucose were used as controls with wheat, onion and garlic extracted fructans 
tested.  
 
Wheat fructan supported the growth of all mutants and wild type, but to a lesser 
extent than glucose or inulin control (Figure 4.34). The SusC-homologue 
knockout, bacova_04505, grows to a lower OD than the other strains, which 
suggests that some structures within this fructan mixture require import through 
the SusC-h transporter. Both the SusD-h knockout, Δbacova_04504 and the 
putative surface exo-fructosidase mutant, Δbacova_04507 D265A, seem to have a 
slight growth defect. The defect from Δbacova_04504 suggests that a portion of 
this fructan extract is comprised of short chain FOS. The Δbacova_04507 D265A 
defect is intriguing as it is possible that wheat fructan contains the preferred 
substrate for this enzyme. 
 
Fructan extracted from onion produces similar growth profiles to the chicory 
inulin control for each strain (Figure 4.34). It is therefore likely that this substrate 
is comprised mostly of linear inulin, or has a secondary structure very similar to 
linear inulin. DFA is produced during growth demonstrating that the GH91 endo-
inulinase (BACOVA_04502/3) is active, this enzyme is not active on short FOS, 
therefore linear inulin with DP > ~6 must be present within this fructan extract. 
 
Fructan extracted from garlic has a similar growth profile to the inulin control 
(Figure 4.34), however no DFA is produced in the supernatant (Chapter 3. Figure 
3.5 B).  
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These data support the characterisation of garlic inulin as a β2-1 inulin polymer 
with short β2-6 linkages, as described by Baumgartner et al., 2011. Short levan 
decorations may occlude the action of the GH91 enzyme, preventing DFA 
production. 
Figure 4.34. B. ovatus mutants were grown on a variety of fructan structures. 
Mutants were grown on various fructan substrates to determine any growth defects. 
Minimal media supplemented with 0.5 % of either linear inulin, glucose, wheat, onion or 
garlic fructans was monitored. Growth of bacova_04507 D265A on garlic was not 
reproducible and has not been shown. Multiple datasets were obtained for each condition 
(2-4) and representative data performed in triplicate are shown. 
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4.10.  Exploring the Creation and Degradation of DFA and 
DFA-FOS within the Gut using Faecal Samples. 
4.10.1. Detection of DFA Within Cultures Supplemented with 
Inulin 
Bacterial cultures obtained from fresh human faecal samples can shed light upon 
how glycans are degraded in vivo without requiring extensive or invasive 
procedures; faecal slurry from three healthy human donors was used to inoculate 
pH controlled batch cultures as described (Chapter 2.18) to investigate if DFA is 
produced from inulin under these conditions. Basal media was supplemented with 
Inulin, FOS (Orafti ® 95) and a negative control without sugar for comparison. 
Samples from each vessel were taken at 0, 4, 8, 24 and 48 hours. Supernatant fluid 
from each sample was visualised using TLC so that any DFA created could be 
observed (Figure 4.35).  
 
No DFA was created from vessels containing FOS, which is consistent with the 
characterisation of the B. ovatus GH91 which is not active upon inulin with a DP 
< ~6. DFA was detected within vessels containing inulin (Figure 4.35). 
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Figure 4.35. TLC visualisation of DFA production from inulin by the faecal cultures. 
TLC visualisation of culture supernatant fluid removed from the fermentation vessels at 
defined time points (0 – 48 hours) allowed visualisation of inulin and FOS breakdown 
products by complex faecal microbiota. All three donors are shown for each glycan, also 
shown are 2 mg/ml each of standards (highlighted for clarity): S1 contains fructose (F), 
sucrose (Suc), kestose (K3), kestotetraose (K4) and kestopentase (K5), S2 contains DFA 
and fructose. DFA was produced from inulin cultures but not FOS cultures. 
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4.11.  Examining the Degradation of DFA-FOS and DFA by the 
Faecal Microbiota 
Using batch cultures set up at the same time and in the same manner as the 
previous experiment, the degradation of DFA by the faecal microbiota was 
probed. Two additional batch cultures, containing DFA and DFA-FOS were set 
up, and samples taken at 0, 4, 8, 24 and 48 hours (Figure 4.36). DFA-FOS was 
utilised over time, however DFA was released and accumulated in the media. This 
implies that the DFA-FOS produced extracellularly by B. ovatus (or other species) 
can be utilised either directly by B. ovatus or by other species, however the DFA 
portion of the chain cannot be utilised. Vessels supplemented with DFA did not 
show any significant reduction in DFA content over the course of the experiment 
(Figure 4.36). These data, taken with those from the previous experiment (Figure 
4.35) suggest that DFA is produced during inulin degradation by the normal gut 
microbiota, but that this DFA is not utilised. 
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Figure 4.36. TLC visualisation shows that DFA is not degraded by the faecal 
microbiota. This experiment was conducted at the same time and in the same manner as 
the previous experiment and shows culture supernatant fluid removed from the 
fermentation vessels at defined time points (0h-48h). All three donors are shown for each 
glycan, also shown are 2 mg/ml each of standards (highlighted for clarity): S1 contains 
fructose (F), sucrose (Suc), kestose (K3), kestotetraose (K4) and kestopentase (K5), S2 
contains DFA and fructose. DFA samples were diluted 1 in 10 for clarity. DFA was not 
degraded in either condition. 
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4.12.  Discussion 
4.12.1. Fructan Utilisation in other Bacteroides spp. 
In this chapter, we demonstrate how inulin is utilised by the B. ovatus inulin PUL, 
to put this system in context here we explore the fructan utilisation apparatus of 
other Bacteroides species.  
 
Linear inulin with a DP > ~6 is broken up at the B. ovatus cell surface by a 
heteromeric GH91 endo-inulinase (Chapter 4.6.2). Further inulin processing 
requires the action of one or both exo-fructosidase enzymes (BACOVA_04501 
and BACOVA_04507) which do not display a linkage preference (Chapter 4.8). 
This system is similar to that of B. thetaiotaomicron levan PUL, where specificity 
for levan is observed in the surface endo-levanase (BT1760) but not in the exo-
fructosidase enzymes (BT1759, BT1765 and BT3082). The exo-fructosidase 
enzymes from B. ovatus and B. thetaiotaomicron have high sequence identity 
(Figure 4.2) and are biochemically similar (Chapter 4.8; Sonnenburg et al., 
2010); therefore these enzymes perform a core role in fructan utilisation that is 
not-linkage specific. Furthermore, as the SusC/D-homologue pair is divergent 
between the fructan PUL of B. ovatus and B. thetaiotaomicron we suspect that 
this import apparatus must be specialised for the target fructan; we demonstrate 
that the B. ovatus SusD-homologue (BACOVA_04504) recognises a sucrose 
moiety in inulin (Chapter 4.6) and the B. thetaiotaomicron SusD-homologue 
recognises levan but not inulin (Sonnenburg et al., 2010) supporting that the 
import apparatus is specific for the target glycan. 
 
To explore this further we examined the GH32 content from various Bacteroides 
species, looked for other GH91 encoding Bacteroides species and examined the 
divergence of SusD-homologues from other fructan PUL. The aim of this was to 
understand whether there was a connection between the PUL encoded apparatus 
and linkage specificity. Seven Bacteroides spp. were grown on inulin and levan 
(Appendix I. Figure I.6.) to confirm fructan specificity.  
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Two FOS users (B. fragilis, B. vulgatus), two levan users (B. thetaiotaomicron, B. 
intestinalis) and three inulin users (B. ovatus, B. thetaiotaomicron 8763, B. 
uniformis) were examined. 
 
The putative fructan PUL from each species was identified by searching for 
homologues to the BT1754 HTCS as described by Sonnenburg et al., 2010. 
Within each PUL up to four GH32 encoding genes were present, these were 
aligned and a neighbour joining tree was generated (Figure 4.37). BT1760 is an 
endo-levanase (Sonnenburg et al., 2010) and it is likely that BACINT_03199 is 
also an endo-levanase as B. intestinalis is a levan user and the two enzymes are 
closely related. B. uniformis is an inulin user; BACUNI_01155 contains reversed 
catalytic residues as seen in a GH32 endo-inulinase enzyme (Puyez et al., 2012), 
suggesting that this enzyme is likely to be an endo-inulinase, however it is 
predicted to localise to the periplasm, this enzyme is more similar to the endo-
levanases BT1760 and BACINT_03199 (Figure 4.37). All polymeric fructan 
users contain a BACOVA_04501 homologue, whereas the two FOS users, B. 
fragilis and B. vulgatus, contain a more divergent predicted lipoprotein more 
similar to BACOVA_04507 exo-fructosidase (Figure 4.37). The inulin using B. 
thetaiotaomicron 8736 contains homologues of the B. thetaiotaomicron exo-
fructosidases but lacks the endo-levanase (Figure 4.37); this is interesting as it 
supports the hypothesis that an endo-inulinase is not necessary for growth on 
inulin (Chapter 4.9.3) and shows that the exo-fructosidase enzymes are not 
linkage specific. 
 
These data assist predictions regarding how Bacteroides spp. utilise fructans, and 
demonstrate that several fructan acquisition strategies are apparent within the 
Bacteroides genus. 
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Figure 4.37. The GH32 enzymes from seven Bacteroides fructan PUL. A tree was 
generated using FigTree (http://tree.bio.ed.ac.uk/software/figtree/) from an alignment of 
19 GH32s from seven Bacteroides spp. colour coded by fructan preference of the 
originating species; FOS (red), inulin (green) or levan (blue). Sequences with a putative 
type II signal sequence (predicted extracellular lipoproteins) are labelled with a yellow 
node terminus, all others have a putative Type I signal sequence (predicted periplasmic). 
Characterised enzymes from B. ovatus and B. thetaiotaomicron are annotated.  
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The distribution of GH91 encoding genes within sequenced Bacteroides genomes 
are very narrow. Bacova_04502/3 homologues are found within B. caccae and B. 
xylanisolvens where the genomic context of the inulin PUL is conserved (Figure 
4.38). No other GH91 enzymes have been identified from Bacteroides spp at this 
time.  
Figure 4.38. Exploring the distribution of GH91 encoding genes within Bacteroides 
spp. Three species of Bacteroides, including the characterised B. ovatus contain a PUL 
encoded GH91. B. xylanisolvens and B. caccae contain homologues of the 
BACOVA_04502/3 enzyme which is embedded within a homologous inulin utilisation 
PUL. 
 
The distribution of GH91 enzymes within the CAZy database demonstrate that 
GH91 encoding genes are more commonly associated with species isolated from 
soil, such as from the Bacillus, Arthrobacter and Rhizobium genera 
(www.cazy.org). GH91 enzymes have been isolated from Klebsiella spp., this 
genus has been isolated from a wide range of environments including human 
samples (Brisse et al., 2006). 
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As the distribution of GH91 encoding genes is narrow and Bacteroides spp. are 
prominent resident microbiota, it is likely that much or all of the DFA produced 
by faecal cultures is generated by the action of the inulin utilisation PULs from 
Bacteroides spp. (Figure 4.35; Figure 4.38). 
 
The SusD-homologues from each fructan PUL were aligned and a tree generated 
(Figure 4.39), B. vulgatus was not included as this species does not have a 
candidate fructan binding SusD-homologue. The SusD-homologues clustered by 
preference for inulin or levan, with B. fragilis FOS SusD-homologue the most 
divergent (Figure 4.39). 
Figure 4.39. Fructan PUL encoded SusD-homologues. SusD-homologues from fructan 
PUL were aligned. Each are labelled according to the originating species and are colour 
coded to demonstrate fructan preference. SusD-homologues cluster by fructan specificity. 
The inulin utilising strain of B. thetaiotaomicron 8736 has a SusD-homologue closest to 
B. thetaiotaomicron, but this protein is quite divergent as expected as the strain is able to 
utilise inulin. 
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4.12.2. Understanding the Role of the GH91 Enzyme 
4.12.2.1. Re-evaluating the Role of the BACOVA_04502 CBM 
We show that the CBM appended to the GH91 enzyme does contribute slightly to 
enzyme activity rate on chicory inulin, but that it is not crucial for enzyme activity 
(Chapter 4.6.4). As discussed in the introduction (Chapter 1.7.1) Bacteroides 
SUS-like systems, including the canonical SUS, often display polysaccharide 
binding proteins on the cell surface. Many PULs contain a SusE-like binding 
protein, thought to help the bacterial cell latch onto insoluble substrate, or to 
tether large polysaccharides to the cell surface prior to, or to assist with, 
processing and import (Martens et al., 2009; Sonnenburg et al., 2010).  
 
During initial BACOVA_04502 characterisation during a Masters project 
(Shapiro, MRes thesis, 2012), it was proposed that as this enzyme was inactive 
and it was functioning solely as a SusE-like binding protein; with the GH91 
domain acting as a spacer domain. We now know that this is not the case, as the 
GH91 domain is indeed active, therefore the role of the CBM may be more 
similar to other CBM, such as to target insoluble material (Boraston et al., 2004) 
or the binding role may fulfil the role of a SusE-like gene, and mediate binding of 
polysaccharide to the cell surface. It is unclear whether the slight retardation of 
enzyme activity rate (Figure 4.11) is due to the CBM binding role, or simply that 
the lack of this region disrupts the BACOVA_04502/3 protein-protein interaction. 
Further experiments should be done to characterise this binding domain as if it is a 
CBM operating through a proximity effect it is the founding member of a novel 
CAZy CBM family. 
 
Surface polysaccharide binding is important in other Bacteroides SUS-like 
systems. Cameron et al., 2014, characterised the eight starch binding subsites 
found across the surface apparatus of the canonical SUS.  
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It was shown that each binding site fulfilled similar roles during in vitro binding 
assays, however mutant strains lacking individual binding sites demonstrated that 
several sites had more complex functions during in vivo growth assays, either 
through regulation of the system or compensating for capsule expression. In light 
of this information, it would be pertinent to further explore fructan binding at the 
cell surface, particularly in the GH91 (BACOVA_04502/3) CBM. 
 
As the genomic knock-out strain, Δbacova_04502, did not display any notable 
defects compared with wild-type, no conclusions could be drawn regarding the 
role of this binding domain and indeed the full length enzyme within the inulin 
utilisation system. The lack of a phenotype suggests that either the apparatus is 
fine-tuned to out-compete other members of the microbiota such that defects 
within monocultures cannot be detected, or that the true target for this enzyme has 
not yet been explored. 
 
Using tagged mutant strains, it would be possible to design a competition assay 
with a binding mutant of bacova_04502 CBM against WT, this may reveal 
whether the binding role confers a competitive advantage.  
 
4.12.2.2. A Putative Model for the GH91, BACOVA_04502/3, 
Catalytic Mechanism 
The GH91 enzyme (BACOVA_04502/3) is the first example of an endo-inulinase 
in the GH91 family, furthermore it is the example of a hetero-oligomeric enzyme 
in CAZy (Chapter 4.6). The enzyme is active on linear inulin with a DP > ~6 and 
creates a range of oligosaccharide products which contain a DFA moiety at what 
would otherwise be the non-reducing end. 
 
During GH91 characterisation, two catalytic residues were determined through 
targeted mutagenesis, BACOVA_04502 D185 and BACOVA_04503 E196. Both 
residues are conserved within the GH91 family.  
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As BsIFTase shares conserved catalytic apparatus and produced an anhydrous 
product, it seems likely that a similar mechanism for catalysis will be conserved 
between the two homologues. Using these data, and the mechanism elucidated by 
Jung et al., a mechanism for the action of the GH91 enzyme was predicted 
(Figure 4.40).  
 
D185, contributed by BACOVA_04502 co-ordinates the fructose at the +1 
subsite. E196, contributed by BACOVA_04503 activates nucleophilic attack from 
the C3 carbon of F2 on the C1 carbon of F1, forming a new glycoside bond and 
breaking the bond which was present between the C1 carbon of F1 and the C2 
carbon of the fructose at the -1 subsite. As this is an inverting reaction, the 
conformation of the new glycosidic bond, which was originally β- becomes α-. 
We predict, based upon BsIFTase data, that DFA III will be produced however 
the linkage of the secondary glycosidic bond has not been determined. Whilst this 
mechanism has not been formally elucidated, this model provides a good fit for 
the observations made both with BACOVA_04502/3 and other members of the 
GH91 family. 
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Figure 4.40. Proposed catalytic mechanism for GH91, BACOVA_04502/3. This 
model is based on the model proposed by Jung et al. for BsIFTase as these enzymes 
belong to the same CAZy family and are likely to have the same mechanism. 
BACOVA_04502/3 cleaves inulin internally to produce DFA-FOS whereas BsIFTase is 
exo-acting and produces FOS. Catalysis occurs through the inverting mechanism, with a 
single nucleophilic attack event. D185, contributed by BACOVA_04502 co-ordinates the 
fructose at the +1 position (F2). E196, contributed by BACOVA_04503 is the catalytic 
base, activating the nucleophilic group at C3. A new glycosidic bond is formed at the C1 
carbon of the F1 fructose (F1 α13 F2), which breaks the glycosidic bond which was 
present between this carbon and the second carbon at the fructose at the -1 position. 
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4.12.2.3. The GH91 Enzyme is not Required for Growth on 
Inulin 
The current paradigm for SUS-like systems is that the surface localised endo-
active enzyme is required for growth on the polysaccharide, indeed a mutant B. 
thetaiotaomicron strain lacking the endo-levanase, BT1760, is unable to grow on 
levan (Martens et al., 2009; Sonnenburg et al., 2010). 
 
No detectable growth defect is displayed by the Δbacova_04502 knockout strain 
or the Δbacova_04503 E196Q catalytic mutant on inulin despite loss of surface 
endo activity (Chapter 4.9.3), which was unexpected. It is likely that either the 
inulin substrates used during this project are smaller or otherwise not 
representative of the inulin targeted by the system in vivo; or that this enzyme, 
including the CBM, provide a significant competitive or symbiotic advantage to 
B. ovatus in vivo which cannot be detected with the techniques used in this study. 
DFA-FOS is produced by the GH91 enzyme (BACOVA_04502/3) and the DFA 
moiety is inaccessible to B. ovatus; this means that B. ovatus is losing large 
quantities of otherwise accessible carbon and energy through the action of the 
GH91 enzyme. As this enzyme is not required for inulin utilisation it is highly 
unlikely that this activity would occur without a selective advantage. 
 
One possibility is that large inulin polymers may be present within the intestinal 
environment and these may only be utilised by after initial processing by endo-
acting enzymes, either to break large substrates into smaller chunks which may be 
imported or to release soluble material from insoluble bulk. In this instance, the 
production of the waste product, DFA, maybe compensated by access to an 
otherwise inaccessible glycan.  
 
Another theory is that the GH91 enzymes confer a selective advantage to B. 
ovatus through allowing rapid processing of inulin, simply by generating 
oligosaccharides inulin can be harvested more quickly and sequestered away from 
competitors, however as oligosaccharides are apparent in the media, ready for 
scavenging by competing microbes, this hypothesis seems unlikely.  
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Finally, the GH91 may confer a selective advantage through beneficial sharing 
interactions with other endogenous species. B. ovatus releases inulin breakdown 
products into the intestinal lumen which may be accessed by other microbes 
(Rakoff-Nahoum et al., 2014). We demonstrated that the GH91 inulin breakdown 
products were preferential substrates for two Bifidobacterium species (Appendix 
I. Figure I.7).  
 
Many efficient FOS utilising species are unable to directly access polymeric 
inulin (Watson et al., 2013), we speculate that by generating substrate for FOS 
utilising strains in the immediate area, B. ovatus may dilute out competitors for 
the polymer, ensuring that a specific niche for an inulin-sharing microbe such as 
itself is retained. In this scenario, DFA may directly feed a symbiont or may 
simply be a justifiable loss of energy during the sharing process, as substrate will 
be lost to competitors through this mechanism by definition. This mechanism is 
directly opposed to the recently elucidated mechanism adopted by Ruminoccous 
gnavus which creates a 2,7-anhydro-Neu5Ac instead of sialic acid during cleavage 
of sialic acid from host glycans; by creating an anhydrous product the organism 
prevents species other than itself from breaking down the liberated sugar (Tailford 
et al., 2015).  
 
Further experiments should be undertaken to test these hypotheses. The catalytic 
mutant strain, Δbacova_04503 E196A should be tested with insoluble and 
recalcitrant material to see if a growth defect is observed. Further experiments to 
test the role of the GH91 in vivo could be conducted by inoculating germ-free 
mice with both wild type and Δbacova_04503 E196A strains of B. ovatus. If the 
GH91 mutant is unable to colonise the host in the presence of the wild-type strain 
during an inulin rich diet, it can be concluded that the GH91 enzyme is vital for 
normal inulin usage in vivo. Competition assays using humanised mice could be 
undertaken, to demonstrate whether the GH91 enzyme confers an advantage only 
in the presence of other members of the microbiota (e.g. due to sharing). 
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4.12.2.4. The Role of DFA in the Gut 
Whatever the benefit of the GH91 enzyme, the down-stream effects of its 
cleavage product, DFA, remain a mystery. There is no evidence that DFA is 
utilised by other members of the microbiota as our data shows DFA is not broken 
down by any of the three faecal cultures (Figure 4.36).  
 
There may be an underlying symbiotic interaction between B. ovatus and the host; 
DFA has been shown to enhance iron and calcium absorption through the host 
epithelium (Hara et al., 2008; Mineo et al., 2002; Mineo et al., 2003). However it 
is difficult to speculate on how B. ovatus may benefit from such an interaction 
without further investigation into the role of DFA within the gut.  
 
4.12.3. Sucrose Recognition and the SusD-homologue, 
BACOVA_04504 
BACOVA_04504 binding to the terminal sucrose moiety was unexpected, as 
sucrose is a minor component of the inulin chain, and will be lost after the 
polysaccharide is broken down into shorter fructo-oligosaccharides e.g. by acid 
hydrolysis in the stomach or by bacterial enzymes such as the GH91 
(BACOVA_04502/3) presented by B. ovatus. Other SusD-homologues have been 
shown to target the breakdown products created by surface localised endo-acting 
enzymes, and BACOVA_04504 defies this paradigm. 
 
An explanation for this unusual characteristic may be that BACOVA_04504 is 
recognising short chain fructo-oligosaccharides for direct import. Short FOS are 
created by many plants and can be seen in the extracts used in this study (onion, 
wheat and garlic). Short FOS are used by more members of the microbiota than 
inulin polysaccharide (Watson et al., 2013) by targeting short chain FOS for direct 
import B. ovatus may sequester this desirable carbohydrate away from 
competitors.  
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Additionally, we speculate that recognition of a sucrose terminus, may allow the 
SusD-homologue to import short FOS of either β2-1 or β2-6 linkage. Such 
substrates would be small enough not to require extracellular processing, and 
could be processed by the periplasmic GH32, BACOVA_04501. 
 
Future work should be undertaken to examine whether BACOVA_04504 is 
specific to β2-1 linked FOS or whether it is also able to bind to sucrose terminated 
β2-6 levan oligosaccharides using ITC analysis.  
This experiment could not be conducted, as sucrose terminated levan 
oligosaccharides could not be successfully created. Co-cultures of 
Δbacova_04504 with wild-type on inulin and FOS could be tried to assess the 
impact of the loss of BACOVA_04504 in a more competitive environment.  
 
4.12.4.  Evaluating the Role of the putative extracellular 
GH32, BACOVA_04507 
The GH32 BACOVA_04507 does not have a clear role within the B. ovatus inulin 
utilisation locus. The enzyme appears to be presented on the cell surface (Figure 
4.28) and cleaves short chain fructo-oligosaccharides and sucrose (Table 4.2). No 
phenotype was observed in the genomic knockout strain, Δbacova_04507 D265A 
(Figure 4.32.). 
 
The presence of a homologue of BACOVA_04507, BT1765, within the B. 
thetaiotaomicron levan PUL strongly suggests that the role of this protein is non-
linkage specific (Figure 4.2, Figure 4.37).  
 
Both wild-type B. thetaiotaomicron (unpublished data) and the B. ovatus SusC-
homologue knockout (Figure 4.33), Δbacova_04505 are able to utilise inulin after 
a significant lag phase (>24 hours).  
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Despite lacking the protein apparatus to import this glycan; it is possible that in 
both cases the surface located GH32 homologues, BT1765 and BACOVA_04507, 
are able to release enough free fructose from inulin to support growth, however 
this does not explain why growth occurs after a lag rather than gradually. 
 
The role of this enzyme is unclear, and relatively unexplored. Sucrose is likely to 
be completely removed by host absorption in the early G.I. tract and thus seems to 
be an unlikely target substrate; future experiments should be undertaken to 
determine whether this protein is targeting a different small fructan. 
BACOVA_04507 may remove fructose from raffinose, a trisaccharide comprised 
of F2β1αGα61Gal.  
The SusD-homologue, BACOVA_04504 did not bind to raffinose during ITC 
analysis, which was expected as the galactose unit likely blocks interaction with 
the sucrose moiety (data not shown). Whilst B. ovatus can grow on raffinose, 
culture supernatant profiles differed between B. ovatus, B. caccae and B. 
xylanisolvens, these species contain highly similar inulin PUL (Figure 4.38) and 
different breakdown patterns suggested that the fructan PUL was not involved in 
raffinose processing (data not shown) and we did not explore this substrate further 
 
4.12.5. Towards a Model for Inulin Utilisation by Bacteroides 
ovatus 
Our data outlined in this chapter allow us to demonstrate a model for inulin 
utilisation by B. ovatus (Figure 4.41).  
 
Polymeric inulin bound at the cell surface by the CBM appended to the 
heteromeric GH91 family enzyme (Shapiro, MRes thesis, 2012). The GH91 
enzyme is comprised of two gene products, BACOVA_04502 and 
BACOVA_04503 and is an endo-acting inulinase which creates an anhydrous 
terminus (Chapter 4.6). The SusD-homolog, BACOVA_04504, recognises 
sucrose terminated FOS and inulin at the cell surface, likely targeting desirable 
FOS for direct import (Chapter 4.7, Chapter 4.12.3).  
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GH91 breakdown products, polymeric inulin and FOS are imported through the 
SusC-homolog, BACOVA_04505 (Chapter 4.9.1). Imported fructan is 
deconstructed to component monosaccharides by a periplasmic GH32 family 
enzyme, BACOVA_04501. Periplasmic fructose is bound by the periplasmic 
binding domain of the HTCS which presumably propagates a conformational 
change through the proteins transmembrane region and cytoplasmic domains, 
triggering up-regulation of the locus (Sonnenburg et al., 2010; Bolam & 
Sonnenburg, 2011; Figure 1.17; Chapter 4.5). An inner-membrane fructose 
permease and cytoplasmic fructose kinase import free fructose into the cytosol 
and phosphorylate it for downstream metabolic use (Chapter 4.4). This model for 
inulin utilisation is illustrated (Figure 4.41). 
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Figure 4.41. Proposed model for inulin utilisation by Bacteroides ovatus. Inulin is 
recognised at the cell surface by an inulin binding domain appended to the GH91 enzyme 
and is then broken into DFA-FOS by the GH91 enzyme. Sucrose terminated FOS are 
recognised by the SusD-homologue for direct import. FOS and DFA-FOS is imported 
through the TonB dependent SusC-homologue into the periplasm, where the periplasmic 
GH32 depolymerises imported fructans. Fructose is recognised by the periplasmic 
domain of the HTCS sensor-regulator, and induces PUL expression. Fructose is imported 
to the cytoplasm through a fructose permease and phosphorylated by the fructokinase for 
further downstream metabolism by the cell. * DFA is exported across the membrane by 
an unknown mechanism into the environment. 
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Chapter 5. Inulin Utilisation by Bifidobacterium adolescentis 
 
5.1.   Chapter Overview 
Bifidobacterium are the most common targets for inulin and FOS prebiotics, 
which can increase the relative abundance of this genus, despite making up only a 
small portion of the microbial community (Schaafsma & Slavin, 2015; Eckburg et 
al., 2005). Members of the Bifidobacterium genera are particularly prominent in 
the healthy infant microbiota and increases in Bifidobacterium populations in 
adults have been associated with therapeutic effects including a lowering of 
intestinal pH, the production of vitamins and the generation of short chain fatty 
acids (Gibson & Roberfroid, 1995; Koenig et al., 2011).  
 
Inulin and fructo-oligosaccharides have a bifidogenic effect on the colonic 
microbiota when consumed, leading to the use of these glycans to modulate the 
microbiota towards health (Roberfroid et al,. 1998; Gibson et al., 2004). Most 
Bifidobacterium species are able to use FOS and inulin is able to stimulate the 
genus in vivo, despite a relatively narrow distribution of Bifidobacterium species 
able to directly utilise the polysaccharide (Schaafsma & Slavin, 2015; Watson et 
al., 2013). Despite concentrated efforts to stimulate Bifidobacterium populations 
in vivo using prebiotics, very little mechanistic insight into inulin utilisation in the 
genus has been undertaken. 
 
Several glycan utilisation clusters, containing predicted enzymes, substrate 
binding proteins and ABC permeases, were identified in Bifidobacterium longum 
subspecies infantis (Garrido et al., 2011). Garrido et al., show up regulation of 
these clusters using qPCR analysis after growth on various glycans, these data 
demonstrated that these clusters were regulated in response to environmental 
glycans. It was discovered that this species has a preference for human milk 
oligosaccharides over plant glycans such as FOS (Garrido et al., 2011).  
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The strategies employed by Bifidobacterium spp. to degrade environmental 
glycans appear varied. Degradation of the HMO lacto-N-tetraose in B. bifidum 
requires an extracellular enzyme, lacto-N-biosidase, to cleave the tetramer into 
two disaccharides which are subsequently imported, however B. longum 
subspecies infantis imports the tetramer for internalised degradation (Marcobal & 
Sonnenburg, 2013; Sela & Millis, 2010; Yoshida et al., 2012). Other species, such 
as B. breve require the action of other members of the intestinal microbiota to 
degrade HMOs into monosaccharide components before it may import them for 
energy (Sela & Millis, 2010). 
 
A GH32 enzyme from Bifidobacterium longum KN29.1 was identified and 
characterised, kinetic parameters were elucidated in addition to a crystal structure 
of the enzyme (Bujacz et al., 2011; Jedrzejczak-Krzepkowska et al., 2011). It was 
demonstrated that this species could efficiently utilise short chain FOS, a 
phenotype confirmed by Watson and colleagues in 2013. The GH32 enzyme 
displayed a β propeller fold typical of the GH32 family, and was able to liberate 
fructose from non-reducing chain termini through the retaining mechanism 
(Jedrzejczak-Krzepkowska et al., 2011, Bujacz et al., 2011). It was not clear in 
these studies if the GH32 was expressed intra- or extracellularly. 
 
Bifidobacterium employ ABC transport systems to import mono- and oligo-
saccharides across the membrane. Several ABC transporter associated 
Extracellular Substrate Binding Proteins (ESBPs) have been identified in 
Bifidobacterium and other Gram positive genera which have been associated with 
glycan uptake. ESBPs are generally composed of two discrete domains joined by 
a hinge region, upon ligand binding the ESBP undergoes a significant 
conformational change as these two domains move relative to one another around 
the hinge region to form a binding pocket around the ligand (Berntsson et al., 
2010). Crystal structures of ESBPs are elucidated in either open form, with no 
ligand bound, or closed form, generally with a ligand in the active site; both 
structures of an ESBP must be obtained to observe the conformational changes 
undergone during ligand binding (Berntsson et al., 2010).  
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Cockburn et al., demonstrated with the inclusion of a closed-form crystal 
structure, the role of a starch binding ESBP during starch scavenging by E. rectale 
(Cockburn et al., 2013). The authors demonstrate that initial starch degradation 
takes place though a peptidoglycan associated enzyme prior to ABC permease 
mediated oligosaccharide import (Cockburn et al., 2013).  Another ESBP 
structure was elucidated in closed form which is crucial to 
arabinoxylooligosaccharide uptake by Bifidobacterium animalis subspecies lactis 
for internal degradation (Ejby et al., 2013; Van Den Broek et al., 2005). At 
present, few ESBPs which bind to oligosaccharides have been characterised and 
the conformational shift in these proteins has not yet been observed; furthermore 
no fructan binding ESBP has yet been characterised. 
 
Bifidobacterium adolescentis was identified as able to utilise inulin 
polysaccharide directly (Watson et al., 2013). This phenotype was of particular 
interest as direct utilisation of the inulin polysaccharide appears to be relatively 
uncommon in the genus. Furthermore very little mechanistic insight has been 
elucidated between the most commonly targeted probiotic genera, 
Bifidobacterium, and the most commonly used prebiotic class, fructans. 
Understanding how this mechanism works, particularly how inulin is recognised 
by the cell, may underpin future prebiotic design towards more personalised or 
more targeted prebiotics. 
 
In this chapter we identify putative fructan associated genes within B. adolescentis 
and show that the expression of several of these genes is induced in the presence 
of inulin and FOS. Amongst the inulin inducible genes, we identify a GH32 
family enzyme (BAD_1325) which is active on inulin, a LacI-homologue 
(BAD_1326) which bound to fructans during ITC analysis and an ESBP 
(BAD_1330) which bound to inulin and was successfully crystallised in both open 
and closed conformation. These data demonstrate the fructan-associated roles 
within the gene cluster, particularly the BAD_1330 ESBP reveals how long chain 
inulin is recognised at the cell surface prior to import through the membrane for 
internalised degradation. 
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5.2. Objectives 
• To identify putative inulin associated genes from B. adolescentis 
• To characterise the GH32 enzymes deployed during fructan degradation 
by B. adolescentis. 
• To further understand how inulin is recognised at the cell surface. 
• To determine whether or not inulin is broken up prior to import through 
the cell membrane. 
• To propose a model for inulin capture and utilisation by B. adolescentis.  
 
5.3. Growth of Bifidobacterium adolescentis and 
Bifodobacterium longum on Inulin and FOS. 
B. adolescentis and B. longum were cultured upon minimal media supplemented 
with glucose, fructose, sucrose, inulin and FOS to confirm the growth phenotypes 
observed by Watson and colleagues in 2013. Previously, B. longum was found to 
only utilise short chain fructans, whereas B. adolescentis was capable of utilising 
FOS and inulin polysaccharide (Watson et al., 2013). Glucose, fructose and 
sucrose were used as controls to visualise robust growth of each species. We 
wished to focus on B. adolescentis due to the comparatively unusual ability to 
utilise inulin polysaccharide; however B. longum serves as a negative control for 
this inulin utilisation phenotype and allows for comparison. Our data matched 
previous findings; B. adolescentis was able to utilise inulin, whereas B. longum 
could not. B. longum utilised FOS, but did not achieve the same final OD on this 
substrate as on glucose, suggesting a portion of this FOS could not be utilised 
(Figure 5.1 A). To determine the maximum chain length of FOS which could be 
accessed by B. longum it was grown upon defined oligosaccharides and inulin, our 
data show that B. longum is able to utilise the trisaccharide kestose but not the 
tetrasaccharide kestotetraose (Figure 5.1 B).  
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Bifidobacterium species proved more difficult than Bacteroides to culture within 
the smaller volumes used during plate reader analysis, and B. adolescentis 
consistently failed to achieve the same final OD as B. longum even on the 
monosaccharide controls, however robust growth comparable to B. longum was 
observed in larger (5 ml) culture volumes. 
 
Figure 5.1. The growth of Bifidobacterium adolescentis and Bifidobacterium longum 
upon glucose, fructose, sucrose, FOS and inulin. (A) B. adolescentis and B. longum 
were cultured in minimal media supplemented with 0.5 % glucose, fructose, sucrose, FOS 
(DP 3-4) or inulin. B. adolescentis was able to grow on all substrates in a similar manner, 
where B. longum was unable to utilise inulin, and could not fully utilise FOS. B. 
adolescentis consistently grew to a lower OD than B. longum when cultured in the small 
(250 µl) volumes used in conjunction with the plate reader. (B) As B. longum grew to a 
lower final OD on FOS than fructose and glucose we further explored FOS utilisation by 
growing B. longum on FOS of defined length, here we show that B. longum can use 
kestose (DP = 3) but not kestotetraose (DP = 4), explaining the lower final OD observed 
in panel A. Each experiment was conducted in triplicate and average values plotted. The 
experiment was repeated with consistent growth phenotypes. 
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Both species were grown in minimal media supplemented with 0.5 % of either 
inulin, FOS (DP = 3-4) or fructose (Figure 5.2).  
After 24 hours the OD600nm of each culture was noted before the spent supernatant 
was visualised via TLC. Media only controls were set up for comparison and to 
ensure no contamination occurred during the growth period.  
 
The spent supernatants are in agreement with the growth data and show that B. 
longum is able to utilise FOS but not inulin whilst B. adolescentis utilised both. 
Breakdown products are detected in the spent supernatant, this activity is more 
pronounced during growth on FOS of both species with comparably little fructose 
release during inulin processing by B. adolescentis (Figure 5.2). 
 
  
Figure 5.2. Spent culture supernatant fluid from the growth of B. longum and B. 
adolescentis on inulin and FOS. B. longum (L) and B. adolescentis (A) were cultured 
upon minimal media supplemented with fructose, FOS (DP = 3-4) or inulin and the spent 
supernatant fluid visualised using TLC. An increased cell density (OD600nm) correlates 
with a reduction of glycan remaining in the media as expected. Standards (S) consisting 
of 2 mg/ml each of fructose (F), sucrose (Suc), kestose (K3), kestotetraose (K4) and 
kestopentaose (K5) were visualised for comparison, as were cultures consisting of media 
and sugar only (Cntrl). B. adolescentis is able to utilise both FOS and inulin, whereas B. 
longum is only able to utilise the shorter FOS substrate. Duplicate cultures were used to 
ensure consistent growth phenotype, only one of these cultures was used for supernatant 
fluid analysis however no differences were noted between replicate final OD. 
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5.4. Identification of Putative Inulin Utilisation Genes 
5.4.1.  Two Putative Gene Clusters May be Involved in 
Inulin Utilisation 
The genomes Bifidobacterium longum subspecies longum JCM 1217 and 
Bifidobacterium adolescentis ATCC 15703 were used throughout this chapter, 
these were avaliable on the Integrated Microbial Genomes database having been 
sequenced by the HMP Reference Genome Project and Suzuki et al. respectively 
(HMP Consortium, 2010; Suzuki et al., 2006). Whilst only one GH32 was found 
within B. longum (BLLJ_1341); two GH32 enzymes are present within the B. 
adolescentis genome (BAD_1150 and BAD_1325), these enzymes have 28 % 
identity to each other.  
The first GH32, BAD_1150, shared 84 % identity with the only GH32 from B. 
longum (BLLJ_1341); suggesting that these enzymes are likely to perform the 
same role. The second GH32, BAD_1325, was more divergent from this enzyme, 
sharing only 29 % identity.  
 
The GH32 enzyme previously characterised by Bujacz and colleagues was from 
B. longum subspecies longum KN29.1 (Bujacz et al., 2011). The strain of B. 
longum used in this thesis was B. longum subspecies longum JCM 1217, however, 
the characterised GH32 and the GH32 from retain the strain used in this thesis 
(BLLJ_1341) had 99.03 % identity with each other and are unlikely to differ 
significantly. 
 
Both GH32 encoding genes were embedded within a genomic context which had 
the potential to be geared towards glycan utilisation as genes annotated as ABC 
permeases and a LacI-homologue were nearby. The first gene cluster (BAD_1148 
 BAD_1152) was highly similar (Figure 5.3) to the cluster containing the 
characterised GH32 homologue from B. longum (BLLJ_1341). It was therefore 
hypothesised that this cluster was involved in short chain FOS acquisition and 
operates in the same manner as the cluster from B. longum. The second gene 
cluster was more divergent from this cluster and was hypothesised to confer the 
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extra ability to utilise inulin seen in B. adolescentis but not B. longum (Figure 5.1, 
Figure 5.3).  
 
 
The first cluster contains 5 genes annotated as a LacI-homologue, a sucrose 
permease, the GH32 (bad_1150), an ABC transporter permease and an 
extracellular substrate binding protein (ESBP). The second cluster contains six 
genes; three ABC transporter permeases, an ESBP, a LacI class regulator and the 
predicted GH32 (bad_1325) as illustrated (Figure 5.3). 
 
Figure 5.3. Comparison of predicted fructan utilisation loci in B. adolescentis and B. 
longum. The two putative gene clusters identified within the B. adolescentis genome are 
displayed (Top panel: B. adolescentis, bottom panel: B. longum). The first cluster 
contains 5 genes which retain high similarity to the 5 genes encoded by B. longum (ID > 
70 %) and were therefore expected to perform the same role. The second cluster contains 
6 genes which were divergent with B. longum genes. The second, more divergent, gene 
cluster was hypothesised to be involved in inulin capture and degradation. 
 
5.4.2. qPCR Reveals Substrate Induced Gene Expression 
To confirm whether either of these clusters was involved in inulin or FOS 
acquisition, cultures were grown in the presence of glucose, FOS and inulin 
before harvest at mid-exponential phase. RNA extracted from these cultures was 
quantified using qPCR and the fold change between glucose grown cultures and 
FOS or inulin grown cultures were measured. The data show a clear up-regulation 
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of the second gene cluster in the presence of inulin and FOS, however neither 
substrate appears to induce the expression of the first cluster (Figure 5.4). Raw 
data is plotted (Appendix I, Table I.3). 
 
Figure 5.4. qPCR shows the inducible expression of genes from the second gene 
cluster in the presence of inulin and FOS.  B. adolescentis was grown on minimal 
media supplemented with glucose, inulin, FOS or sucrose in triplicates. RNA extracted 
from these cultures was quantified through qPCR. qPCR was performed in triplicate and 
the data averaged with standard error. Probe sets for genes within both gene clusters 
(bad_1148  bad_1153; bad_1325  bad_1330) were used, alongside probes targeting 
the 16S subunit. Cq values were normalised for cell number using the 16S probe set. Each 
gene under inulin, FOS and sucrose conditions were compared to the same gene under 
glucose conditions, and the fold change recorded. These data show the second gene 
cluster (bad_1325  bad_1330) is up-regulated with all genes undergoing a significant 
fold change on both FOS and inulin but not sucrose. The first gene cluster however was 
not upregulated on any substrate tested. Statistical significance was examined using a 
one-way ANOVA between the glucose mean and the experimental mean for each 
condition, and is shown (* P < 0.05, ** P < 0.01, *** P < 0.001) 
 
As only genes from the second gene cluster (bad_1325  bad_1130) were 
induced by inulin, this cluster became the focus of the study and is henceforth 
regarded as the inulin utilisation cluster. The first cluster, (bad_1148  
bad_1153) does not appear to be involved during inulin utilisation in B. 
adolescentis but the GH32 from B. longum (BLLJ_1341) is almost certainly 
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involved in FOS processing as it is the only GH32 in the genome; therefore this 
cluster is henceforth referred to as the FOS utilisation cluster.  
5.5. Characterisation of Two GH32 Enzymes 
The two GH32 enzymes, BAD_1150 and BAD_1325, were cloned, expressed and 
raw kinetic data generated by a summer student, Ms. Harriet Lane, under my 
supervision. Cloning and expression in recombinant E. coli were undertaken as 
described (Chapters 2.9.7 and 2.11). Proteins were purified using IMAC (Chapter 
2.12.1). Further construct details are listed (Appendix I.8). Data generated during 
this project was analysed by myself. 
 
The FOS-active GH32 (BAD_1150) and the inulin-active GH32 (BAD_1325) 
were cloned and expressed using pET-28b vector. Enzyme assays were 
undertaken using fructose detection through a linked enzyme assay kit (Figure 
5.5, Figure 5.6). Here we show that BAD_1150 is highly active on short chain 
FOS but has much lower activity on sucrose and inulin, these data are similar to 
the findings of Bujacz et al., 2011 and confirm the hypothesis that the two highly 
similar GH32 family enzymes (BLLJ_1341 and BAD_1150) are functionally 
identical β-fructosidase enzymes which target FOS (Table 5.1, Figure 5.5, 
Figure 5.6, Bujacz et al., 2011). BAD_1325 has increased activity on FOS and is 
poor on sucrose. Whilst neither enzyme was inactive on levan, the activity on this 
substrate was very low in both cases (Table 5.1, Figure 5.5, Figure 5.6). These 
data are consistent with the hypothesis that BAD_1325 plays a role in the 
utilisation of inulin, and BAD_1150 does not. 
Table 5.1. Kinetic parameters of the two GH32s (BAD_1150 and BAD_1325) 
  
 
 
BAD_1150 BAD_1325 
Kcat  
(Min-1) 
Km  
(mM) 
Kcat/Km  
(min-1/mM-1) 
Kcat  
(Min-1) 
Km  
(mM) 
Kcat/Km  
(min-1/mM-1) 
Sucrose 158  
± 9 
2.9  
± 0.5 
55 325  
± 25 
7.5 
± 1.2 
44 
Kestotetraose 221  
± 6  
0.1  
± 0.09 
2353 338  
± 17 
0.2 
± 0.05 
1770 
Inulin* 108  
± 5  
5.4  
± 0.015 
20 335  
± 8.5 
1.2 
± 0.12 
279 
Levan* 3  
± 0.5 
0.275  
± 0.05 
10.9 N/A  
 
N/A 96 
* Concentration of inulin and levan were estimated as described in Chapter 2.13.2. 
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Figure 5.5. Michaelis-Menton plots demonstrate the activity of two GH32s, 
BAD_1150 and BAD_1325 on fructans. Both BAD_1150 and BAD_1325 were active 
on sucrose, inulin, FOS and Levan. All enzyme assays were conducted in triplicate. Two 
separate protein preparations of each enzyme were used to ensure reproducibility. Data 
were averaged, and standard deviation shown. Concentrations of inulin and levan were 
calculated as outlined (Chapter 2.13.2). 
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Figure 5.6. Comparison of enzyme rates (Kcat/Km) for GH32 family enzymes. 
Illustrated are the average specific activities for each GH32 enzyme described in the text 
(BLLJ_1341, BAD_1150 and BAD_1325) on sucrose, kestotetraose, inulin and levan. 
BLLJ_1341 and BAD_1150 share 84 % sequence identity and appear to be functionally 
identical, BAD_1325 has a higher specific activity on longer substrates. 
 
5.6. Specificity of the LacI-homologue, BAD_1326 
A final year undergraduate project was undertaken by Mr Alex Bond with the aim 
of cloning, expressing and generating ITC data for the binding domain of the 
inulin inducible LacI-homologue regulator, BAD_1326. The project was 
supervised by Dr David Bolam and myself. Mr. Carl Morland generated replicate 
ITC data for the purposes of reproducibility. Cloning and expression using 
recombinant E. coli was undertaken as described (Chapters 2.9.7 and 2.11). 
Proteins were purified using IMAC (Chapter 2.12.1). Further construct details are 
listed (Appendix I.8).Data analysis was undertaken by myself. 
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The full length construct of the LacI homologue, BAD_1326 (1 aa – 362 aa), was 
insoluble during over expression in E. coli. A truncated construct, based upon an 
alignment with LacI was thus generated (73aa – 362aa) in order to remove the 
putative DNA binding domain and retain only the substrate binding domain 
(Figure 5.7). This construct was expressed successfully and the resultant protein 
was soluble.  
 
 
Figure 5.7. Domain structure of the LacI Repressor and LacI homologue, 
BAD_1326. (A) Crystal structure of the LacI Repressor from E. coli (PDB ID: 1LBG), 
showing the DNA binding, hinge and substrate binding domains (Lewis, 2005; Lewis et 
al., 1996). (B) Predicted domain structure of the LacI homologue, BAD_1325 (top) based 
upon LacI, and the construct used for these experiments (bottom). 
 
The LacI-homologue substrate binding domain bound to FOS (Kd ~ 1 µM), inulin 
(Kd ~ 7 µM) and levan (Kd ~ 9 µM) but did not bind to fructose or sucrose (Figure 
5.8). Affinity for oligosaccharides increased as DP increased, suggesting that longer 
substrates are the preferred binding target (Table 5.2). 
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Table 5.2 Binding Parameters of the LacI homologue substrate binding domain 
(BAD_1326), from ITC Datasets 
* In some cases (kestotetraose, inulin, levan) only one ITC trace was generated. In these 
cases, errors are from the fit to the model. For all other conditions at least 2 datasets were 
generated and standard deviations were calculated. 
+ Concentration of inulin and levan were estimated as described in Chapter 2.13.2. 
 
Ligand N  
 
Ka  
(x104 M-1) 
 ΔG  
(kcal mol-1) 
ΔH  
(kcal mol-1) 
TΔS  
(kcal mol-1) 
Fructose  No Binding 
Sucrose  No Binding 
Kestose 1  
±0.1 
2.3  
±0.0 
 -5.9 
 
-4.8 
±0.5 
-1.1 
Kestotetraose* 0.6  
±0.2 
4.7  
±1.5 
 -6.4  -7.6  
±2.4 
-1.2 
Kestopentaose 0.8 
±0.4 
5.1 
±1.2 
 -6.4 
 
-12 
±2.9 
-5.6 
Inulin*+ 1  
±0.2 
1.5  
±0.2 
 -5.7  -5  
±1.1 
+0.7 
Levan*+ 0.7 
 ±0.4 
1.1  
±0.3 
 -5.5  -7.7  
±4.6 
-2.2 
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Figure 5.8. ITC analysis of the lacI-homologue substrate binding domain, 
BAD_1326. ITC analysis of the LacI homologue reveals high affinity binding to FOS and 
inulin, with weak binding to levan and no binding to sucrose or fructose. ITC traces for 
each experiment are shown, the top frame shows the raw heats and the bottom shows the 
integrated peak areas fitted to a one site model using Microcal origin software, apart from 
fructose and sucrose which did not bind and only the ITC traces are shown. Full binding 
parameters are shown separately (Table 5.2). * Concentrations calculated as shown in 
Chapter 2.13.2. 
 
5.7. Structural and Functional Insights into the Inulin Binding 
ESBP, BAD_1330 
5.7.1.  The ESBP, BAD_1330, Recognises Inulin 
The ESBP, BAD_1330, contains a type II signal peptide predicted to facilitate 
localisation at the cell surface (Bagos et al., 2008), this was removed prior to 
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cloning and expression using recombinant E. coli as described (Chapter 2.9.7 and 
2.11). Protein was purified using IMAC (Chapter 2.12.1).  
Further construct details are listed (Appendix I.8).  
ITC binding analysis (Figure 5.9) revealed that the ESBP bound to inulin (Kd ~ 
0.04 mM) and FOS, but did not bind to sucrose. It bound more weakly to levan 
(Kd ~ 0.1 mM). The affinity of the ESBP for kestotetraose and kestopentaose were 
greater than that of kestose suggesting that at least three fructose units are 
required for optimal binding. Full binding parameters are listed below (Table 
5.3). 
Table 5.3. Binding Parameters of BAD_1330 from ITC Datasets 
Multiple datasets (3-5) were obtained with at least two freshly prepared protein samples 
to ensure results were reproducible and to calculate standard deviations 
+ Concentration of inulin and levan were estimated as described in Chapter 2.13.2. 
Δ An interaction was observed with levan, but this was too weak to fit to the model. Refer 
to main text. 
 
Ligand N  
 
Ka  
(x 104 M-1) 
ΔG  
(kcal mol-1) 
ΔH  
(kcal mol-1) 
TΔS  
( kcal mol-1) 
Sucrose No Binding  
Kestose 1.2  
±0.4 
0.5 
±0.05 
-5.0 -6.3 
±3.6 
-1.3 
Kestotetraose 0.9  
±0.4 
8.1 
±3.1 
-6.7 -9.3 
±2.8 
-2.6 
Kestopentaose 1  
±0.4 
5.1 
±4.5 
-6.4 -8.2 
±4.7 
-1.8 
Inulin+ 1.1 
±0.0 
4.8 
±1.6 
-6.4 -11 
±1 
-4.6 
Levan+ Binding too weak to fitΔ 
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Figure 5.9. ITC analysis of the ESBP, BAD_1330. ITC analysis of the ESBP reveals 
high affinity binding to FOS and inulin, binding to levan and no binding to sucrose. 2-5 
datasets were obtained and representative traces for each experiment are shown. ITC was 
performed in 20 mM HEPES, pH 7. * Concentrations in mM were calculated as shown in 
Chapter 2.13.2. 
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5.7.2.  The Crystal Structure of the inulin binding 
BAD_1330 ESBP 
Crystals were harvested, data collected and the structure solved by Dr. Arnaud 
Baslé as part of a collaboration with the Structural Biology Lab (SBL), Newcastle 
University. Crystallography data tables generated by Dr. Arnaud Baslé are shown 
(Appendix I, Table I.4 and I.5) 
 
The ESBP was purified using IMAC followed by Gel Filtration chromatography 
as outlined (Chapter 2.12.1 and 2.12.3) and crystallised as described (Chapter 
2.13.3).  
 
The structure of the ESBP in open form was solved (Figure 5.10). The protein 
consists of two distinct domains (Domain one: 35 – 157, 345-437 aa; Domain 
two: 158 – 344, 438 – 532 aa) connected by two loops and an alpha helix. Both 
domains are formed by central β-sheets surrounded by α helices. This structure 
has a similar overall fold and domain structure with other elucidated class 1 
substrate binding proteins (Berntsson et al., 2010).  
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Figure 5.10. The Structure of the ESBP, BAD_1330 in Open Conformation. The 
crystal structure of the ESBP was solved in open conformation. The protein consists of 
two distinct domains (domain 1, coloured blue and domain 2, coloured red) joined by two 
loop regions and an α helix. The protein is displayed from two angles to demonstrate the 
two domain regions and the three linker regions where the domains meet. Panel B has 
been rotated 270° along the x axis relative to panel A. 
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The Dali server was used to identify close structural homologues to the ESBP, 
BAD_1330 (Holm & Rosenström, 2010). The closest structural homologue to 
BAD_1330 is BLON_2351 (3OMB), an ESBP from B. longum subspecies 
infantis, which retains 47 % ID, however there is no biochemical characterisation 
accompanying this structure at present. All other structural homologues have 
relatively low identity (>25 %).  
BAD_1330 retained low identity to the two ESBP structures discussed in the 
chapter overview, the arabinoxylan oligosaccharide specific ESBP (13 % ID) 
from B. animalis (Ejby et al., 2013) and the starch specific ESBP (14 % ID) from 
E. rectale (Cockburn et al., 2013). 
 
5.7.3. A Significant Conformational Change Occurs Upon 
Ligand Binding 
The ESBP was purified using IMAC followed by Gel Filtration chromatography 
as outlined (Chapter 2.12.1 and 2.12.3) and crystallised with kestotetraose as 
described (Chapter 2.13.3). The crystal structure was solved in complex with 
kestotetraose (Figure 5.11) 
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Figure 5.11. The structure of the ESBP, BAD_1330, was solved in complex with 
kestotetraose. The crystal structure of the ESBP was solved after co-crystallisation with 
kestotetraose (K4), revealing the protein in a closed conformation with ligand bound. The 
two domains are coloured (domain 1, blue and domain 2, red). (A) BAD_1330 shown in 
surface representation and K4 (yellow), interacting residues in green. (B) As in panel A, 
with the protein rotated on the x axis by 80° showing a top down view of the binding 
pocket. (C) BAD_1330, with K4 bound, is shown as a cartoon. Inset: The structure of K4 
as it appears in the binding pocket, K4 is a tetramer comprised of a glucose (G) as part of 
a sucrose moiety and two fructose (F) units linked as follows: Gα12βF3β21βF2β21βF1. 
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A significant conformational change upon ligand binding is clearly observed in 
this structure compared to that of the open form (Figure 5.12). DynDom 
(Poornam et al., 2009) was used to further quantify the change between 
conformers and to identify hinge regions. The two domains rotated around the 
hinge region at an angle of 26.5°. Three hinge regions were identified (156-158 
aa, 343-349 aa and 437-438 aa) which correspond to the three regions joining the 
two domains (Figure 5.12). The movement can also be quantified by measuring 
the distance between residues in the closed and open conformers; Q81 moves the 
greatest distance (8.9 Å) as the two domains are drawn closer together.  
The binding pocket is formed upon ligand binding as the two domains move 
together around the ligand. Most of the interaction takes place at the non-reducing 
fructose terminus, where the protein forms extensive interactions with the 
terminal fructose. The pocket opens up into a wide channel in which the glucose 
end of the ligand is poorly co-ordinated, this widening of the channel presumably 
allows the ESBP to bind to longer oligosaccharides and polymeric inulin, which 
can protrude through the channel into the extracellular space.  
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Figure 5.12. The binding site is formed by a change in the relative positions of the 
two domains. The BAD_1330 binding site is formed upon ligand binding as the two 
domains move closer together. Domain one (blue) and domain two (red) move around a 
hinge region (green). N denotes the amine or “N” -terminus of the protein. (A) 
BAD_1330 in open form, displayed as a cartoon (right), and as a surface with 
kestotetraose (yellow) superimposed (left). (B) BAD_1330 in closed form displayed as a 
cartoon (right) and as a surface in complex with kestotetraose (left). (C) Protein 
secondary structure diagram generated with PDBsum Generate (De Beer, 2014) and 
coloured to represent the domains and hinge regions. 
N 
N 
N-terminus 
C-terminus 
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5.7.4. Insight into Ligand Binding by the Inulin ESBP, 
BAD_1330 
The ESBP structure in complex with kestotetraose allows considerable insight 
into the binding mechanism of this protein. From the structure, several residues 
form hydrogen bonds with the kestotetraose ligand (Figure 5.13). Most of these 
form bonds with the non-reducing fructose terminus, F1 (R153, D413, Q420, 
D421, N438). The subsequent fructose units, F2 and F3 are bound by two residues 
each (D421 and R422; R45 and D77 respectively). W306 stacks against the F1 
ring and W218 protrudes into the space created by the curvature of the ligand, 
creating a hydrophobic environment energetically favourable with the ligand in 
this position. 
 
A pocket is formed in which the kestotetraose non-reducing fructose end is co-
ordinated. Most of the recognition seems to be driven by the terminal sugar, 
however the subsequent two fructose units also form interactions with the binding 
pocket (Figure 5.13). It is difficult to analyse binding to the fourth sugar, as this is 
glucose within the complex but binding to inulin and FOS with a DP > 4 will 
present a fructose at this position. However the ITC data (Table 5.3) shows that 
maximal affinity may be achieved with kestotetraose, which suggests few further 
interactions take place; in contrast, there is a marked 10 fold decrease in affinity 
for kestose (Table 5.3). 
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Figure 5.13. The ESBP crystal structure reveals interactions with kestotetraose. (A) 
The BAD_1330 structure showing the location of the binding site. Inset: A 3D 
representation of the binding pocket. Hydrogen bonding to the non-reducing fructose 
terminus (F1) is mediated by N438, D413, Q420 and N421. Less hydrogen bonding to 
subsequent fructose units is observed with N421, R153 and R422 bonding F2, and R45 
and D77 bonding to F3. Glucose (G) does not form any interactions. W218 creates an 
energetically favourable hydrophobic region against the curvature of the ligand. W306 
(not shown in panel B) stacks in plane against the F1 ring, creating another hydrophobic 
interaction. (B) PoseView (Stierand & Rarey, 2010) was used to create a 2D diagram of 
the interactions between key residues and the kestotetraose in the crystal structure. This 
diagram was then edited for clarity and to show putative bond length measured in 
PyMOL. 
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5.8. Discussion 
5.8.1.  A Model for Inulin Utilisation in B. adolescentis 
One objective of this research was to identify whether inulin was processed 
outside of the cell, or whether it was first imported for internal processing. 
Initially as neither of the GH32 encoding genes (bad_1326 or bad_1150) 
contained a predicted signal peptide and were suspected to localise to the 
cytoplasm, we hypothesised that processing occurred internally.  
 
This hypothesis is strengthened by the observation that the LacI-homologue 
construct, BAD_1326PBP, recognises FOS and inulin, and not fructose 
monosaccharide. The LacI homologue, BAD_1326, contains a DNA binding 
domain and a periplasmic binding protein (PBP) domain and is suspected to 
perform a regulatory function within the cytoplasm. As oligo- and 
polysaccharides are recognised, it appears clear that these substrates must be 
imported whole prior to regulation.  
 
In addition, the presence of the inulin binding ESBP BAD_1330 also strongly 
indicated that inulin is pulled into the cell prior to degradation. ESBP have been 
shown to mediate the import of carbohydrates into the cell cytoplasm (Ejby et al., 
2013; Cockburn et al., 2015).  
 
B. adolescentis cells grown on inulin produced small amounts of fructose over the 
course of growth (Figure 5.2) which is consistent with internal inulin degredation. 
The utilisation of small FOS is less clear as during growth on FOS, fructose and 
small FOS breakdown products were produced within the culture supernatant 
suggesting the presence of an extracellular enzyme (Figure 5.2). This extra-
cellular activity may be the result of cell lysis leading to the release of 
cytoplasmic GH32 enzyme rather than the co-ordinated secretion of one or both of 
the GH32 enzymes. We suspect that this extra-cellular activity is artefactual as 
neither GH32 enzymes contained a signal sequence.  
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The data obtained within this chapter allow us to present a model for inulin 
utilisation within Bifidobacterium adolescentis (Figure 5.14). Inulin is recognised 
at the cell surface by the ESBP, BAD_1330, and pulled through the membrane by 
an associated ABC permease (BAD_1327, BAD_1328 and/or BAD_1329). Once 
imported to the cytoplasm, the lacI-homologue, BAD_1326, recognises FOS and 
inulin and propagates the up-regulation of the gene cluster.  
Finally, the GH32, BAD_1325, depolymerises imported fructans for use by the 
cell as energy (Figure 5.14). 
 
 
Figure 5.14. A model for inulin utilisation by Bifidobacterium adolescentis. The data 
elucidated from this chapter allow a model for inulin utilisation by B. adolescentis to be 
put forward. (A) Inulin and FOS are recognised at the cell surface by the ESBP and 
imported (B) through the associated ABC permeases. (C) Cytoplasmic FOS and inulin 
are bound by the LacI-homologue and the gene cluster is up-regulated. (D) The GH32, 
BAD_1325, mediates the depolymerisation of these substrates for downstream use by the 
cell.  
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5.8.2.  The FOS-Utilisation Cluster 
B. longum contains one GH32 encoding gene (bllj_1341) whereas B. adolescentis 
contains two (bad_1150 and bad_1325); bllj_1341 has high sequence identity to 
bad_1150, and bad_1325, from the inulin utilisation cluster, is more divergent 
(Figure 5.3).  
 
 
As bllj_1341 is the only fructan active enzyme predicted within the B. longum 
genome, we make the assumption that this enzyme enables growth on FOS 
(Figure 5.1). The genomic context of bllj_1341 (bad_1339  bad_1343) is 
highly similar to the context of bad_1150 (bad_1148  bad_1152), thus it seems 
likely that this cluster performs the same role in both species. This cluster was 
explored with limited success, however, a mechanism of action may be put 
forward. B. longum contains a gene cluster with high sequence identity to the FOS 
utilisation cluster in B. adolescentis (Figure 5.3) but does not contain any other 
GH32 enzymes, or other candidate fructan utilisation systems. We make the 
assumption, due to this high identity, that these clusters operate in the same 
manner and this cluster, in B. longum is involved in FOS degradation. 
 
 
B. longum did not reach the maximal cell density on FOS of DP 3-4 as on glucose 
(Figure 5.1) indicating that the full range of oligosaccharides could not be 
utilised. Growth experiments with this species confirmed that B. longum could use 
kestose but not kestotetraose (Figure 5.1 B).  
 
Characterisation of the ESBP from this cluster, BAD_1152, was attempted; 
however no binding during ITC analysis to fructans was observed (Appendix I, 
Figure I.3). This protein is a different class of ESBP to the characterised ESBP 
BAD_1330 and is annotated as pfam NMT1, a family associated with thiamine 
biosynthesis and regulation. The lack of growth of B. longum on longer FOS 
substrates suggests that a bottleneck exists at the import stage.  
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Furthermore, a permease, bad_1149, is encoded within this cluster which may be 
the sole FOS importer. It seems likely that the permease, bad_1149, is responsible 
for short chain FOS up-take while the ABC permease and associated ESBP are 
not involved in fructan utilisation at all. It is possible, however, that the expressed 
ESBP was non-functional during ITC analysis, leading to the negative results 
obtained. 
 
 
No upregulation of the FOS cluster was detected on FOS, inulin or sucrose 
(Figure 5.4). We speculate that the relevant genes are either constitutively 
expressed such that no fold change is observed between glucose and fructan 
substrates, or that the substrate bound by the lacI class regulator was not tested. 
The former instance seems unlikely, as lacI class regulators normally propagate an 
induction of expression, though this protein may not be involved in fructan 
utilisation or linked to the GH32 enzyme. In the latter instance, it may be that the 
regulator binds to a specific substrate such as kestose, fructobiose, fructotriose etc. 
It is unlikely that fructose is recognised as the GH32 enzymes will produce this 
during inulin and FOS breakdown, and some up-regulation would have likely 
been observed. Further experiments should be conducted to elucidate which 
hypothesis (if either) is correct, this could be done through qPCR analysis using 
the aforementioned substrates, and the lacI class regulator, bad_1148, should be 
characterised. 
 
From these data it is speculated that the ABC transporter and ESBP (BAD_1151 
and BAD_1152) are not part of this cluster. As only kestose, sucrose and 
monosaccharides were utilised well (and there is no recognisable signal peptide), 
we speculate that the GH32 enzyme is located within the cytoplasm as this 
enzyme does not demonstrate the tight specificity seen during growth. It is likely 
that the permease, BAD_1149 facilitates the import of small FOS across the 
membrane. The LacI class regulator may bind fructose as a proxy for FOS, but is 
more likely to bind to a di- or tri-saccharide if it is involved within the system.  
 
 215 
These speculations are under the assumption that the B. longum FOS-utilisation 
cluster (bllj_1339  bllj_1341) operates in an identical manner to the 
homologous cluster from B. adolescentis – a dangerous assumption to make, 
despite high sequence identity of the cluster components (Figure 5.3). Indeed, it 
may be that the acquisition of the inulin utilisation cluster has rendered the FOS 
utilisation cluster defunct in B. adolescentis, and it is no longer required or 
regulated in response to fructans. The speculated mechanism for FOS utilisation 
by this cluster are illustrated in the figure below (Figure 5.15) however future 
experiments are required to before conclusions about this system can be drawn. 
 
Figure 5.15. A potential mechanism by which the FOS-utilisation cluster may 
function in B. adolescentis. We were unable to satisfactorily characterise the FOS-
associated gene cluster (bad_1148  bad_1150). A potential mechanism by which these 
genes may operate is shown. (A) Short chain FOS are imported through the permease, 
BAD_1149. (B) The LacI class regulator, BAD_1148, recognises imported FOS or a 
component of this imported FOS to induce the expression of the gene cluster. (C) The 
GH32, BAD_1150, depolymerises this imported FOS. 
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5.8.3.  Insight into Fructan Utilisation by Bifidobacterium 
spp. 
There is a paucity of literature regarding the fructan degradative apparatus of 
Bifidobacterium species. It is, therefore, difficult to understand how inulin 
prebiotics are able to stimulate a bifidogenic affect (Schaafsma & Slavin; 2015, 
Patel & Goyal, 2012; Dewulf et al., 2013). Here we demonstrate that B. 
adolescentis can utilise inulin directly however most members of the 
Bifidobacterium genus appear to utilise only short chain FOS (Watson et al., 
2013). Other members of the microbiota, such as B. ovatus, degrade inulin 
externally, creating substrate for other microbes (Rakoff-Naouhm et al., 2014; 
Chapter 4.3). We demonstrate that B. ovatus breakdown products are the preferred 
substrate for both B. longum and B. adolescentis (Appendix I, Figure I.7), 
supporting the hypothesis that glycans may be “shared” or “scavenged” across 
intestinal microbial communities. 
  
 217 
Chapter 6. Final Discussion 
 
6.1. Summary 
The aim of this thesis was to explore non-linear fructan and the utilisation of 
inulin by key members of the microbiota.  
 
In chapter 3 we demonstrate evidence to support the literature showing that 
fructan from onion, wheat, agave and garlic is non-linear (Chapter 3.0, Chapter 
3.3). This includes structures with; a β2-1 backbone with β2-6 branches, a β2-6 
backbone with β2-1 branches, bifurcose, and bifurcose-series fructans, though a 
detailed analysis of linkage types could not be undertaken and suspected linkage 
types were based upon previous studies (Baumgartner et al., 2000; Arrizon et al., 
2010; Velazquez-Martinez et al., 2014; Verspreet et al., 2007; Bancal et al., 1991; 
Vijn et al., 1997). Bacteroides ovatus and Bacteroides thetaiotaomicron, have 
been shown previously to have a mutually exclusive preference for either inulin or 
levan respectively (Sonnenburg et al., 2010), our data show that non-linear 
fructans, which we speculate make up a large portion of dietary fructan; can 
provide carbon and energy to the gut microbiota (Chapter 3.4). The data also 
demonstrate that B. ovatus and B. thetaiotaomicron have overlapping niches 
within the intestine, despite divergent linkage specificity (Sonnenburg et al., 2010, 
Chapter 3.4).  
 
In chapter 4 we elucidate the mechanism by which B. ovatus is able to utilise 
inulin. B. ovatus is a highly prominent Gram negative member of the gut 
microbiota capable of degrading a wide range of glycans (Martens et al., 2011). 
We confirmed putative inulin associated genes through qPCR analysis 
(Sonnenburg et al., 2010; Chapter 4.5). We show that inulin is broken up 
extracellularly by a heteromeric GH91 enzyme into DFA-FOS (Chapter 4.6).  
 
Sucrose terminated inulin and FOS are targeted for direct import by a SusD-
homologue, we show the putative binding site of this SusD-homologue through x-
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ray crystallographic studies, targeted alanine mutagenesis and ITC analysis 
(Chapter 4.7). Extracellular inulin and FOS are imported through a SusC-
homologue (Chapter 4.9.1) and degraded in the periplasm by a GH32 (Chapter 
4.8). DFA is produced as a waste product during growth on inulin (Chapter 4.6.7), 
both in B. ovatus mono-cultures and in faecal sample batch cultures (Chapter 4.6, 
Chapter 4.10.1), our data indicate that this DFA is not degraded by other 
microbiota (Chapter 4.10.2). 
 
In chapter 5 we explore the mechanism by which Bifidobacterium adolescentis is 
able to utilise inulin. Bifidobacterium are prominent members of the microbiota 
and are thought to be health-promoting (Fanning et al., 2012a; Fanning et al., 
2012b; Picard et al., 2005; Fukuda et al., 2011); as such, Bifidobacterium spp. are 
the classic target for prebiotic treatment (Gibson & Roberfroid, 1995). Among 
Bifidobacterium spp., the ability to utilise inulin polysaccharide is relatively rare 
despite widespread FOS utilisation in this genus (Watson et al., 2013). We 
demonstrate that B. adolescentis contains a divergent gene cluster which is 
upregulated in the presence of inulin and FOS (Chapter 5.4.2). Inulin is bound by 
an ESBP. We characterise through x-ray crystallography the binding site of this 
ESBP protein, along with the significant conformational change which is 
undertaken upon ligand binding (Chapter 5.7.3). Inulin is recognised in the 
cytoplasm by the PBP domain of a LacI-homologue, presumably this protein 
mediates the up-regulation of inulin associated genes (Chapter 5.6). Inulin 
degradation takes place internally, through the action of a GH32 (Chapter 5.8.1). 
 
 
Our data expands our understanding of the types of fructans available to our 
microbiota and demonstrates detailed analysis of how inulin is captured and 
utilised by two key members of the microbiota. Our data allows deeper insight 
into the ecological niches adopted by members of the intestinal microbiota during 
nutrient acquisition. Understanding how inulin is used at the molecular level may 
underpin the design and development of novel prebiotic treatments, and enhance 
our understanding of how microbes are able to respond to prebiotic intervention. 
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6.2. The Role of Insoluble Inulin and Branched Fructans in the 
Diet 
Ingested MACs move through the digestive tract and by doing so, are exposed to 
microbial degradation (Flint et al., 20012). Theoretically, short, simple and 
soluble substrates can be more easily accessed whereas insoluble, complex or 
otherwise recalcitrant structures require more specialised apparatus to degrade and 
may persist in the lumen longer; therefore a gradient of increasingly recalcitrant 
carbohydrate structures may exist along the length of the intestinal tract (Figure 
6.1, Koropatkin et al., 2012). Furthermore, the mucous layer thickens in the late 
G.I. tract and is thought to provide a better environment for microbes which target 
host mucins (Koropatkin et al., 2012; Eckburg et al., 2005).  
 
 
Figure 6.1. Glycan availability changes across the digestive tract (Koropatkin et al., 
2012).  A glycan gradient is likely to exist across the host digestive system. Early areas of 
the G.I. tract move more rapidly, have a thinner mucous layer and contain less recalcitrant 
glycans than later areas. This potentially creates microenvironments in which distinct 
microbes reside (Koropatkin et al., 2012). 
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We speculate that the non-linear fructans such as those examined in Chapter 3 
may be more recalcitrant to microbial degradation and may persist longer in the 
G.I. tract to form a niche in the mid-late digestive tract. We also speculate that 
high degree of branching may occlude import apparatus and/or prevent enzymes 
from cleaving. In Bacteroides, PUL systems which tackle branched carbohydrates 
appear complex often containing enzymes which are able to remove side-chains, 
or cleave the backbone extracellularly to reduce glycan size prior to import 
(Cuskin et al., 2015; Rogowski et al., 2015). Therefore, to tackle large, highly 
branched fructans, we would expect to see extracellular processing.  
Whilst extracellular DFA-terminated oligosaccharides are produced during 
growth on inulin by B. ovatus through the action of the GH91 enzyme, we do not 
see DFA production on garlic fructan, suggesting that branching occludes the 
function of the GH91 enzyme (Chapter 3.4; Baumgartner et al., 2000). 
Experiments have not yet been conducted to show how the comparatively simple 
import mechanism of B. adolescentis copes with non-linear fructan structures, and 
should be undertaken to further our understanding of the niche non-linear fructan 
structures provide within the gut. 
 
Insoluble inulin represents another distinct niche; insoluble matter is more 
recalcitrant to enzymatic degradation and may require co-ordination between 
binding domains and enzymes (Boraston et al., 2004). Short chain inulin is easily 
solubilised; however this short chain substrate may not be the full complement of 
inulin present in the human bowel. Much of the inulin used for commercial and 
research purposes is obtained by hot water extraction from the plant, commonly 
chicory root (Gupta et al., 2003). Hot water extractions rely on solubilising inulin 
and removing insoluble matter, therefore by performing these extractions any 
insoluble inulin is discarded. All substrates used in this study were obtained by 
hot water extraction and as such any insoluble material present in the original 
sample was lost, and not tested (Figure 6.2.). 
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Figure 6.2. Hot water extraction of soluble plant fructans. During this study fructans 
were acquired from hot water extractions as outlined in Chapter 2.17.1; this technique 
removes any insoluble matter and thus insoluble fructan was not tested. 
 
Bacteroides ovatus contains apparatus, including the extracellular endo-acting 
GH91 enzyme, which appears to be redundant and does not contribute much 
obvious benefit to the degradation of linear, soluble inulin (Chapter 4.9.3). It is 
possible that B. ovatus is able to mediate the breakdown of insoluble inulin 
through the co-ordinated action of the GH91 enzyme and appended CBM. We 
propose that by doing this or through the breakdown of non-linear fructans, B. 
ovatus would be able to colonise areas further down the colon, where only the 
more recalcitrant carbohydrates remain available. It is also speculated that the 
comparatively simple B. adolescentis import apparatus will not be able to handle 
insoluble or highly branched fructans and will occupy a niche earlier in the 
digestive tract. In support of this theory, we show that B. longum is unable to 
utilise FOS of DP > 3 (Chapter 5.3) despite using FOS of DP = 3, this suggested 
that FOS utilisation is constrained at import and is unable to accommodate 
additions to the glycan chain. To test how well the B. adolescentis import 
mechanisms can handle non-linear fructan, ITC should be conducted with the 
ESBP against garlic or wheat fructan and growth experiments with these 
substrates should be conducted. 
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6.3. Fructan Acquisition Niches in the Bacteroides and 
Bifidobacterium genera 
Both B. ovatus (Chapter 4.3) and B. thetaiotaomicron (Sonnenburg et al., 2010) 
produce extracellular oligosaccharides during growth on inulin and levan 
respectively. Oligosaccharides released into the intestinal lumen are likely to be 
scavenged by competing microbiota which have the ability to process short chain 
FOS, but lack the ability to utilise the polysaccharide (Figure 6.3).  
Rakoff-Naoum and colleagues show this effect well, demonstrating that these 
oligosaccharides can indeed be utilised by other members of the microbiota 
(Rakoff-Nahoum et al., 2014). There is a clear advantage to oligosaccharide 
scavenging; fewer, less specialised enzymes and binding proteins and thus less 
energy is required to import and degrade simple carbohydrates.  
 
 
A scavenging system, in the case of fructans, is quite versatile as short chain FOS 
will exist in the diet in addition to being produced and released by species such as 
B. ovatus; therefore, scavengers may occupy multiple niches along the G.I. tract 
with minimal expended energy. The advantage to the producer of these 
oligosaccharides is less clear, as these bacteria lose material to scavengers (Figure 
6.3). It is possible that by “sharing” resources with scavengers, these bacteria 
cultivate a niche for themselves occluding the growth of other species able to 
access the polysaccharide directly which do not release oligosaccharides. It is 
plausible that other, more complex, relationships exist between producer and 
scavenger; however these relationships are difficult to quantify and examine. 
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Figure 6.3. Selfish, sharing and scavenging niches. Three mechanisms for utilising 
inulin are proposed; a selfish mechanism (e.g. Bif. adolescentis) which is able to utilise 
HMW inulin and LMW FOS from the diet without the production of extracellular 
oligosaccharides and thus does not lose substrate to scavengers, a “sharing” mechanism 
(e.g. Bac. ovatus) which produces extracellular oligosaccharides which may be scavenged 
by other organisms and, a “scavenging” mechanism (e.g. Bif. longum) which is able to 
use LMW FOS only both from the diet and from sharing microbes. 
 
Not all Bacteroides species are able to grow on polymeric inulin or levan; 
Bacteroides vulgatus is able to use FOS only, and whilst Sonnenburg et al. 
demonstrate that B. fragilis grew on inulin, we found that it was only able to 
utilise FOS (Appendix I, Figure I.6; Sonnenburg et al., 2010). These FOS users, 
are potentially able to scavenge oligosaccharides produced by B. ovatus and B. 
thetaiotaomicron on polymeric fructan.  
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Not all inulin using Bacteroides spp. produce extracellular oligosaccharides which 
may be shared; Bacteroides uniformis contains a set of four GH32 family 
enzymes, one of which displays catalytic residues suggestive of an endo-
mechanism (Bolam & Sonnenburg, 2011; Lammens et al., 2009; Pouyez et al., 
2012; Vandamme et al., 2013) however when B. uniformis whole cells were 
incubated with inulin, no extracellular oligosaccharides were produced (Appendix 
I, Figure I.4.; Mr. Carl Morland, unpublished data). This suggests that B. 
uniformis might have internalised endo-activity, presumably to prevent loss of 
glycan to the intestinal environment whilst retaining functionality, such as seen 
during the growth of B. thetaiotaomicron on mannan (Cuskin et al., 2015). This 
hypothesis is supported by the putative type I (periplasmic) signal peptide present 
at the start of the predicted endo-inulinase GH32 sequence. It was also shown that 
the inulin utilising strain B. thetaiotaomicron 8736 does not produce extracellular 
oligosaccharides (Appendix I, Figure I.4.; Mr. Carl Morland, unpublished data). 
This data was less surprising as B. thetaiotaomicron 8736 does not contain a 
candidate endo-inulinase. Furthermore, the GH91 knockout and mutant strains of 
B. ovatus (Δbacova_04502, Δbacova_04503 E196Q) retain WT-like growth on 
inulin despite loss of endo-activity (Chapter 4.9.3). These data strongly suggest 
that endo-inulinase activity is not necessary to utilise inulin in Bacteroides spp., or 
indeed by Bifidobacterium adolescentis (Chapter 5). We speculate that the 
presence of endo-enzymes confers a selective advantage either due to sharing of 
inulins or by gaining access to insoluble inulin substrate. 
 
The B. ovatus SusD homologue, recognises sucrose terminated glycans (Chapter 
4.7.3). SusD and other characterised SusD-homologues generally recognise the 
breakdown products from the endo-acting enzyme, but this is not the case in the 
B. ovatus inulin SusD-homologue. We speculate that the recognition of the 
sucrose terminus allows the organism to recognise the highly desirable dietary 
FOS, which contains more sucrose per weight than long chain, branched or 
insoluble inulin. By targeting this FOS for rapid, direct import, we speculate that 
B. ovatus can compete in niches higher up the digestive tract where these 
desirable glycans are still available, effectively adopting a “scavenging” niche in 
these circumstances. 
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Most Bifidobacterium species will utilise short chain FOS but not polymeric 
fructans (Watson et al., 2013). This is consistent with the concept that 
Bifidobacterium are scavenging species or are able to utilise dietary FOS earlier in 
the digestive tract. B. adolescentis has an expanded ability to utilise inulin due to 
the ABC transport system with the inclusion of an inulin binding ESBP. The 
ability to import soluble inulin may confer an advantage to B. adolescentis 
compared to FOS utilising Bifidobacterium species as this allows B. adolescentis 
to harvest a wider range of FOS and inulin type fructans. We speculate that 
members of the Bifidobacterium are under strong competition for accessible 
glycans and likely occupy niches in the early digestive tract where these desirable 
carbohydrates are likely to be most abundant (Koropatkin et al., 2012).  
 
6.4. A Comparison between Bacteroides ovatus and 
Bifidobacterium adolescentis with Regards to Fructan 
Utilisation 
Bifidobacterium adolescentis and Bacteroides ovatus display very different glycan 
utilisation systems. The main contrast between the two organisms is the cell wall; 
B. adolescentis is Gram positive whereas B. ovatus is Gram negative. The 
presence of the additional cell wall is an asset to B. ovatus during glycan 
degradation, as membrane anchored proteins and a periplasmic space lend itself to 
step-wise degradation and import, PUL encoded systems are incredibly versatile 
and tightly regulated (Martens et al., 2009; Larsbrink et al., 2014; Cuskin et al., 
2015; Rogowski et al., 2015). In contrast, B. longum does not co-ordinate such 
extensive apparatus at the cell surface and glycans which cannot be imported 
directly cannot be accessed. Gram positive species are able to degrade complex 
glycans; the extracellular cellulosome encoded by species such as Clostridium 
thermocellum is a powerful example of this (Flint et al., 2012), however few 
examples of such complex extracellular glycan degradation structures have been 
elucidated from human gut microbiota.  
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Some examples of degradation at the peptidoglycan layer have been elucidated 
(Cockburn et al., 2015) but it is unclear how common and versatile these 
mechanisms are.  
 
In contrast Gram negative Bacteroides spp. are highly versatile and able to 
degrade a wide variety of glycans (Martens et al., 2011). The findings of both the 
MetaHIT and HMP metagenomics studies show that within the Gram negative 
Bacteroidetes phylum only the Bacteroides and Prevotella genera are highly 
prevalent; in contrast the Gram positive Firmicutes phylum has a much more 
varied distribution of genera (Arumugam et al., 2011; Huttenhower et al., 2012). 
We speculate that Gram negative species are able to target a wide variety of 
nutrients, whereas Gram positive species are generally specialised to scavenge a 
smaller subset of glycans. 
 
6.5. Developing Novel Fructan Based Prebiotics 
The human microbiota is highly personalised at the species level, this variability 
likely reflects the variability in diet and lifestyle of individuals (Lozupone et al., 
2012). This variability may result in highly divergent and personalised metabolic 
power as the apparatus encoded by different species of the same genus may be 
specialised and diverse (Kaoutari et al., 2013). When known pathogenic species 
are not regarded it becomes clear that genus diversity is lost between healthy 
individuals and those suffering from digestive diseases (Claesson et al., 2012; 
Chatelier et al., 2013; Gevers et al., 2014; Qin et al., 2012). More concerning, 
there appears to be a reduction of diversity in the typical western gut microbiota 
compared to that of non-western individuals, it has been speculated that this loss 
of diversity is due to increasing hygiene standards and sanitisation, processing of 
foods, antibiotic use, C-sections and infant formula (Figure 6.4., Sonnenburg & 
Sonnenburg, 2014). In light of this, it is pertinent to begin to develop personalised 
pre- and pro-biotics, to modulate the microbiota toward host health by 
introduction of relevant microbial metabolic pathways and by increasing the non-
pathogenic diversity of the microbiota. 
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We speculate that currently, probiotic choice is relatively poorly informed as the 
interactions between beneficial species, the existing microbial community and the 
host are poorly understood.  
More work should be undertaken to identify and utilise species which have the 
highest impact on host health, through factors such as short chain fatty acid 
production, effect on local pH and effect on inflammation and the immune system 
such that more informed choices can be made regarding probiotic administration.  
 
Furthermore, work should be undertaken to examine the relationship between 
oligosaccharide producers and oligosaccharide scavengers; if the desired probiotic 
species is supported by other, oligosaccharide producing, species within the gut, 
then these species in turn may become “probiotic” or targets for novel prebiotics. 
Indeed we speculate that the absence of the extracellular oligosaccharide 
producing species may lead to the absence of scavengers, it is possible that 
reintroduction of this producer species could restore scavenger populations and 
the probiotic administering of scavengers alone may not be sufficient. 
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Figure 6.4. Reduction of diversity within the human intestinal microbiota 
(Sonnenburg & Sonnenburg, 2014). A visual representation of  the loss of microbial 
diversity over the past 10,000 years. (A) Proposed timescale and causes for the reduction 
of microbial diversity. Development of new therapies to reintroduce lost species and 
recover microbial diversity is needed. (B) A visual representation of the potential causes 
of microbial diversity loss (Sonnenburg & Sonnenburg, 2014). 
 
 
Probiotics may be vulnerable to acidic conditions in the stomach and viability 
may decrease during storage and processing (Saunders & Marco, 2010). 
Prebiotics are, by definition, able to traverse the early G.I. tract intact, and are 
generally easy to handle and process (Gibson et al., 2004). As more information 
regarding which species target which prebiotics becomes available, it should 
become easier to rationally manipulate the microbiota using a specific mixture of 
prebiotic compounds. 
 
It is worth considering the use of longer chain, insoluble or highly branched 
prebiotics, as these may be more recalcitrant to the microbiota in the early 
digestive tract and may provide nutrition for species towards the large bowel, 
potentially shifting the available niches away from host glycan degradation 
(Koropatkin et al., 2012). 
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As part of this project, we identified the production of DFA-FOS and DFA during 
inulin degradation. DFA has been shown to increase absorption of ions at cell 
junctions in the epithelial layer (Hara et al., 2010; Mineo et al., 2002; Mineo et 
al., 2004) and may enhance host health. If there is indeed a benefit to the host 
from DFA production, then DFA-FOS, which is easily produced from the GH91 
enzyme, maybe be a good candidate for a novel prebiotic compound; the FOS 
component will still act as a prebiotic and the released DFA may have a beneficial 
secondary effect. 
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6.6. Concluding Remarks 
The rapid expansion of our understanding of the human microbiota, both in the 
intestine and at other body sites, has already yielded many new insights into 
health and disease. The field, whilst no longer truly in its infancy, is developing at 
a fast pace and relies on the development and perfection of a suite of novel 
research tools. For this reason, future work must be conducted with the latest 
research tools in mind and must be in line with the current generation of literature. 
 
The main goal of most research into the human microbiota is to probe the 
complex interactions between these organisms and the host in order to understand 
how these are compromised during disease, with the long term goal of restoring 
these microbiota-host interactions during the treatment of disease. Pro- and 
prebiotics have become widely used therapies and prophylactics for the 
maintenance of gut health, however the choice of pro- or prebiotic is often not 
well informed and the interactions involved are not well understood. Future work 
must focus on achieving a deeper understanding of the mechanisms of action of 
these therapies, and the development of more informed, personalised therapeutic 
routes for more effective treatment. 
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Appendix I - Supplemental Data 
 
I.1.  Appendix Overview 
The data contained within this appendix relates to the central results of this thesis 
(contained within Chapters 3-5). These data were not central to the chapter and 
were not included, however are displayed here to provide further insight into the 
results obtained or the interpretations made either as part of the chapter discussion 
sections or as part of the final discussion. Each figure or table is accompanied by a 
reference to the main body of text in which it is discussed, in addition to a short 
description of the data. 
 
I.2. qPCR Raw Data 
Tables I.1., I.2 and I.3 display the raw data obtained during qPCR analysis of 
genes within putative fructan PULs (Chapters 4.5 and 5.4.2). The tables show the 
Cq value for each condition, normalised for cell density using the 16S primers for 
the same condition. The data is analysed as described (Chapter 2.15).  
Table I.1. Up-regulation of SusC-homologues on Inulin and Fructose and Xylan 
Compared to Glucose (Chapter 4.5) 
Probe Set  Substrate Normalised 
Cq Value 
Difference 
(Glucose –
Substrate Cq) 
Fold Change 
(2^Difference) 
Standard 
Error 
Xylan associated 
SusC-homologue 
(bacova_04393) 
Glucose 21.29 0 1 1.46 
Fructose 20.12 -0.38 0.86 0.21 
Inulin 20.11 -0.37 1.10 0.46 
Xylan 10.42 9.32 660.56 127.64 
Xylan associated 
SusC-homologue 
(bacova_04505) 
Glucose 20.00 0 1 0.22 
Fructose 16.62 3.38 27.33 18.35 
Inulin 12.35 7.66 259.92 95.33 
Xylan 18.83 1.16 2.25 0.12 
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Table I.2. The putative B. ovatus fructan locus is upregulated in the presence of 
inulin and fructose (Chapter 4.5) 
  
Probe Set 
(Locus Tag) 
Substrate Normalised 
Cq Value 
Difference 
(Glucose – 
Substrate Cq) 
Fold Change 
(2^Difference) 
Standard 
Error 
 Glucose 18.27 0 1 1.56 
bacova_04496 Fructose 15.79 2.48 5.58 0.49 
 Inulin 13.94 4.33 20.12 0.28 
 Glucose 22.26 0 1 2.12 
bacova_04498 Fructose 17.42 4.84 28.61 0.60 
 Inulin 15.61 6.65 100.46 0.14 
 Glucose 20.68 0 1 2.00 
bacova_04500 Fructose 14.13 6.55 93.76 0.05 
 Inulin 16.10 4.57 23.83 2.71 
 Glucose 20.22 0 1 2.22 
bacova_04501 Fructose 14.26 5.97 62.61 0.04 
 Inulin 13.02 7.20 147.50 0.20 
 Glucose 20.79 0 1 2.29 
bacova_04502 Fructose 15.58 5.21 37.04 0.53 
 Inulin 14.32 6.47 88.54 0.24 
 Glucose 20.67 0 1 2.03 
bacova_04503 Fructose 15.58 5.84 57.41 0.39 
 Inulin 14.32 7.67 203.42 0.31 
 Glucose 20.67 0 1 2.27 
bacova_04504 Fructose 14.83 5.57 47.61 0.47 
 Inulin 13.00 7.35 163.33 0.13 
 Glucose 21.14 0 1 2.62 
bacova_04505 Fructose 15.78 5.36 41.11 0.63 
 Inulin 13.57 7.57 189.96 0.40 
 Glucose 19.33 0 1 1.61 
bacova_04506 Fructose 17.12 2.21 4.64 1.26 
 Inulin 16.75 2.58 6.00 1.60 
 Glucose 19.07 0 1 1.56 
bacova_04507 Fructose 15.02 4.05 16.56 0.04 
 Inulin 13.76 5.31 39.73 0.32 
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Table I.3. The Second Putative Inulin Associated Gene Cluster is Upregulated in the 
Presence of Inulin and FOS (Chapter 5.4.2)  
Probe Set 
(Locus Tag) 
Substrate Normalised 
Cq Value 
Difference (Glucose – 
Substrate Cq) 
Fold Change 
(2^Difference) 
Standard 
Error 
 Glucose 20.07 0 1 2.43 
bad_1148 FOS 17.73 2.34 5.05 0.41 
 Inulin 18.77 1.31 2.47 2.04 
 Glucose 11.75 0 1 0.21 
bad_1149 FOS 14.09 -2.34 0.20 0.21 
 Inulin 14.28 -2.53 0.17 0.34 
 Glucose 13.02 0 1 0.24 
bad_1150 FOS 16.20 -3.17 0.11 0.40 
 Inulin 14.75 -1.72 0.30 0.79 
 Glucose 16.22 0 1 0.46 
bad_1151 FOS 16.29 -0.07 0.95 0.07 
 Inulin 16.84 -0.63 0.65 0.82 
 Glucose 12.85 0 1 0.51 
bad_1152 FOS 11.85 1.00 2.00 1.23 
 Inulin 13.79 -0.95 0.52 0.39 
 Glucose 15.13 0 1 0.19 
bad_1153 FOS 14.55 0.58 1.49 0.10 
 Inulin 14.71 0.43 1.34 0.52 
 Glucose 16.78 0 1 0.89 
bad_1325 FOS 13.31 3.47 11.10 0.15 
 Inulin 12.25 4.54 23.19 0.89 
 Glucose 16.33 0 1 0.6 
bad_1326 FOS 12.31 4.02 16.23 0.07 
 Inulin 12.82 3.51 11.39 0.23 
 Glucose 15.55 0 1 0.37 
bad_1328 FOS 11.85 3.69 12.92 0.45 
 Inulin 12.21 3.34 10.12 0.60 
 Glucose 17.22 0 1 0.26 
bad_1329 FOS 13.21 4.01 16.10 0.57 
 Inulin 13.92 3.30 9.85 0.61 
 Glucose 17.05 0 1 1.12 
bad_1330 FOS 13.25 3.79 13.87 1.19 
 Inulin 12.36 4.69 25.77 1.63 
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I.3.  FPLC Chromatographs 
FPLC Chromatographs were obtained when attempting to investigate the 
interaction between the two GH91 monomers (Chapter 4.6.8). The enlarged 
graphs are shown here for clarity. Both GH91 monomers, BACOVA_04502 and 
BACOVA_04503 eluted in defined peaks, regardless of whether these proteins 
were loaded separately (Figure I.1) or incubated for 10 minutes and loaded 
together (Figure I.2). 
 264 
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Figure I.1. FPLC Chromatograms of the two GH91 Enzymes. The two GH91 proteins 
(A) BACOVA_04502 and (B) BACOVA_04503 elute from the column at 70-80ml, and 
BACOVA_04503 77.5-86ml respectively when applied to the column individually. 
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Figure I.2. FPLC Chromatogram showing the elution of the two GH91 enzymes 
after an incubation period. Each elutes in monomeric state, BACOVA_04502 between 
70-80ml, and BACOVA_04503 between 77.5-86ml, despite pre-incubation of both 
enzymes together prior to application to the column. 
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I.4. Structural Models 
Crystals were harvested, crystallography datasets were collected, the phase 
problem solved and models generated by Dr. Arnaud Baslé. Dr. Arnaud Baslé was 
instrumental during crystallography studies, three structures were obtained as part 
of this thesis, the SusD-homologue, BACOVA_04504 (Chapter 4.7.4) and both 
the open and closed form of the ESBP, BAD_1330 (Chapter 5.7.2). Here we show 
the data statistics (Table I.4.) and refinement details (Table I.5) for each of these 
structures. 
Table I.4. Data statistics 
Data statistics* 
 SusD-homologue 
(BACOVA_04504) 
ESBP – OPEN 
(BAD_1330o) 
ESBP – CLOSED 
(BAD_1330c) 
Beamline I02 I02 I02 
Date 26/01/14 25/01/15 25/01/15 
Wavelength (Å) 0.97949 0.9749 0.9749 
Resolution (Å) 48.89-1.80 (1.83-1.80) 48.47 – 1.35 (1.37 -
1.35) 
48.86 – 1.55 (1.58 -
1.55) 
Space group P21 P22121 P21 
Unit-cell parameters 
a (Å) 97.78 56.39 97.7 
b (Å) 65.72 106.24 108.04 
c (Å) 97.78 118.51 101.85 
α = β = γ (°) 90 90 90  90 90 90 90 113.4 90 
Unit-cell volume (Å3) 628312 709967 986970 
Solvent content (%) 51 57 38 
No. of measured 
reflections             
369373 (17152) 1121421 (37355) 1052069 (51623) 
No. of independent 
reflections             
114809 (5569) 156497 (7600) 280325 (13822) 
Completeness (%) 99.7 (99.6) 100.0 (99.2) 95.3 (94.4) 
Redundancy   3.2 (3.1) 7.2 (4.9) 3.8 (3.7) 
Rmerge (%) 9.3 (53.0) 5.9 (58.1) 7.2 (62.2) 
<I>/<σ(I)> 6.5 (1.6) 13.9 (1.9) 8.1 (1.6) 
*(Values in parenthesis are for the highest resolution shell). 
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Table I.5. Refinement details. 
Refinement statistics*  
 SusD-homologue 
(BACOVA_04504) 
ESBP – OPEN 
(BAD_1330o) 
ESBP – CLOSED 
(BAD_1330c) 
Rwork (%) 16.20 15.03 15.50 
Rfree# (%) 19.43 17.81 20.27 
No. of non-H atoms   
No. of protein, atoms 8587 3949 15791 
No. of solvent atoms 986 428 1442 
No. of ligand atoms 0 0 180 
R.m.s. deviation from ideal values 
Bond angle (°) 1.4 2.53 1.6 
Bond length (Å) 0.012 0.03 0.012 
Average B factor (Å2)    
Protein 21.7 17.0 25.3 
Solvent 25 25.6 34.7 
Ligand N. A. N.A. 20.4 
Ramachandran plot+, 
residues in 
most favoured regions 
(%) 
   
100 100 100 
*(Values in parenthesis are for the highest resolution shell). 
#5% of the randomly selected reflections excluded from refinement. 
+Calculated using MOLPROBITY. 
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I.5. B. adolescentis FOS-Utilisation Cluster 
Putative fructan-associated genes close to the candidate FOS utilising GH32 within 
this cluster in B. adolescentis were investigated. The ESBP and associated permease 
was a candidate for FOS import, however no binding was observed between the 
annotated ESBP, BAD_1152 and fructose, sucrose or kestose (Figure I.3).  
 
 
Figure I.3. No Binding to Fructose, Sucrose or Kestose was observed with 
BAD_1152 ESBP. ITC characterisation was attempted with BAD_1152 ESBP, however 
no binding of this protein to (A) fructose, (B) sucrose or (C) kestose was observed. This 
experiment was repeated with two protein batches and was run with and without calcium 
in case the protein was metal dependent however no binding was detected. 
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I.6. Investigation of Bacteroides spp. 
Several Bacteroides species were available for study during the course of the 
project. As discussed (Chapter 6.3.) these species are likely to adopt various 
divergent niches in the human gut during inulin degradation. Mr. Carl Morland 
demonstrated that B. uniformis does not produce extracellular oligosaccharides 
through whole cell assays incubated on inulin with cells prepared after growth on 
inulin (Figure I.4 A), this is in contrast to B. ovatus (Figure I.4 B) which does 
produce oligosaccharides as described (Chapter 4.3). As discussed (Chapter 
4.12.1, Chapter 6.3.) B. uniformis contains a putative endo-active GH32 family 
enzyme which appears to localise to the cell periplasm, rather than the cell surface 
as in other fructan SUS-like systems, such as B. ovatus inulin PUL and B. 
thetaiotaomicron PUL.  
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Figure I.4. Production of extracellular oligosaccharides by Bacteroides species. This 
experiment was performed by Mr. Carl Morland. B uniformis, B. thetaiotaomicron 8736, 
B. caccae and B. ovatus were grown on inulin and whole cells prepared. Whole cells were 
incubated with inulin for 0 – 5 hours to examine cell surface activity. B. uniformis and B. 
thetaiotaomicron 8736 demonstrate no endo-inulinase activity at the cell surface, 
however B. ovatus and B. caccae whole cell assays show endo-inulinase activity 
characteristic of the heteromeric GH91 (BACOVA_04502/3 in B. ovatus). DFA 
(arrowed) is produced by both B. ovatus and B. caccae. Standards consisting of fructose 
(f), sucrose (suc), kestose (K3), kestotetraose (K4) and kestopentaose (K5) were run for 
comparison. 
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Glucose was used as a control for Bacteroides spp. growth experiments, this is 
because glucose supported the growth of all species tested well and allowed us to 
ensure that cultures were viable. We demonstrate this robust growth on glucose in 
Bacteroides ovatus and Bacteriodes thetaiotaomicron (Figure I.5) as discussed 
(Chapter 3.4) 
Figure I.5. Bacteroides thetaiotaomicron and Bacteroides ovatus are both able to 
utilise glucose. Glucose was used as a control during growth experiments using 
Bacteroides species. Here we show one of these controls conducted in triplicate, this data 
is representative. 
 
As discussed (Chapter 4.12.1, Chapter 6.3) growth experiments were conducted 
with various available Bacteroides species on a number of fructan substrates 
(Figure I.6). Glucose controls are displayed within the figure to demonstrate 
robust growth, and media-only controls are also displayed as some substrates 
result in an increased baseline optical density at 600nm (Figure I.6). 
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Figure I.6. The growth of various Bacteroides species upon Fructans. Each species 
was grown in triplicate on 0.25% inulin (chicory), Levan from E. herbicola (Eh), Levan 
from Z. mobilis (Zm), Glucose, FOS (DP 3-4) or wheat fructan and the data averaged. 
Three datasets were obtained to ensure consistency, this dataset is representative. Each 
dataset was conducted in duplicate.  
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The growth data shows that there was no significant difference between Eh and 
Zm levan with any of the species tested. As shown previously (Sonnenburg et al., 
2010; Chapter 3.4) B. thetaiotaomicron is a levan user and does not use inulin, 
whilst B. ovatus is an inulin user and does not use levan. Wheat fructan is able to 
support the growth of both B. ovatus and B. thetaiotaomicron. FOS was able to 
support the growth of all species except B. thetaiotaomicron, which was not 
supported well. 
 
Of the Bacteroides species used, most display a preference for linkage type where 
polymeric fructans are utilised (B. thetaiotaomicron, B. ovatus, B. intestinalis). 
Only the B. thetaiotaomicron 8763 strain was able to utilise both levan and inulin, 
though a large lag period was seen during growth on both levans tested. B. 
intestinalis appears to grow on all substrates apart from inulin, these data suggest 
a preference for levan, yet with better performance on FOS than B. 
thetaiotaomicron. Sonnenburg and colleagues showed that B. fragilis and B. 
vulgatus used fructose, but both contained GH32 family enzymes, suggesting 
fructans, potentially LMW FOS were degraded (Sonnenburg et al., 2010). Here 
we demonstrate that these species are able to utilise the shorter FOS substrates. 
Furthermore, B. vulgatus appears to be able to use wheat fructan. 
 
B. uniformis did grow on inulin and did not grow on levan, however, this 
phenotype was only seen using 5 ml culture volumes and could not be reproduced 
within the plate reader assays.  
 
We speculate that Bacteroides generally fit into a levan utilisation or inulin 
utilisation niche, potentially due to the sensing of fructose as a proxy for the 
polymer (Bolam & Sonnenburg, 2011). By sensing fructose, and not a component 
of the polysaccharide chain, information regarding linkage type is lost such that 
regulation to either inulin or levan is impossible with this system. It may be 
metabolically expensive to encode extra proteins, including a SusC/D pair, to deal 
with both linkage types simultaneously. It is unclear whether B. thetaiotaomicron 
8763 is able to do this, whilst our data was reproducible this scenario seems 
unlikely and further experiments should be performed to confirm this phenotype. 
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I.7. Bifidobacterium spp. Prefer GH91 products to HMW Inulin 
To demonstrate whether it was likely that B. ovatus “shares” inulin with 
Bifidobacterium spp. GH91 products or inulin were used as the sole carbon source 
during the growth of B. longum and B. adolescentis (Figure 1.7). These data 
demonstrate that both Bifidobacterium species grow more rapidly and to a higher 
final density on GH91 products compared with inulin; indeed B. longum appears 
to only utilise the breakdown products and cannot grow on inulin. 
 
Figure I.7. B. adolescentis and B. longum prefer GH91 breakdown products to inulin 
as a source of carbon and energy. Inulin or GH91 products were used as the sole carbon 
source during growth of B. adolescentis or B. longum. Here we show that GH91 
breakdown products are the preferred energy and carbon source for both species; B. 
adolescentis grows more rapidly and to a higher final OD. B. longum cannot grow on 
inulin, but some growth is supported by the GH91 products. 
 
I.8. Protein Constructs and Primers used in this Study 
The following figure shows example gels from the purification of each protein 
construct described in this thesis (Figure I.8). Key protein constructs are 
described (Table I.6.) and key primer sets listed (Table I.7.). All proteins were 
expressed with a his tag for initial studies, and all example gels show his tagged 
constructs purified using IMAC. For further information on his tag purification 
using IMAC, and on interpreting the gels, please refer to Chapter 2.12.1. 
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Table I.6. Protein constructs used throughout this project 
Protein (Locus 
tag) 
Vector 
(Restriction 
Enzymes) 
Features Primer Set ID Construct 
Size 
(kDa) 
BACOVA_04501 
(GH32) 
pET-28a 
(NheI, XhoI) 
N-Terminal 
His-tag 
04501 66 
BACOVA_04502 
(GH91) 
pET-28a 
(NheI, XhoI) 
N-Terminal 
His-tag 
04502 69 
BACOVA_04502 
NTD (GH91) 
pET-28a 
(NheI, XhoI) 
N-Terminal 
His-tag 
04502_NTD 39 
BACOVA_04502 
CTD (CBM) 
pET-28a 
(NheI, XhoI) 
N-Terminal 
His-tag 
04502_CTD 30 
BACOVA_04503 
(GH91) 
pET-28a 
(NheI, XhoI) 
N-Terminal 
His-tag 
04503 38 
BACOVA_04504 
T3 pET28a 
(SusD-h) 
pET-28a 
(Nhe, XhoI)  
N-Terminal 
His-tag 
04504_pET28a  65  
BACOVA_04504 
T3 pGEX6P1 
pGEX-6P-1 
(BamHI,XhoI) 
N-Terminal 
GST-tag 
04504_pGEX6P1 82 
BACOVA_04507 
(GH32) 
pET-28a 
(NheI, XhoI) 
N-terminal His-
tag 
04507 68 
BAD_1325 
(GH32) 
pET-28a 
(NheI, XhoI) 
N-terminal His-
tag 
1325 70 
BAD_1326_PBP 
(LacI-h PBP) 
pET-28a 
(NcoI, XhoI) 
C-terminal His-
tag 
1326_PBP 32 
BAD_1330 
(ESBP) 
pET-28b 
(NcoI, NdeI) 
C-terminal His-
tag 
1330 57 
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Table I.7. Primers used throughout this project 
Primer Set ID Forward Primer Reverse Primer 
Cloning Primers (5’ – 3’)  
see Table I.6 for construct details 
04501 CTCGCTAGCACTTCTTCCTTA
TTAATAAAAG 
CTCCTCGAGTTATGGCTTCAACTT
ATGAAC 
04502 CTCGCTAGCCCTTCCGAA
GCGCAGGATTTGACA 
CTCCTCGAGCTATTTCTTAGCGCT
TAGATAATG 
04502_NTD CTCGCTAGCCCTTCCGAA
GCGCAGGATTTGACA 
CTCCTCGAGTTTCACCTTTAT
ATTTTCTTCCGTC 
04502_CTD CTCGCTAGCCCTTCCGAAGCG
CAGGATTTGACA 
CTCCTCGAGCTATTTCTTAGCGCT
TAGATAATG 
04503 CTCGCTAGCGATAGTGATGAT
AATCTGTTGTGT 
CTCCTCGAGTTATTCTACTATGCT
CACCTTATC 
04504_T3_pET28 CTCGCTAGCGTTACTTCAGCT
TATGCAGG 
CTCCTCGAGCTAGTTAAACTTAC
CGTATC 
04504_T3_pGEX6P1 CTCGGATCCGTTACTTCAGCT
TATGCAGG 
CTCCTCGAGCTAGTTAAACTTAC
CGTATC 
04507 CTCGCTAGCCACACCACTAA
AAGCAAG 
CTCCTCGAGTTATAAACCCAACC
GATACG 
1325 CTCGCTAGCATGTCGAATACC
TATTCCATC 
CTCCTCGAGTTAGCGCCAAATAC
CGTTCAATG 
1326_PBP CTCCCATGGCCAGCAGGTCG
TATGTCCTCGG 
CTCCTCGAGGGAAACGATCGAAT
CGCGTTC 
1330 CTCCCATGGCGCAGGCCACC
ACAGACGAG 
CTCGCTAGCCTTGGTGTACTTGTC
GTACCAC 
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Table I.7. Primers used throughout this project (continued) 
Primer Set ID Forward Primer(s) Reverse Primer(s) 
Sewing Primers (5’ – 3’)  
used with pExchange (XbaI, BamHI) see Figure 2.3. 
04502_KO Primer 1:            
CTCTCTAGAAATAGTGCT
ATTGCTTCCTTG 
Primer 3:     
CATTATTAATATAGTAACA
CCATCGGTAACATTTTTTT
TATC 
Primer 2: 
GATAAAAAAAATGTTACCGAT
GGTGTTACTATATTAATAATG 
Primer 4: 
CTCGGATCCAATACCATGATC
CAGCGTTTG 
04503_E196Q_KO Primer 1: 
CTCTCTAGACAAGGAAAG
GCATATACTC 
Primer 3: 
GTATAAATTCCTTAAATAT
AAATCCTCCTCAACATACA
CC 
Primer 2: 
GGTGTATGTTGAGGAGGATTT
ATATTTAAGGAATTTATAC 
Primer 4: 
CTCGGATCCAGCCACCTGAA
TGGTGTTCG 
04504 _KO Primer 1: 
CTCTCTAGATGCTTTCTTT
GACAACCGTTTG  
Primer 3: 
TATCCTAAATACAGAACAT
TTATAAATTCCTTAAATAT
AA 
Primer 2: 
TTATATTTAAGGAATTTATAA
ATGTTCTGTATTTAGGATA 
Primer 4: 
CTCGGATCCAGTATAAGCCC
ATTCACATG 
04505 _KO Primer 1: 
CTCTCTAGATTGCAGGTG
GAGACCAAAGAC 
Primer 3: 
CTTTTAATTTAATAACATC
AAACTATTTTTATCCTAAA
TACAGAAC 
Primer 2: 
GTTCTGTATTTAGGATAAAAA
TAGTTTGATGTTATTAAATTA
AAAG 
Primer 4: 
CTCGGATCCGACTGGGTAAG
AAAAATCCG 
04507_D265A _KO Primer 1: 
CTCTCTAGACCGATTTTCT
CCGCTACGCTTC 
Primer 3: 
CTAGGAATACTTTGTTGCC
TAGAAATAGAAGTTACAC
AATAG 
Primer 2: 
CTATTGTGTAACTTCTATTTCT
AGGCAACAAAGTATTCCTAG 
Primer 4: 
CTCGGATCCCTCACGGAGCT
GAACTCTGC 
 
  
 279 
Figure I.8. Visualisation of Protein Constructs used in this Thesis. Included in this 
figure are example IMAC purification of each protein construct characterised in this 
thesis as described (Chapter 2.12.1). Purified target protein is arrowed and the size 
indicated for each example, molecular weight ladders are labelled for reference. For 
further information on IMAC purification and how to interpret these gels, please refer to 
Chapter 2.12.1. 
 280 
Appendix II – Chemicals, Media, Enzymes and Kits 
 
II.1. Chemicals 
Amersham-Boehringer Mannheim 
2’-Deoxyadenosine 5’-triphosphate (dATP) 
2’-Deoxycytidine 5’-triphosphate (dCTP) 
2’-Deoxyguanosine 5’-triphosphate (dGTP) 
2’-Deoxythymidine 5’-triphosphate (dTTP) 
 
BioGene 
 Electrophoresis grade agarose 
 
British Drug Houses (BDH) 
 Acetic Acid (Glacial) 
 Acrylamide solution (40% w/v; Electran) 
 Boric acid 
 Bromophenol blue 
 Citric Acid 
 Calcium Chloride 
 Chloroform 
 Dimethylformamide 
 Ethanol (industrial grade) 
 Hydrochloric acid 
 Isopropanol 
 Magnesium Chloride 
 Magnesium sulphate 
 Methanol  
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 Polyethelene glycol MW 400 (PEG-400) 
Polyethelene glycol MW 550 (PEG-5500) 
 
Polyethelene glycol MW 1000 (PEG-1000) 
Polyethelene glycol MW 20000 (PEG-20000) 
Sodium acetate 
Sodium Chloride 
Sulphuric acid 
 
Fisions 
 46/48% w/v NaOH 
 Sodium acetate trihydrate 
 
James Burrough (F.A.D.) Ltd 
 Ethanol 
 
Megazyme 
 Inulin from chicory 
 Fructan from onion 
 Fructan from wheat 
 Fructan from agave 
 Neosugar (FOS) 
 Raftilose (FOS) 
 Kestose 
 Kestotetraose 
 Kestopentaose 
 Fructotriose 
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Melford Laboratories  
Isopropyl-β-D-thiogalactosidase (IPTG) 
HEPES 
 
G.E. Healthcare 
Agarose (ultrapure) 
 
Sigma-Aldrich 
3,5-Dinitrosalasylic acid (DNSA) 
Ammonium persulphate 
Ampicillin 
Bis tris propane 
Bovine serum albumin, fraction V (BSA) 
Chloramphenicol 
Coomassie brilliant blue G 
D-Glucose 
di-Sodium hydrogen phosphate 
Ethelene diamine tetra-acetic acid, disodium salt (EDTA) 
Ethidium bromide 
Ethylene glycol 
Glycerol 
Imidazole 
Kanamycin 
Levan from E. herbicola 
Levan from Z. mobilis 
N,N,N’,N,-Tetramethylethylene diamine (TEMED) 
Nicotinamide adenine dinucleotide-reduced 
Phenol 
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Polyethylene glycol MW 3350 (PEG-3350) 
Sodium bicarbonate 
Sodium carbonate 
Sodium dihydrogen orthophosphate 
Sodium dodecyl sulphate (SDS) 
Sucrose (nuclease free) 
Trizma base (Tris) 
Β-Mercaptoethanol 
 
II.2.  Media 
Difco 
Bacto®tryptone 
Bacto®yeast extract 
 
Oxoid 
 Bacteriological Agar 
 
Sigma-Aldrich 
LB Broth 
 
II.3.  Enzymes 
MBI Fermentase 
 DNA restriction endonucleases 
 
Invitrogen 
 Bacteriophage T4 DNA ligase 
 
Novagen 
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 KOD HotStart DNA polymerase 
 
Stratagene 
 Dpn1 restriction endonuclease 
  
II.4.  Kits 
Qiagen 
 Plasmid Mini Kit 
 Plasmid Midi Kit 
 Qiaquik Gel Extraction Kit 
 Qiaquik PCR Purification Kit 
 QuantiTect Reverse Transcription Kit 
 RNA Protect/RNeasy RNA Extraction Kit 
 
Sigma-Aldrich 
 GeneEluteTM Bacterial Genomic DNA Kit 
  
Stratagene 
 QuikChangeTM Site-Directed Mutagenesis Kit 
 
Megazyme 
 D-Mannose/D-Fructose/D-Glucose assay Kit  
 
Roche 
 LightCycler® 480 SYBR Green I Master 
 
 
